
<html lang="en"     class="pb-page"  data-request-id="bc9f0f5d-cf48-495f-a862-95b9c8e00cea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-21;article:article:10.1021/acs.jmedchem.6b01315;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas" /></meta><meta name="dc.Creator" content="Rishi G.  Vaswani" /></meta><meta name="dc.Creator" content="Victor S.  Gehling" /></meta><meta name="dc.Creator" content="Les A.  Dakin" /></meta><meta name="dc.Creator" content="Andrew S.  Cook" /></meta><meta name="dc.Creator" content="Christopher G.  Nasveschuk" /></meta><meta name="dc.Creator" content="Martin  Duplessis" /></meta><meta name="dc.Creator" content="Priyadarshini  Iyer" /></meta><meta name="dc.Creator" content="Srividya  Balasubramanian" /></meta><meta name="dc.Creator" content="Feng  Zhao" /></meta><meta name="dc.Creator" content="Andrew C.  Good" /></meta><meta name="dc.Creator" content="Robert  Campbell" /></meta><meta name="dc.Creator" content="Christina  Lee" /></meta><meta name="dc.Creator" content="Nico  Cantone" /></meta><meta name="dc.Creator" content="Richard T.  Cummings" /></meta><meta name="dc.Creator" content="Emmanuel  Normant" /></meta><meta name="dc.Creator" content="Steven F.  Bellon" /></meta><meta name="dc.Creator" content="Brian K.  Albrecht" /></meta><meta name="dc.Creator" content="Jean-Christophe  Harmange" /></meta><meta name="dc.Creator" content="Patrick  Trojer" /></meta><meta name="dc.Creator" content="James E.  Audia" /></meta><meta name="dc.Creator" content="Ying  Zhang" /></meta><meta name="dc.Creator" content="Neil  Justin" /></meta><meta name="dc.Creator" content="Shuyang  Chen" /></meta><meta name="dc.Creator" content="Jon R.  Wilson" /></meta><meta name="dc.Creator" content="Steven J.  Gamblin" /></meta><meta name="dc.Description" content="Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3. Dysregulation of PRC2 functi..." /></meta><meta name="Description" content="Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3. Dysregulation of PRC2 functi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 28, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01315" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01315" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01315" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01315" /></link>
        
    
    

<title>Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01315" /></meta><meta property="og:title" content="Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0011.jpeg" /></meta><meta property="og:description" content="Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3. Dysregulation of PRC2 function correlates with certain malignancies and poor prognosis. EZH2 is the catalytic engine of the PRC2 complex and thus represents a key candidate oncology target for pharmacological intervention. Here we report the optimization of our indole-based EZH2 inhibitor series that led to the identification of CPI-1205, a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2. This compound demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clinical trials. Additionally, we disclose the co-crystal structure of our inhibitor series bound to the human PRC2 complex." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01315"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01315">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01315&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01315&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01315&amp;href=/doi/10.1021/acs.jmedchem.6b01315" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9928-9941</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01258" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01385" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rishi+G.++Vaswani">Rishi G. Vaswani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>δ</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victor+S.++Gehling">Victor S. Gehling</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Les+A.++Dakin">Les A. Dakin</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+S.++Cook">Andrew S. Cook</a></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+G.++Nasveschuk">Christopher G. Nasveschuk</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Duplessis">Martin Duplessis</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Priyadarshini++Iyer">Priyadarshini Iyer</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srividya++Balasubramanian">Srividya Balasubramanian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Zhao">Feng Zhao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Good">Andrew C. Good</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Campbell">Robert Campbell</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Lee">Christina Lee</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Cantone">Nico Cantone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+T.++Cummings">Richard T. Cummings</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emmanuel++Normant">Emmanuel Normant</a></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+F.++Bellon">Steven F. Bellon</a></span><span class="author-xref-symbol "><sup>∂</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+K.++Albrecht">Brian K. Albrecht</a></span><span class="author-xref-symbol "><sup>⧫</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Harmange">Jean-Christophe Harmange</a></span><span class="author-xref-symbol "><sup>⧫</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Trojer">Patrick Trojer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+E.++Audia">James E. Audia</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Zhang">Ying Zhang</a></span><span class="author-xref-symbol "><sup>≠</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neil++Justin">Neil Justin</a></span><span class="author-xref-symbol "><sup>≠</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuyang++Chen">Shuyang Chen</a></span><span class="author-xref-symbol "><sup>≠</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+R.++Wilson">Jon R. Wilson</a></span><span class="author-xref-symbol "><sup>≠</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+J.++Gamblin">Steven J. Gamblin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>≠</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>(R.G.V.) Email: <a href="/cdn-cgi/l/email-protection#45372c362d2c6b226b33243632242b2c052228242c296b262a28"><span class="__cf_email__" data-cfemail="acdec5dfc4c582cb82dacddfdbcdc2c5eccbc1cdc5c082cfc3c1">[email protected]</span></a>. Phone: (617) 844-8220.</div><div class="corresp-info"><strong>*</strong>(V.G.) Email: <a href="/cdn-cgi/l/email-protection#95e3fcf6e1fae7bbf2f0fdf9fcfbf2d5f6fafbe6e1f0f9f9f4e1fcfafbe5fdf4e7f8f4bbf6faf8"><span class="__cf_email__" data-cfemail="d1a7b8b2a5bea3ffb6b4b9bdb8bfb691b2bebfa2a5b4bdbdb0a5b8bebfa1b9b0a3bcb0ffb2bebc">[email protected]</span></a>. Phone: (617)-714-0540.</div><div class="corresp-info"><strong>*</strong>(J.E.A.) E-mail: <a href="/cdn-cgi/l/email-protection#94fefdf9baf5e1f0fdf5d4f7fbfae7e0f1f8f8f5e0fdfbfae4fcf5e6f9f5baf7fbf9"><span class="__cf_email__" data-cfemail="33595a5e1d5246575a5273505c5d4047565f5f52475a5c5d435b52415e521d505c5e">[email protected]</span></a>. Phone: (617)-714-0555.</div><div class="corresp-info"><strong>*</strong>(S.G.) Email: <a href="/cdn-cgi/l/email-protection#e19295849784cf86808c838d888fa1829388828acf8082cf948a"><span class="__cf_email__" data-cfemail="ec9f98899a89c28b8d818e808582ac8f9e858f87c28d8fc29987">[email protected]</span></a>. Phone: +44 (0)20 3796 1081.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01315&amp;href=/doi/10.1021%2Facs.jmedchem.6b01315" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9928–9941</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 14, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2016</li><li><span class="item_label"><b>Published</b> online</span>28 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01315" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01315</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01315"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5666</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">101</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01315" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rishi&quot;,&quot;last_name&quot;:&quot;G. Vaswani&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;S. Gehling&quot;},{&quot;first_name&quot;:&quot;Les&quot;,&quot;last_name&quot;:&quot;A. Dakin&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;S. Cook&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;G. Nasveschuk&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Duplessis&quot;},{&quot;first_name&quot;:&quot;Priyadarshini&quot;,&quot;last_name&quot;:&quot;Iyer&quot;},{&quot;first_name&quot;:&quot;Srividya&quot;,&quot;last_name&quot;:&quot;Balasubramanian&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Good&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Campbell&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Cantone&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;T. Cummings&quot;},{&quot;first_name&quot;:&quot;Emmanuel&quot;,&quot;last_name&quot;:&quot;Normant&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;F. Bellon&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;K. Albrecht&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Harmange&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Trojer&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;E. Audia&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Neil&quot;,&quot;last_name&quot;:&quot;Justin&quot;},{&quot;first_name&quot;:&quot;Shuyang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;R. Wilson&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;J. Gamblin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9928-9941&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01315&quot;},&quot;abstract&quot;:&quot;Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3. Dysregulation of PRC2 function correlates with certain malignancies and poor prognosis. EZH2 is the catalytic engine of the PRC2 complex and thus represents a key candidate oncology target for pharmacological intervention. Here we report the optimization of our indole-based EZH2 inhibitor series that led to the identification of CPI-1205, a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2. This compound demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clinical trials. Additionally, we disclose the co-crystal structure of our inhibitor series bound to the human PRC2 complex.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01315&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01315" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01315&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01315" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01315&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01315" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01315&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01315&amp;href=/doi/10.1021/acs.jmedchem.6b01315" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01315" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01315" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01315%26sid%3Dliteratum%253Aachs%26pmid%3D27739677%26genre%3Darticle%26aulast%3DVaswani%26date%3D2016%26atitle%3DIdentification%2Bof%2B%2528R%2529-N-%2528%25284-Methoxy-6-methyl-2-oxo-1%252C2-dihydropyridin-3-yl%2529methyl%2529-2-methyl-1-%25281-%25281-%25282%252C2%252C2-trifluoroethyl%2529piperidin-4-yl%2529ethyl%2529-1H-indole-3-carboxamide%2B%2528CPI-1205%2529%252C%2Ba%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2BHistone%2BMethyltransferase%2BEZH2%252C%2BSuitable%2Bfor%2BPhase%2BI%2BClinical%2BTrials%2Bfor%2BB-Cell%2BLymphomas%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D21%26spage%3D9928%26epage%3D9941%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292593" title="Liquid chromatography-mass spectrometry">Liquid chromatography-mass spectrometry</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/jmcmar.2016.59.issue-21/20161110/jmcmar.2016.59.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3. Dysregulation of PRC2 function correlates with certain malignancies and poor prognosis. EZH2 is the catalytic engine of the PRC2 complex and thus represents a key candidate oncology target for pharmacological intervention. Here we report the optimization of our indole-based EZH2 inhibitor series that led to the identification of CPI-1205, a highly potent (biochemical IC<sub>50</sub> = 0.002 μM, cellular EC<sub>50</sub> = 0.032 μM) and selective inhibitor of EZH2. This compound demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clinical trials. Additionally, we disclose the co-crystal structure of our inhibitor series bound to the human PRC2 complex.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is well-established that trimethylation of lysine 27 on histone 3 (H3K27) contributes to the modification of chromatin structure, which serves to repress transcription.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> The addition of trimethyl “marks” on H3K27 is generally catalyzed by the multimeric protein complex polycomb repressive complex 2 (PRC2), through its enzymatic subunit enhancer of zeste homologue 2 (EZH2). EZH2 catalyzes the transfer of a methyl group from the cofactor S-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine (SAM) to the ε-NH<sub>2</sub> group of H3K27 culminating in trimethylation of H3K27 (H3K27me3) and subsequent silencing of targeted genes.</div><div class="NLM_p">Dysregulation of mechanisms that alter chromatin structure has been implicated in a variety of disease processes, particularly oncogenesis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> EZH2 is frequently overexpressed in a broad spectrum of solid and hematological cancers such as prostate, breast, kidney, lung, myeloma, and lymphoma.<a onclick="showRef(event, 'ref2 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref4">(2, 4)</a> Elevated EZH2 transcript and protein levels in these cancers usually correlate with greater levels of H3K27me3, advanced stages of disease, and poor prognosis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Additionally, somatic recurrent mutations within the catalytic domain of EZH2 (the <u class="uu">s</u>uppressor of variegation, <u class="uu">e</u>nhancer of zeste, <u class="uu">t</u>rithorax (SET) domain) have been identified in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and melanoma.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These mutations alter the substrate specificity of EZH2 culminating in an increase in global levels of H3K27me3.<a onclick="showRef(event, 'ref4 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref4 ref8 ref9 ref10">(4, 8-10)</a> Consequently, the increase in levels of H3K27me3, either by overexpression of EZH2 or its altered function through mutations, in cancer tissues may reinforce the silencing of target genes that promote differentiation and restrain proliferation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Alternatively, EZH2 may serve to silence genes not targeted in normal cells to afford growth and survival advantage in the malignant setting. Collectively, these observations offer a compelling argument for the inhibition of EZH2 as a potential therapeutic approach for the treatment of cancer.</div><div class="NLM_p">The development of small molecule inhibitors of EZH2 has been an intense area of research. Several potent EZH2 inhibitors demonstrating promising antitumor activity in preclinical species have been disclosed. These EZH2 inhibitors include EPZ-005687,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> EPZ-6438,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> EPZ-011989,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> GSK-343,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> GSK-126,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> UNC-1999,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> EI1,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and our previously disclosed probes CPI-360<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and <b>1</b> (CPI-169).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Although these inhibitors originated from independent high-throughput screening efforts, they all share a common structural feature, a pyridone core. The prevalence of a pyridone motif embedded within these inhibitors highlights the importance of this functionality for high-affinity binding. While a novel series of 4-amino-2,2′,6,6′-tetramethylpiperidine analogues has also been identified as SAM-competitive inhibitors of EZH2, these analogues demonstrated inferior cellular potency when compared to the pyridone-based inhibitors.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Currently, Phase I clinical trials of three different pyridone-based EZH2 inhibitors tazemetostat (EPZ-6438) (NCT01897571, NCT02601937, NCT02601950), GSK-126 (NCT02082977), and <b>13</b> (CPI-1205) (NCT02395601) have been reported (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported EZH2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Medicinal Chemistry and Structure–Activity Relationships</h3><div class="NLM_p">We recently disclosed <b>1</b>, a potent indole based EZH2 inhibitor that showed robust antitumor activity and pharmacodynamic (PD) target engagement in a KARPAS-422 lymphoma xenograft model in mice.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This compound, however, suffered from limited oral bioavailability (0.09% F and 0.12% F observed in rats and dogs, respectively).) As part of our ongoing drug discovery and development efforts, we continued to optimize the indole-based scaffold toward clinical candidate selection. Herein we report the optimization of the indole based EZH2 inhibitor series that led to the identification of <b>13</b>, a potent and selective inhibitor of EZH2 currently under evaluation in Phase I clinical trials. In addition, we report the co-crystal structure of a similar pyridone containing inhibitor (<b>10</b>) bound to human PRC2. This structure has provided a context for the molecular nature of the interaction between our chemical series and its target.</div><div class="NLM_p">In an attempt to improve upon the physical properties of <b>1</b>, we began the investigation of our structure–activity relationship (SAR) with different N-substituents on the piperidine ring. We rationalized that the pyridone-indole core was previously optimized with respect to biochemical potencies (against both wild-type and mutant EZH2) as evidenced by N–H piperidine (<b>2</b>) and N–Me piperidine (<b>3</b>) analogues (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Unfortunately both <b>2</b> and <b>3</b> suffered from considerable loss in cellular potency in the HeLa H3K27me3 mechanism of action (MOA) assay. Derivatization of the N–H piperidine to a variety of amides, ureas, carbamates, and sulfonamides yielded biochemically potent analogues. However, these analogues displayed less than ideal cellular potencies when examined in the MOA assay. For example, substitution of the piperidine N-atom to give the corresponding isobutyl amide (<b>4</b>), isopropyl carbamate (<b>5</b>), and N–Me–urea (<b>6</b>) afforded approximately 5-, 2-, and 11-fold loss in cellular potencies relative to <b>1</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Piperidine Structure–Activity Relationships</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0001.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0002.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Biochemical data generated via scintillation proximity assay (SPA) with PRC2, H3K27me3 activator peptide and biotinylated oligonucleosomes and <sup>3</sup>[H]-SAM. IC<sub>50</sub> values reported as an average ≥2 determinations.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">The mechanism of action cellular assay measured global H3K27me3 levels in HeLa cells; see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">Supporting Information</a> for further details.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">p<i>K</i><sub>a</sub> values generated via ChemDraw version 15.0</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> value from a single determination.</p></div></div><div></div></div><div class="NLM_p">In addition to the disparate trends in potencies (i.e., poor translation into cellular assays), N-acylated derivatives (e.g., amides, ureas, carbamates, and sulfonamides) generally suffered from high microsomal clearance or rapid clearance <i>in vivo</i> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In contrast, a variety of basic amines derived from piperidine <b>2</b> showed acceptable ADME properties (low Cl<sub>int</sub> and low CYP inhibition). As such, we subsequently sought to improve the physiochemical properties of piperdine <b>2</b> to attain the desired <i>in vitro</i> and <i>in vivo</i> potencies.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General trends in structure–activity relationships.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We found that attenuation of the basicity and hence perturbation of the piperidine p<i>K</i><sub>a</sub> had profound effects on the cellular potency, selectivity, toxicity, bioavailability, and PK properties.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For example, oxetane <b>7</b> (ChemDraw calculated p<i>K</i><sub>a</sub> was 7.6) demonstrated a 10-fold improvement in the cellular potency when compared to piperidine <b>2</b> (ChemDraw calculated p<i>K</i><sub>a</sub> was 9.7).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Other electron-withdrawing substituents, such as acetate <b>8</b> also afforded improvement in cellular potencies.</div><div class="NLM_p last">We synthesized <i>n</i>-trifluoropropyl piperidine analogue <b>9</b> (calculated p<i>K</i><sub>a</sub> ∼ 8.2) and observed an over 3-fold increase in potency (EC<sub>50</sub> of 0.29 μM) relative to piperidine <b>2</b> when tested in the cellular MOA assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). While introduction of the <i>n</i>-trifluoropropyl motif was a step in the right direction, we believed that cellular potency could be further enhanced. To examine the effect of keeping the three-carbon linker fixed, and moving the fluorine atoms to the 2-position of the alkyl chain, we subsequently synthesized the 2,2-difluoropropyl containing analogue (<b>10</b>). The p<i>K</i><sub>a</sub> was calculated to decrease by half a log unit relative to analogue <b>9</b> (Chemdraw calculated p<i>K</i><sub>a</sub> 7.6 versus 8.2, respectively), but gratifyingly, even this modest decrease in basicity resulted in a 10-fold gain in cellular potency (EC<sub>50</sub> of 0.020 μM) over the linear <i>n</i>-trifluoropropyl analogue. The addition of fluorine atoms in the β-carbon (with respect to the piperidine nitrogen) appeared optimal for attenuation of basicity of the piperidine and increase in cellular potency. As such, a series of analogues that embedded the β,β-difluoroethyl motif were synthesized and further examined. The tetrafluoropropyl (<b>11</b>), difluoroethyl (<b>12</b>), and trifluoroethyl (<b>13</b>) piperidines were prepared, and these fluorinated analogues were comparable in potency (EC<sub>50</sub> of 0.038, 0.039, and 0.032 μM, respectively) to <b>10</b>.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Co-crystal of Ligand Bound to PRC2 Complex</h3><div class="NLM_p">In order to understand the mechanism of action within this lead series, we were able to exploit the crystallization system developed for our recent structure of the human PRC2 catalytic complex.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Co-crystals were obtained with the 2,2-difluoropropyl analogue (<b>10</b>) that diffracted to 3.5 Å and the structure determined by molecular replacement (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>). Electron density corresponding to compound <b>10</b> was identified in a pocket at the interface of the EZH2 SET domain, the SAL region of the EZH2 N-terminus and EED (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). The electron density was improved by 4-fold averaging, so that even at 3.5 Å it is remarkably well-defined and the position and orientation of the inhibitor could be unambiguously determined (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Surface representation of the co-crystal structure of <b>10</b> (yellow spheres) bound to the PRC2 complex (EED (gray), SUZ12 (pink), EZH2 (pale blue at N-terminus to blue at C-terminus) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>). (B) Electron density (NCS averaged Fourier Map (2Fo-Fc map contoured at 2σ)) surrounding compound <b>10</b>. Main interactions are between pyridone of <b>10</b> and key residues from the SET-I and SAL domains of EZH2 and from EED (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>). (C) The PRC2-compound <b>10</b> complex (colored as above) superimposed on the PRC2 complex with SAH cofactor and peptide (green). (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). (D) The pyridone and indole are constrained in a binding site composed of residues from both the SET domain (blue) and SAL region (pale blue) of EZH2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Key residues that define the inhibitor pocket include EZH2 SET domain Tyr661, Phe665, Tyr658, and Phe686, the EZH2 SAL region Tyr111 and Met110, and EED residues His213 and Asp237.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Although the inhibitor binding site partially overlaps with the pocket for SAH (superimposed from PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>), it then extends in the opposite direction and is therefore distinct from both the substrate and cofactor binding sites (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). The partial overlap between the 2,2-difluoropropyl piperidine <b>10</b> and the SAH carboxylic acid is consistent with a SAM competitive mechanism of inhibition.</div><div class="NLM_p">Overall, <b>10</b> adopts a zigzag like shape, which is defined by both the constraints of the pocket, as well as the preorganized conformation induced by the chiral methyl proximal to the indole and the torsional angle defined by the C3-indole amide connecting to the pyridone. The indole and piperidine are tightly constrained by the narrow hydrophobic channel and by a putative hydrogen bond from the EED Asp237 side-chain to one of the fluorine atoms. Beyond the piperidine, the pocket widens considerably, which is consistent with the diverse array of substituents tolerated in this region (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). At the opposite end of the molecule the pyridone is surrounded by the side chains of Phe665, Phe686, and Trp624 and has the potential to form two hydrogen bonds with the protein backbone of Trp624 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>D). Recently, a co-crystal structure of a human/chameleon hybrid PRC2 construct was reported that also contained a pyridone-based EZH2 inhibitor (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7">5IJ7</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ8">5IJ8</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Both pyridone orientation and binding is consistent between the two structures.</div><div class="NLM_p">A major difference between the inhibitor complex structure and that obtained with peptide/SAH occurs at the active site of the EZH2 SET domain (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). In the absence of substrate peptide, the C-terminus of the SET domain occupies the histone binding groove with the side chains of Tyr728 and Phe667 located to the target lysine channel. In the inhibitor complex beyond residue Ser729, the C-terminus is disordered. Similarly, in the structure of the isolated apo EZH2, there is a pronounced rearrangement of this region.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The alternate conformation of the EZH2 C-terminus observed in these structures are indicative of its inherent flexibility. It is not clear to what extent the conformation observed in the inhibitor complex structure is due to the binding of inhibitor or reflects the absence of cofactor and/or histone substrate.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the EZH2 C-terminus with the SET domain active site. (A) Human PRC2 complex with compound <b>10</b>. (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>) (B) Equivalent region of the human PRC2-H3K27M-SAH complex, (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>) with cofactor (orange) and histone H3 peptide (red). (C) Overlay of residues forming the SET domain lysine channel for both complexes, highlighting that the position of the C-terminus conformation observed in the compound complex is incompatible with substrate binding (red). (D) and (E) Surface representations showing that the lysine binding channel is closed in the PRC2-compound <b>10</b> complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>) but accessible in the SAH/substrate complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). (F) Surface representation of EZH2 observed in the PRC2-compound <b>10</b> complex but with the H3 peptide overlaid from the PRC2-H3K27M-SAH complex, confirming that substrate binding is incompatible with the EZH2 conformation in the PRC2-compound <b>10</b> complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <i>In Vitro</i> ADME and <i>In Vivo</i> Pharmacokinetics of Fluorinated Analogues</h3><div class="NLM_p">Having established sufficient activity in the MOA assay, we subsequently profiled <b>9</b>, <b>10</b>, <b>12</b>, and <b>13</b> in an ADME panel (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Relative to <b>1</b>, these fluorinated analogues generally displayed higher plasma protein binding and <i>in vitro</i> clearance, which is presumably a function of their increased lipophilicity (cLogP). Interestingly, there were significant interspecies differences observed with regards to the <i>in vitro</i> microsomal clearances and PPB. The highest <i>in vitro</i> microsomal clearance (>100 μL/min/mg protein) and plasma protein binding (>97% bound) were uniformly observed in mice for <b>10</b>, <b>12</b>, and <b>13</b>. Additionally, the <i>in vitro</i> clearance measured from rat-derived microsomes closely mirrored those derived from humans for these analogues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. ADME of Fluorinated Analogues <b>9</b>, <b>10</b>, <b>12</b>, and <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center"><b>12</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">cLogP<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">3.39</td><td class="colsep0 rowsep0" align="center">3.71</td><td class="colsep0 rowsep0" align="center">3.19</td><td class="colsep0 rowsep0" align="center">3.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center" valign="bottom">LiPE<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" valign="bottom">3.1</td><td class="colsep0 rowsep0" align="center" valign="bottom">4.0</td><td class="colsep0 rowsep0" align="center" valign="bottom">4.2</td><td class="colsep0 rowsep0" align="center" valign="bottom">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="13" align="center"><i>in vitro</i> ADME</td><td class="colsep0 rowsep0" rowspan="4" align="center">Cl<sub>int</sub> (μL/min/mg protein)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">mouse</td><td class="colsep0 rowsep0" align="center">61.3</td><td class="colsep0 rowsep0" align="center">193</td><td class="colsep0 rowsep0" align="center">131</td><td class="colsep0 rowsep0" align="center">159</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">rat</td><td class="colsep0 rowsep0" align="center">25.7</td><td class="colsep0 rowsep0" align="center">86.1</td><td class="colsep0 rowsep0" align="center">71.3</td><td class="colsep0 rowsep0" align="center">99.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">dog</td><td class="colsep0 rowsep0" align="center">35.3</td><td class="colsep0 rowsep0" align="center">68.9</td><td class="colsep0 rowsep0" align="center">52.4</td><td class="colsep0 rowsep0" align="center">73.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">human</td><td class="colsep0 rowsep0" align="center">35.4</td><td class="colsep0 rowsep0" align="center">83.8</td><td class="colsep0 rowsep0" align="center">73.6</td><td class="colsep0 rowsep0" align="center">104</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="center">PPB (% bound)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">mouse</td><td class="colsep0 rowsep0" align="center">99.7</td><td class="colsep0 rowsep0" align="center">99.4</td><td class="colsep0 rowsep0" align="center">97.8</td><td class="colsep0 rowsep0" align="center">97.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">rat</td><td class="colsep0 rowsep0" align="center">97.4</td><td class="colsep0 rowsep0" align="center">92.4</td><td class="colsep0 rowsep0" align="center">83.1</td><td class="colsep0 rowsep0" align="center">89.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">dog</td><td class="colsep0 rowsep0" align="center">96.3</td><td class="colsep0 rowsep0" align="center">93.6</td><td class="colsep0 rowsep0" align="center">64.3</td><td class="colsep0 rowsep0" align="center">90.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">human</td><td class="colsep0 rowsep0" align="center">95.9</td><td class="colsep0 rowsep0" align="center">94.7</td><td class="colsep0 rowsep0" align="center">83.3</td><td class="colsep0 rowsep0" align="center">92.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="center">CYP inh. (% at 10 μM)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">3A4</td><td class="colsep0 rowsep0" align="center">5.0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">25.2</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">2D6</td><td class="colsep0 rowsep0" align="center">17.2</td><td class="colsep0 rowsep0" align="center">7.7</td><td class="colsep0 rowsep0" align="center">26.1</td><td class="colsep0 rowsep0" align="center">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">2C8</td><td class="colsep0 rowsep0" align="center">23.1</td><td class="colsep0 rowsep0" align="center">50.9</td><td class="colsep0 rowsep0" align="center">18.9</td><td class="colsep0 rowsep0" align="center">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">1A2</td><td class="colsep0 rowsep0" align="center">19.4</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">28.6</td><td class="colsep0 rowsep0" align="center">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">2C9</td><td class="colsep0 rowsep0" align="center">11.6</td><td class="colsep0 rowsep0" align="center">5.0</td><td class="colsep0 rowsep0" align="center">25.4</td><td class="colsep0 rowsep0" align="center">11.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">ClogP values were generated with ChemDraw Professional 15.0.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">LiPE = lipophilic efficiency = pEC<sub>50</sub> – cLogP (ChemDraw 15.0).</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Intrinsic clearance (Cl<sub>int</sub>) of compounds in mouse/rat/dog/human liver microsomes (expressed in μL/min/mg protein).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Measured <i>in vitro</i> binding of compounds to mouse/rat/dog/human plasma protein bindings (expressed in % bound).</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last"><i>In vitro</i> inhibition of cytochrome P450 isoforms at single concentration (10 μM).</p></div></div></div><div class="NLM_p">Based on their combination of potency and <i>in vitro</i> profile <b>12</b> and <b>13</b> were subsequently evaluated for their <i>in vivo</i> metabolic profile and systemic exposure in mice in advance of planned pharmacodynamic (PD) and efficacy studies (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Both <b>12</b> and <b>13</b> showed excellent oral bioavailability demonstrating significant improvement over <b>1</b>. Surprisingly, <b>12</b> displayed a poor overall PK profile when compared to <b>13</b>. When dosed in mice at 1 mg/kg <i>intravenous</i> (iv) and 100 mg/kg <i>per os</i> (po), <b>12</b> displayed high clearance of 4.45 L/h/kg (82% liver blood flow), low volume of distribution (1.10 L/kg), short half-life (0.40 h), and excellent bioavailability (∼92% F). In contrast, <b>13</b> exhibited moderate clearance of 2.16 L/h/kg (40% liver blood flow), a half-life of ∼1.6 h, similar volume of distribution (1.4 L/kg), and excellent bioavailability (100% F). As part of the comparison, we also examined total exposure (AUC) and unbound exposure (AUC<sub>unbound</sub>) because we were interested in maintaining free levels of compound significantly above the measured HeLa EC<sub>50</sub>. Both <b>12</b> and <b>13</b> achieved unbound exposures well above their respective cellular potencies; however, only the unbound exposure for <b>13</b> remained well above the cellular EC<sub>50</sub> up to 4 h (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Overall, the <i>in vivo</i> metabolic profile of <b>13</b> provided a compelling argument for further evaluation in a mouse xenograft model.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Mouse Pharmacokinetic Profiles for Fluorinated Analogues <b>12</b> and <b>13</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">iv</th><th class="rowsep1 colsep0" colspan="4" align="center">po</th><th class="rowsep1 colsep0" align="center"><i>in vitro</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">CL [CL<sub>unbound</sub>]<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (L/h/kg)</th><th class="colsep0 rowsep0" align="center">%<i>Q</i><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub><a class="ref internalNav" href="#t3fn7" aria-label="g">g</a> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-inf</sub> [AUC<sub>unbound</sub>]<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a> (μM·h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t3fn9" aria-label="i">i</a> [C<sub>max-unbound</sub>] (μM)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub><a class="ref internalNav" href="#t3fn10" aria-label="j">j</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i><a class="ref internalNav" href="#t3fn11" aria-label="k">k</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u</sub><a class="ref internalNav" href="#t3fn12" aria-label="l">l</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">12<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">4.45 [202.3]</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">0.402</td><td class="colsep0 rowsep0" align="center">1.10</td><td class="colsep0 rowsep0" align="center">42.01 [0.924]</td><td class="colsep0 rowsep0" align="center">52.14 [1.15]</td><td class="colsep0 rowsep0" align="center">0.250</td><td class="colsep0 rowsep0" align="center">91.6</td><td class="colsep0 rowsep0" align="center">0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">13<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">2.16 [102.9]</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">1.63</td><td class="colsep0 rowsep0" align="center">1.36</td><td class="colsep0 rowsep0" align="center">88.88 [1.87]</td><td class="colsep0 rowsep0" align="center">67.36 [1.41]</td><td class="colsep0 rowsep0" align="center">-</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">0.021</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Based on an <i>intravenous</i> (iv) dose of 1 mg/kg and a <i>per os</i> (po) dose of 100 mg/kg in fasted male Balb/C mice (except where indicated).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Compound was formulated in 5:25:70 DMA/PEG400/20% SBECD for iv dosing and in 0.5% methyl cellulose (adjusted to pH 3) for po dosing.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Compound was formulated in 5:60:35 DMA/PEG400/20% SBECD for iv dosing and in 0.5% methyl cellulose (adjusted to pH 3–4) for po dosing.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">CL = total clearance. CL<sub>unbound</sub> = CL/free fraction.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last"><i>Q</i> = percent of liver blood flow, based on 5.4 L/h/kg (mouse).</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Plasma half-life.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last"><i>V</i><sub>ss</sub> = volume of distribution at steady state.</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">Extrapolated total exposure following single dose. Calculated unbound exposure is in parentheses.</p></div><div class="footnote" id="t3fn9"><sup>i</sup><p class="last">Maximum plasma concentration achieved.</p></div><div class="footnote" id="t3fn10"><sup>j</sup><p class="last">Time at which maximum plasma concentration was achieved.</p></div><div class="footnote" id="t3fn11"><sup>k</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t3fn12"><sup>l</sup><p class="last"><i>f</i><sub>u</sub> = fraction unbound to plasma protein.</p></div></div></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mouse pharmacokinetic profile of <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of Indole Piperidine Analogues</h3><div class="NLM_p">Many of the analogues profiled in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were prepared by similar synthetic routes, with appropriately substituted building blocks. We identified indole <b>14</b> as a key scaffold for the construction of N-substituted piperidines. Synthetically, the alkylation of 2-methyl-1<i>H</i>-indole-3-carboxylate with branched alkyl electrophiles under a variety of basic conditions failed to deliver desired indole <b>14</b>. The lackluster behavior of 2-methyl-1<i>H</i>-indole-3-carboxylate toward various alkylation conditions was presumably a consequence of deactivation of the indole N-atom by the 3-carboxylate moiety and additional steric constraints imposed by the 2-methyl substitution. As such, we looked to devise an alternative strategy toward a more convergent, robust, and scalable synthesis of indole <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Palladium Mediated Intramolecular C–N Arylation to Indole <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, <i>t-</i>BuOH, reflux (76% yield); (b) RuPhos precatalyst (generation III) (2 mol %), RuPhos (3 mol %), NaOMe (1.5 equiv), 1,4-dioxane, 100 °C, followed by HCl (4 M in 1,4-dioxane) (81% yield over two steps).</p></p></figure><div class="NLM_p">We were drawn to the possibility of utilizing halo-aryl enamines as latent precursors for a palladium-mediated intramolecular C–N bond construction of indoles.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We rationalized that generation of enamines from β-keto esters would allow for the introduction of a variety of amines, and this modular approach would serve as a diversity generating element for our drug discovery efforts. To that end, the construction of indole <b>14</b>, began with the condensation reaction between β-keto ester<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>15</b> and chiral amine<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a><b>16</b> under mildly acidic conditions to deliver enamine <b>17</b>, predominantly as the <i>Z</i>-isomer, in 76% yield. Paramount to the success of this intramolecular C–N arylation was a systemic investigation of palladium catalysts and reactions conditions.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We were gratified to find that treatment of chiral enamine <b>17</b> with Buchwald’s RuPhos precatalyst system in the presence of sodium methoxide cleanly induced intramolecular C–N bond arylation to yield chiral indole piperidine <b>18</b> while maintaining the stereochemical integrity of the chiral center. Subsequent deprotection of <i>N</i>-Boc piperidine <b>18</b> with anhydrous hydrochloric acid produced piperidine <b>14</b> in 81% yield over two steps (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>10</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2,2-trifluoroacetic anhydride (1.4 equiv), <i>i</i>-PrNEt<sub>2</sub> (2.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) BH<sub>3</sub>·THF (2.2 equiv), THF, 70 °C; (c) 6 N aq NaOH (6.0 equiv), EtOH, 85 °C; (d) CDI (1.3 equiv), THF, 60 °C</p></p></figure><div class="NLM_p last">The piperidine <b>14</b>, a common and versatile intermediate, was subsequently utilized for the construction of a variety of analogues, in particular <b>13</b>, via a series of similar chemical transformations. The synthesis of <b>13</b> commenced with amidation of piperidine <b>14</b> (in free base form) with trifluoroacetic anhydride in the presence of Hünig’s base to provide amide <b>19</b> in near quantitative yield. Subsequent reduction of amide <b>19</b> with borane THF complex and heating delivered <i>N</i>-trifluoroethylpiperidine <b>20</b>. Saponification of the pendant methyl ester (<b>20</b>) with 6 N sodium hydroxide gave the penultimate acid <b>21</b> in 99% yield. The requisite amide bond was forged in a CDI mediated union between acid <b>21</b> and pyridone amine <b>22</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to yield the <i>N</i>-trifluoroethylpiperidine analogue (<b>13</b>) in 79% yield. The current synthetic scheme enabled generation of enantiomerically pure <b>13</b> on over 100 g scales for <i>in vivo</i> profiling.</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>In Vivo</i> Efficacy Studies</h3><div class="NLM_p">Having sufficient quantities in hand, we evaluated the performance of inhibitor <b>13</b> for tumor pharmacodynamic effects and antitumor efficacy in a KARPAS-422 B-cell lymphoma xenograft model in mice. KARPAS-422 xenograft cells harbor a recurrent, monoallelic mutation (Y641N) within the EZH2 catalytic domain.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These mutations alter the EZH2 substrate specificity and thus represent a context of constitutive EZH2 pathway activation. Informed by previous <i>in vivo</i> studies, <b>13</b> was dosed at 160 mg/kg orally twice daily (po BID) for 25 days in tumor bearing female CB-17 SCID mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Upon treatment of tumor-bearing CB-17 SCID mice with <b>13</b>, tumor regression was observed within 2 weeks. By the end of day 25, significant tumor growth inhibition was recorded (>97% TGI relative to vehicle, see <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Inhibitor <b>13</b> was well-tolerated for repeat dosing as demonstrated by the absence of significant body weight loss (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). To allow for analysis of tumor tissues at the end of the study, treatment was suspended at day 25. Tumor samples were harvested 1 h post last dose, and their analysis revealed considerable reduction of H3K27me3 (47% reduction in H3K27me3/global H3 ratio relative to vehicle control, see <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Analysis of plasma and tumor PK at 1 h post last dose on day 25 shows sufficient plasma and tumor tissue concentrations of <b>13</b>, 11 388 ng/mL [22 μM] versus 5286 ng/g [10 μM], respectively (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumor xenograft with <b>13</b>. (A) Effect of dosing analogue <b>13</b> at 160 mpk BID for 25 days on KARPAS-422 tumor growth in mouse xenograft. (B) Corresponding body weight change during the course of the study. (C) Pharmacodynamic effect of <b>13</b> on reduction of H3K27me3 normalized to total H3. (D) Analysis of plasma and tumor concentrations of <b>13</b> at 1 h post last dose on day 25.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Selectivity and Additional Profiling</h3><div class="NLM_p">On the basis of the successful KARPAS-422 efficacy, we selected <b>13</b> for further <i>in vivo</i> and <i>in vitro</i> profiling. Additional PK data on <b>13</b> in rats and dogs was collected (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Analogue <b>13</b> shows relatively high clearance in both rats and dogs (3.19 L/h/kg and 1.41 L/h/kg, respectively) but demonstrates good oral bioavailability in both species (44.6% F in rats and 46.2% F in dogs). As part of the characterization of <b>13</b>, its activity against a number of other targets were evaluated. Inhibitor <b>13</b> showed a clean selectivity profile when tested against 30 other histone or DNA methyltransferases.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Additionally, compound <b>13</b> demonstrated modest selectivity (EZH1 IC<sub>50</sub> of 52 ± 11 nM) when tested against enhancer of zeste homologue 1 (EZH1), a methyltransferase highly related to EZH2. Examination of the sequence similarity between EZH1 and EZH2 in the context of the co-crystal structure reveals that the residue positioned in close proximity to the inhibitor, Cys663, is one of only four residues within the EZH2 SET domain that are not conserved in EZH1. The equivalent EZH1 residue is Ser664. Cys663 makes van der Waals contact with the bound inhibitor and is predicted to be a key selectivity determinant with respect to EZH1 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). In order to test this hypothesis, we measured the potency of <b>10</b> and <b>13</b> in the context of an EZH2 version with a single amino acid substitution from cysteine to serine at position 663 (C663S) incorporated into reconstituted PRC2. As expected, the potency of the inhibitors decreased in the mutated EZH2 C663S, which is consistent with the reduction in potency observed in EZH1 enzymatic assays. The fact that this single mutation does not fully recapitulate the EZH2/EZH1 potency differences may reflect a subtle effect of other more distant residue differences between the two proteins.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Data of <b>13</b> in Rats and Dogs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">iv</th><th class="rowsep1 colsep0" colspan="4" align="center">po</th><th class="rowsep1 colsep0" align="center"><i>in vitro</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL [CL<sub>unbound</sub>]<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (L/h/kg)</th><th class="colsep0 rowsep0" align="center">%<i>Q</i><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub><a class="ref internalNav" href="#t4fn6" aria-label="f">f</a> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-inf</sub> [AUC<sub>unbound</sub>]<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a> (μM·h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t4fn8" aria-label="h">h</a> (μM)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub><a class="ref internalNav" href="#t4fn9" aria-label="i">i</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i><a class="ref internalNav" href="#t4fn10" aria-label="j">j</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>f</i><sub>u</sub><a class="ref internalNav" href="#t4fn11" aria-label="k">k</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">3.19 [31.6]</td><td class="colsep0 rowsep0" align="center">97</td><td class="colsep0 rowsep0" align="center">0.653</td><td class="colsep0 rowsep0" align="center">2.22</td><td class="colsep0 rowsep0" align="center">7.06 [0.713]</td><td class="colsep0 rowsep0" align="center">5.88 [0.593]</td><td class="colsep0 rowsep0" align="center">0.50</td><td class="colsep0 rowsep0" align="center">44.6</td><td class="colsep0 rowsep0" align="center">0.098</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1.41 [14.5]</td><td class="colsep0 rowsep0" align="center">76</td><td class="colsep0 rowsep0" align="center">1.84</td><td class="colsep0 rowsep0" align="center">1.60</td><td class="colsep0 rowsep0" align="center">3.19 [0.309]</td><td class="colsep0 rowsep0" align="center">1.24 [0.120]</td><td class="colsep0 rowsep0" align="center">1.67</td><td class="colsep0 rowsep0" align="center">46.2</td><td class="colsep0 rowsep0" align="center">0.089</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Based on an intravenous (iv) dose of 1 mg/kg and a per os (po) dose of 25 mg/kg in male Sprague–Dawley rats. Compound was formulated in 5:60:35 DMA/PEG400/20% SBECD for iv dosing and in 0.5% methyl cellulose (adjusted to pH 3–4) for po dosing.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Based on an intravenous (iv) dose of 1 mg/kg and a per os (po) dose of 5 mg/kg in male beagle dogs. Compound was formulated in 5:25:70 DMA/PEG400/20% SBECD for iv dosing and in 0.5% methyl cellulose for po dosing.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">CL = total clearance. CL<sub>unbound</sub> = CL/free fraction.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last"><i>Q</i> = percent of liver blood flow, based on 3.3 L/h/kg (rat) and 1.85 L/h/kg (dog).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Plasma half-life.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last"><i>V</i><sub>ss</sub> = volume of distribution at steady state.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Extrapolated total exposure following single dose. Calculated unbound exposure is in parentheses.</p></div><div class="footnote" id="t4fn8"><sup>h</sup><p class="last">Maximum plasma concentration achieved.</p></div><div class="footnote" id="t4fn9"><sup>i</sup><p class="last">Time at which maximum plasma concentration was achieved.</p></div><div class="footnote" id="t4fn10"><sup>j</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t4fn11"><sup>k</sup><p class="last"><i>f</i><sub>u</sub> = fraction unbound to plasma protein.</p></div></div></div><div class="NLM_p last">Further <i>in vitro</i> profiling of <b>13</b> showed no time-dependent inhibition (TDI) of the cytochrome P450 enzymes 1A2, 2C9, 2C8, 2D6, and 3A4. Additionally, <b>13</b> was evaluated for secondary pharmacology against a panel of fifty-four physiologically relevant receptors, transporters, and ion channels at 10 μM. As such, <b>13</b> did not inhibit any target more than 50%. Finally, <b>13</b> was examined for any potential cause of cardiac arrhythmias associated with delayed ventricular repolarization (QT interval prolongation). When tested within an <i>in vitro</i> hERG binding assay at concentration ranges of 45 nM to 100 μM, <b>13</b> showed an IC<sub>50</sub> of 21.3 μM. This concentration is well above the free concentration predicted to be achieved in patients.</div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Toxicology Study of <b>13</b></h3><div class="NLM_p last">To establish a safety window for repeat dosing of <b>13</b> in human clinical trials, a preclinical safety study was conducted in two separate species. Compound <b>13</b> was orally administered in a GLP compliant toxicity study for 4 weeks to both Sprague–Dawley rats and beagle dogs followed by a 4-week recovery period. The compound was administered by oral gavage at single daily doses (QD) of 100, 300, and 600 mg/kg to rats for 28 days and at twice daily doses (BID) of 50, 150, and 500 mg/kg for 28 days to dogs. In general, <b>13</b> was well-tolerated in the 28-day GLP toxicology studies, and any findings were reversible over the recovery period. The GLP toxicology studies of <b>13</b> demonstrated an acceptable safety profile and enabled selection of clinical doses.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have reported the discovery of <b>13</b>, a highly potent and selective small molecule inhibitor of EZH2, suitable for introduction into Phase I clinical trials for the treatment of B-cell lymphomas (NCT02395601). Using <b>1</b>, our previously disclosed EZH2 chemical probe as a starting point, we embarked on a focused campaign to optimize the cellular potency and physiochemical properties of our pyridone-indole scaffold. Removal of the sulfonamide functionality (embedded within <b>1</b>) yielded analogues that retained biochemical potency but lacked sufficient cellular activity in the HeLa H3K27me3 assay. Observing that attenuation of the p<i>K</i><sub>a</sub> of the piperidine N-atom has a profound effect on the correlation between biochemical and cellular potency, we ultimately discovered a series of fluorinated analogues with improved cellular activity and good oral bioavailability.</div><div class="NLM_p">During the course of our investigations, we successfully determined the co-crystal structure of compound <b>10</b> bound to human PRC2. The present crystal structure illustrates several distinct binding features. The overall density reveals a zigzag-like shape of the inhibitor, likely a consequence of conformational preorganization induced by the chiral methyl and C3-amide substituents that conforms to the enzyme’s pocket. Additionally, the pyridone motif forms two hydrogen bonds with the protein backbone of Trp624 and is constrained in an aromatic environment created by Phe665, Phe686, and Trp624. These crucial interactions with the pyridone motif explain the importance of this functional group for its high affinity binding, its prevalence in a vast majority of other reported EZH2 inhibitors, and the difficulty in finding suitable pyridone replacements.</div><div class="NLM_p last">After triaging these analogues through <i>in vitro</i> and <i>in vivo</i> experiments, <i>N</i>-trifluoroethylpiperidine analogue <b>13</b> was evaluated in a KARPAS-422 lymphoma xenograft model. Gratifyingly, <b>13</b> was well-tolerated, proved efficacious, and achieved >97% TGI after treatment for 25 days. After further <i>in vitro</i>/<i>in vivo</i> characterization and safety studies, compound <b>13</b> was advanced into human clinical trials. The clinical impact of <b>13</b> on EZH2 inhibition in oncology will be described in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercial reagents and anhydrous solvents were purchased and used without purification, unless specified. Column chromatography was performed using a Biotage chromatography system on Biotage or Silicycle normal phase silica gel columns. NMR spectra were recorded on a Varian Unity Inova (400 MHz) or an Oxford (Varian, 300 MHz) instrument. LC-MS were recorded on an Agilent 1200 series LC connected to an Agilent 6120 MS or Agilent 1100 series LC connected to an Agilent 1956B MS or a Shimadzu LC-MS-2020 system. Preparatory HPLC was performed using a Gilson GX-281 or P230 Gradient System (Elite). Chiral preparatory HPLC were performed using Elite P230 Preparative Gradient System, Thar Prep-80 and Thar SFC X-5 systems. The purity of the final products was >95% as determined by HPLC/MS and <sup>1</sup>H NMR.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-1-(1-(1-(Ethylsulfonyl)piperidin-4-yl)ethyl)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indole-3-carboxamide (<b>1</b>)</h3><div class="NLM_p">Prepared as previously reported.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> LC-MS <i>m</i>/<i>z</i> 529 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1H), 7.82–7.66 (m, 2H), 7.62 (d, <i>J</i> = 7.8, 1H), 7.17–6.99 (m, 2H), 6.15 (s, 1H), 4.32 (d, <i>J</i> = 5.1 Hz, 2H), 4.25–4.15 (m, 1H), 3.84 (s, 3H), 3.73–3.65 (m, 1H), 3.45–3.36 (m, 1H), 2.98 (q, <i>J</i> = 7.4 Hz, 2H), 2.87–2.77 (m, 1H), 2.60 (s, 3H), 2.54–2.45 (m, 1H), 2.42–2.30 (m, 1H), 2.20 (s, 3H), 2.06–1.97 (m, 1H), 1.58–1.48 (m, 3H), 1.42–1.31 (m, 1H), 1.17 (t, <i>J</i> = 7.4 Hz, 3H), 1.13–1.00 (m, 1H), 0.83–0.73 (m, 1H).</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>tert</i>-Butyl (<i>R</i>)-4-(1-((3-(2-Bromophenyl)-4-methoxy-4-oxobut-2-en-2-yl)amino)ethyl)piperidine-1-carboxylate (<b>17</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></h4><div class="NLM_p last">A 2-L three-neck round-bottom flask (fitted with a magnetic stir bar, thermocouple, reflux condenser, and rubber septa) was charged with methyl 2-(2-bromophenyl)-3-oxobutanoate (116.25 g, 428.80 mmol), EtOH (850 mL, ∼7 mL/g), (<i>R</i>)-<i>tert</i>-butyl 4-(1-aminoethyl)piperidine-1-carboxylate (121.00 g, 529.93 mmol), and AcOH (29.50 mL, 515.31 mmol). The reaction vessel was heated over a heating mantle to 80 °C–85 °C for 18 h. After 18 h, the reaction mixture was cooled to ambient temperature, and the <i>tert</i>-butanol was removed <i>in vacuo</i>. The resultant oil was diluted with EtOAc and subsequently poured over saturated aqueous NaHCO<sub>3</sub> while vigorously stirring. Once the evolution of CO<sub>2</sub> (g) ceased, the biphasic solution was transferred to a separatory funnel, and the phases were separated. The aqueous phase was extracted with additional EtOAc (2×). The combined organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford crude product. This material was preabsorbed onto silica gel (∼100 g) and filtered through a fritted funnel with 20% EtOAc to 80% hexanes afford (<i>R</i>)-<i>tert</i>-butyl 4-(1-((3-(2-bromophenyl)-4-methoxy-4-oxobut-2-en-2-yl)amino)ethyl)piperidine-1-carboxylate (155.95 g, 76% yield). The material was used without further purification. LC-MS <i>m</i>/<i>z</i> 481 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl (<i>R</i>)-2-Methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylate hydrochloride (<b>14</b>)</h4><div class="NLM_p">Step 1. To a 2 L 3-neck round-bottom flask (fitted with a magnetic stir bar, thermocouple, reflux condenser, and rubber septa) containing RuPhos precatalyst (generation III) (4.38 g, 5.24 mmol) and dicyclohexyl(2′,6′-diisopropoxy-[1,1′-biphenyl]-2-yl)phosphine (3.67 g, 7.86 mmol) was transferred (<i>R</i>)-<i>tert</i>-butyl 4-(1-((3-(2-bromophenyl)-4-methoxy-4-oxobut-2-en-2-yl)amino)ethyl)piperidine-1-carboxylate (126.11 g, 261.95 mmol) in 1,4-dioxane (800 mL, ∼ 6.4 mL/g). The resultant dark solution was evacuated and purged with N<sub>2</sub> (g). To the mixture was added NaOMe (21.23 g, 392.93 mmol) in four portions, followed by addition of 1,4-dioxane (50 mL, total amount of 850 mL, ∼8 mL/g) to rinse the powder funnel. The resultant heterogeneous mixture was subjected to three cycles of evacuation and purging with N<sub>2</sub> (g). The resultant dark brown/red suspension was heated over a heating mantle to 100 °C for 4–6 h. As the temperature reached 30–40 °C, a visible change in the reaction color was observed, and the mixture turned dark green. After 6 h, LC-MS analysis indicated complete conversion of the enamine to desired indole. The reaction mixture was cooled to ambient temperature and filtered over a pad made of a bed of silica gel over a bed of Celite. The filter cake was washed with EtOAc (3×), and the resultant brown filtrate was concentrated to provide methyl (<i>R</i>)-1-(1-(1-(<i>tert</i>-butoxycarbonyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (104.00 g, 99% yield) as an orange-colored foam. LC-MS <i>m</i>/<i>z</i> 401 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Step 2. To a cooled (0 °C) solution of (<i>R</i>)-methyl 1-(1-(1-(<i>tert</i>-butoxycarbonyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (104.0 g, 259.67 mmol) in MeOH (300 mL, ∼3 mL/g) was added hydrogen chloride (80.0 mL, 320.0 mmol) in a dropwise manner. After complete addition of HCl, the reaction was allowed to gradually warm to ambient temperatures. After 24 h, LC-MS analysis indicated complete conversion of the carbamate to desired product. The reaction mixture was filtered over a pad of Celite and subsequently concentrated in vacuo. (Note: The reaction mixture contained minor quantities of insoluble black solids assumed to be Pd(0)) The resultant dark brown oil was further concentrated from acetone (2 × 50 mL). The oil was diluted in acetone (∼200 mL). The resultant solids were stirred for 2 h and filtered to give 59.58 g (68% recovery after first round) of (<i>R</i>)-4-(1-(3-(methoxycarbonyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidin-1-ium chloride as off-white solids. The filtrate was concentrated and subsequently triturated again with acetone (50 mL). The second crop of solids yielded an additional 10 g of (<i>R</i>)-4-(1-(3-(methoxycarbonyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidin-1-ium chloride (total mass: 70.0 g, 80% yield after two rounds of trituration) as off-white solids. LC-MS <i>m</i>/<i>z</i> 301 [M + H]<sup>+</sup>.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>2</b>)</h4><div class="NLM_p">Step 1. To a solution of (<i>R</i>)-methyl 1-(1-(1-(<i>tert</i>-butoxycarbonyl)piperidim-4-yl)ethyl)-2-methyl-1H-indole-3-carboxylate (5.0 g, 12.5 mmol) in methanol (20 mL) and water (10 mL) was added sodium hydroxide (5.0 g, 125 mmol). The reaction mixture was stirred at 80 °C for 12 h. The mixture was cooled to room temperature and acidified to pH 5 with hydrochloric acid (2 N). The acidic solution was extracted with EtOAc. The combined organics layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford (<i>R</i>)-1-(1-(1-(<i>tert</i>-butoxycarbonyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylic acid (4.5 g, 94% yield) as an off-white solid. LC-MS <i>m</i>/<i>z</i> 409 [M + Na]<sup>+</sup>.</div><div class="NLM_p">Step 2. A 250 mL round-bottom flask was charged with a magnetic stir bar, (<i>R</i>)-1-(1-(1-(<i>tert</i>-butoxycarbonyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylic acid (1.950 g, 5.05 mmol), 3-(aminomethyl)-4-methoxy-6-methylpyridin-2(1H)-one hydrochloride (2.065 g, 10.09 mmol), DMF (25.2 mL, 5.05 mmol), Hunig’s base (3.52 mL, 20.18 mmol). The reaction mixture was cooled to 0 °C, and COMU (2.16 g, 5.05 mmol) was added. The reaction was allowed to stir overnight to room temperature. The reaction mixture was diluted with water and extracted with EtOAc. The combined organic extract was washed with brine, dried with MgSO<sub>4</sub>, filtered and concentrated <i>in vacuo</i> to afford the crude material, which was purified via silica gel chromatography (120 g) using MeOH/ethyl acetate (1:5) as eluent to afford <i>tert</i>-butyl (<i>R</i>)-4-(1-(3-(((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidine-1-carboxylate (1.86 g, 65% yield). LC-MS <i>m</i>/<i>z</i> 537 [M + H]<sup>+ 1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83–11.71 (m, 1 H), 7.80 (br. s., 1 H), 7.73 (d, <i>J</i> = 7.6 Hz, 1 H), 7.62 (d, <i>J</i> = 7.8 Hz, 1 H), 7.06 (td, <i>J</i> = 7.1, 14.4 Hz, 2 H), 6.21 (s, 1 H), 4.32 (br. s., 2 H), 4.16 (br. s., 1 H), 4.02 (br. s., 1 H), 3.85 (s, 3 H), 3.75 (br. s., 1 H), 2.70 (br. s., 1 H), 2.58 (s, 3 H), 2.37 (br. s., 1 H), 2.21 (s, 3 H), 1.90 (d, <i>J</i> = 12.9 Hz, 1 H), 1.53 (d, <i>J</i> = 6.9 Hz, 3 H), 1.35 (s, 10 H), 1.21 (br. s., 1 H), 0.89 (d, <i>J</i> = 8.7 Hz, 1 H), 0.67 (d, <i>J</i> = 11.8 Hz, 1 H).</div><div class="NLM_p last">Step 3. A 250 mL round-bottom flask was charged with a magnetic stir bar, (<i>R</i>)-<i>tert</i>-butyl 4-(1-(3-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methylcarbamoyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidine-1-carboxylate (1.850 g, 3.45 mmol), MeOH (13.79 mL, 3.45 mmol), and HCl (2.59 mL, 10.34 mmol) (4 N in dioxane). The reaction was allowed to stir at room temperature for 6 h before being concentrated <i>in vacuo</i> to afford <b>1</b> (1.65 g, 91% yield). LC-MS <i>m</i>/<i>z</i> 437 [M + H]<sup>+ 1</sup>H NMR (400 MHz, methanol-d<sub>4</sub>) δ 7.62 (d, <i>J</i> = 7.5 Hz, 1 H), 7.52 (d, <i>J</i> = 7.7 Hz, 1 H), 7.08–6.96 (m, 2 H), 6.19 (s, 1 H), 4.43 (s, 2 H), 4.15 (dd, <i>J</i> = 10.4, 7.1 Hz, 1 H), 3.85 (s, 3 H), 3.40 (d, <i>J</i> = 12.8 Hz, 1 H), 3.07 (d, <i>J</i> = 12.6 Hz, 1 H), 2.96 (dt, <i>J</i> = 13.0, 2.8 Hz, 1 H), 2.68–2.50 (m, 5 H), 2.23 (s, 3 H), 2.17 (d, <i>J</i> = 14.3 Hz, 1 H), 1.56 (d, <i>J</i> = 6.8 Hz, 3 H), 1.14–1.05 (m, 1 H), 0.94 (d, <i>J</i> = 13.5 Hz, 1 H), 0.80 (t, <i>J</i> = 6.8 Hz, 1 H).</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-methylpiperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>3</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (0.1 g, 0.229 mmol) in THF (3 mL) was added formaldehyde (0.051 mL, 0.687 mmol). This solution was mixed for 1 h; subsequently, sodium triacetoxyborohydride (0.146 g, 0.687 mmol) was added, and the reaction was mixed at ambient temperature for 2.5 h. The crude reaction was deposited onto silica gel and purified by silica gel chromatography (90:10:1 DCM:MeOH:NH<sub>4</sub>OH) to afford <b>2</b> (68 mg, 66% yield). LC-MS <i>m</i>/<i>z</i> 451 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.58 (s, 1 H), 7.76–7.65 (m, 2 H), 7.59 (d, <i>J</i> = 7.6 Hz, 1 H), 7.11–6.99 (m, 2 H), 6.14 (s, 1 H), 4.31 (d, <i>J</i> = 5.1 Hz, 2 H), 4.13 (br. s., 1 H), 3.83 (s, 3 H), 2.83 (d, <i>J</i> = 10.0 Hz, 1 H), 2.61–2.52 (m, 5 H), 2.19 (s, 3 H), 2.09 (s, 4 H), 1.88 (d, <i>J</i> = 10.7 Hz, 2 H), 1.53 (d, <i>J</i> = 6.7 Hz, 3 H), 1.34 (br. s., 1 H), 1.02 (d, <i>J</i> = 8.2 Hz, 1 H), 0.66 (br. s., 1 H).</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-1-(1-(1-Isobutyrylpiperidin-4-yl)ethyl)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indole-3-carboxamide (<b>4</b>)</h4><div class="NLM_p last">To a round-bottomed flask was added (<i>R</i>)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (60 mg, 0.137 mmol) and DCM (2 mL). The solution was cooled to 0 °C before addition of Et<sub>3</sub>N (21.07 μL, 0.151 mmol) and isobutyryl chloride (15.84 μL, 0.151 mmol). After stirring for 1 h at 0 °C, the reaction mixture was quenched by addition of a solution of 1 N NaOH (aqueous) and MeOH (1 mL). The solution was further stirred at 0 °C for 1 h, and subsequently diluted with MeOH (2 mL) followed by addition of lithium hydroxide monohydrate (11.54 mg, 0.275 mmol). This reaction was diluted with water and extracted with EtOAc. The combined organics layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude residue was purified via silica gel chromatography to afford <b>3</b> (27.7 mg, 39.8% yield). LC-MS <i>m</i>/<i>z</i> 507 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (s, 1 H), 7.75 (d, <i>J</i> = 7.4 Hz, 1 H), 7.72–7.67 (m, 1 H), 7.64 (d, <i>J</i> = 8.0 Hz, 1 H), 7.14–7.01 (m, 2 H), 6.15 (s, 1 H), 4.58–4.46 (m, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.09–3.99 (m, 1 H), 3.84 (s, 3 H), 3.81–3.72 (m, 1 H), 3.08–2.97 (m, 1 H), 2.92–2.81 (m, 1 H), 2.78–2.65 (m, 3 H), 2.59 (br. s., 3 H), 2.20 (s, 3 H), 2.03–1.90 (m, 1 H), 1.59–1.47 (m, 4 H), 1.02–0.86 (m, 6 H), 0.78–0.69 (m, 1 H).</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Isopropyl (<i>R</i>)-4-(1-(3-(((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidine-1-carboxylate (<b>5</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>4</b>. LC-MS <i>m</i>/<i>z</i> 523 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (br. s., 1 H), 7.74 (d, <i>J</i> = 7.8 Hz, 1 H), 7.69 (t, <i>J</i> = 4.9 Hz, 1 H), 7.62 (d, <i>J</i> = 7.8 Hz, 1 H), 7.13–7.01 (m, 2 H), 6.15 (s, 1 H), 4.78–4.67 (m, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.23–4.12 (m, 1 H), 4.12–4.02 (m, 1 H), 3.84 (s, 3 H), 3.82–3.74 (m, 1 H), 2.79–2.66 (m, 1 H), 2.58 (s, 3 H), 2.46–2.34 (m, 2 H), 2.20 (s, 3 H), 1.96–1.88 (m, 1 H), 1.58–1.46 (m, 4 H), 1.15 (d, <i>J</i> = 6.0 Hz, 6 H), 0.95–0.89 (m, 1 H), 0.74–0.65 (m, 1 H).</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-1-(1-(1-(Dimethylcarbamoyl)piperidin-4-yl)ethyl)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indole-3-carboxamide (<b>6</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>4</b>. LC-MS <i>m</i>/<i>z</i> 508 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.70–11.51 (m, 1 H), 7.80–7.54 (m, 3 H), 7.17–6.98 (m, 2 H), 6.15 (s, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.22–4.13 (m, 1 H), 3.84 (s, 3 H), 3.68–3.59 (m, 1 H), 3.40–3.33 (m, 1 H), 2.68 (s, 7 H), 2.60 (s, 3 H), 2.41–2.29 (m, 1 H), 2.20 (s, 3 H), 1.98–1.85 (m, 1 H), 1.55 (d, <i>J</i> = 6.9 Hz, 4 H), 1.35–1.19 (m, 1 H), 1.05–0.92 (m, 1 H), 0.75–0.61 (m, 1 H)</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(oxetan-3-yl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>7</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>3</b>. LC-MS <i>m</i>/<i>z</i> 493 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.58 (s, 1 H), 7.76–7.65 (m, 2 H), 7.59 (d, <i>J</i> = 7.8 Hz, 1 H), 7.10–6.99 (m, 2 H), 6.14 (s, 1 H), 4.49 (t, <i>J</i> = 6.4 Hz, 1 H), 4.43 (t, <i>J</i> = 6.5 Hz, 1 H), 4.37 (t, <i>J</i> = 6.1 Hz, 1 H), 4.34–4.28 (m, 3 H), 4.21–4.10 (m, 1 H), 3.83 (s, 3 H), 3.30–3.23 (m, 1 H), 2.75 (br. s., 1 H), 2.71–2.64 (m, 1 H), 2.60 (s, 3 H), 2.19 (s, 4 H), 1.90 (br. s., 1 H), 1.75 (br. s., 1 H), 1.53 (d, <i>J</i> = 6.9 Hz, 3 H), 1.42 (br. s., 2 H), 1.11–0.98 (m, 1 H), 0.72–0.63 (m, 1 H).</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ethyl (<i>R</i>)-2-(4-(1-(3-(((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1<i>H</i>-indol-1-yl)ethyl)piperidin-1-yl)acetate (<b>8</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>3</b>. LC-MS <i>m</i>/<i>z</i> 523 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (br. s., 1 H), 7.81–7.65 (m, 2 H), 7.60 (d, <i>J</i> = 7.4 Hz, 1 H), 7.16–6.98 (m, 2 H), 6.15 (s, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.23–4.11 (m, 1 H), 4.04 (q, <i>J</i> = 7.0 Hz, 2 H), 3.84 (s, 3 H), 2.95–2.86 (m, 1 H), 2.60 (s, 5 H), 2.20 (s, 4 H), 1.94–1.79 (m, 2 H), 1.54 (d, <i>J</i> = 6.9 Hz, 4 H), 1.41–1.32 (m, 1 H), 1.15 (t, <i>J</i> = 7.1 Hz, 3 H), 1.04 (d, <i>J</i> = 6.0 Hz, 2 H), 0.71–0.61 (m, 1 H).</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(3,3,3-trifluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>9</b>)</h4><div class="NLM_p">Step 1. A sealed tube was charged with a magnetic stir bar, (<i>R</i>)-methyl 2-methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylate (2.45 g, 8.16 mmol), DMF (20 mL), 1,1,1-trifluoro-3-iodopropane (1.92 mL, 16.32 mmol), and potassium carbonate (7 g, 50 mmol). The vessel was sealed and heated to 70 °C with stirring for 4 h before being allowed to cool to room temperature. The reaction was filtered through a bed of Celite which was rinsed with ethyl acetate (2 × 100 mL). The filtrate was washed with water, dried with MgSO4, filtered, and concentrated <i>in vacuo</i> to afford the crude product which was purified via silica gel chromatography (50 g) using ethyl acetate/hexanes (1:1) as eluent to afford the methyl (<i>R</i>)-2-methyl-1-(1-(1-(3,3,3-trifluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylate (2.98 g, 92% yield). LC-MS <i>m</i>/<i>z</i> 533 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br. s., 1 H), 7.78–7.66 (m, 2 H), 7.60 (d, <i>J</i> = 8.2 Hz, 1 H), 7.13–7.00 (m, 2 H), 6.15 (s, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.22–4.09 (m, 1 H), 3.84 (s, 3 H), 3.03–2.91 (m, 1 H), 2.73–2.64 (m, 1 H), 2.60 (s, 3 H), 2.48–2.31 (m, 5 H), 2.20 (s, 3 H), 2.01–1.85 (m, 2 H), 1.58–1.46 (m, 4 H), 1.36–1.29 (m, 1 H), 1.08–0.98 (m, 1 H), 0.73–0.62 (m, 1 H).</div><div class="NLM_p">Step 2. A 200 mL round-bottom flask was charged with a magnetic stir bar, (<i>R</i>)-methyl 2-methyl-1-(1-(1-(3,3,3-trifluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylate (1.15 g, 2.90 mmol), ethanol (10 mL), water (2 mL), and sodium hydroxide (0.46 g, 11.60 mmol) . The reaction was heated to 80 °C with stirring for 12 h before being allowed to cool to room temperature. The ethanol was removed <i>in vacuo</i>, and the resulting mixture was adjusted to pH ∼ 6.5 with 10% HCl. A precipitate formed, which was collected via vacuum filtration using a Buchner funnel. The cake was washed with additional water (∼50 mL) and dried in vacuo to afford (<i>R</i>)-2-methyl-1-(1-(1-(3,3,3-trifluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylic acid (1.02 g, 92% yield) as an off-white solid.</div><div class="NLM_p last">Step 3. A 100 mL round-bottom flask was charged with a magnetic stir bar, (<i>R</i>)-2-methyl-1-(1-(1-(3,3,3-trifluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylic acid (1.02 g, 2.67 mmol), DMF (9 mL), 3-(aminomethyl)-4-methoxy-6-methylpyridin-2(1<i>H</i>)-one hydrochloride (0.82 g, 4.00 mmol), Hunig’s base (2 mL). The reaction was cooled to 0 °C with an ice bath, and COMU (2.29 g) was then added. After stirring for 24 h, the reaction was diluted with water (200 mL) and extracted with ethyl acetate (2 × 200 mL). The combined organic extract was washed with water (200 mL), brine (200 mL), was collected, dried with MgSO4, filtered, and concentrated <i>in vacuo</i> to afford the crude compound. This material was preabsorbed onto silica gel (∼10 g) and purified via silica gel chromatography (100 g) using DCM/MeOH (10:1) with 0.1% NH<sub>4</sub>OH to afford <b>8</b> (859 mg, 60% yield) as an off white solid. LC-MS <i>m</i>/<i>z</i> 533 [M + H]<sup>+</sup>; (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br. s., 1 H), 7.78–7.66 (m, 2 H), 7.60 (d, <i>J</i> = 8.2 Hz, 1 H), 7.13–7.00 (m, 2 H), 6.15 (s, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.22–4.09 (m, 1 H), 3.84 (s, 3 H), 3.03–2.91 (m, 1 H), 2.73–2.64 (m, 1 H), 2.60 (s, 3 H), 2.48–2.31 (m, 5 H), 2.20 (s, 3 H), 2.01–1.85 (m, 2 H), 1.58–1.46 (m, 4 H), 1.36–1.29 (m, 1 H), 1.08–0.98 (m, 1 H), 0.73–0.62 (m, 1 H).</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-1-(1-(1-(2,2-Difluoropropyl)piperidin-4-yl)ethyl)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indole-3-carboxamide (<b>10</b>)</h4><div class="NLM_p">Step 1. To a 500 mL round-bottom flask charged with a magnetic stir bar was added 2,2-difluoropropanoic acid (7.5 g, 68.14 mmol) and DCM (250 mL). The mixture was cooled to 0 °C, and oxalyl dichloride (5.48 mL, 8.22 g, 64.73 mmol) was added over 1 min. To this solution was added DMF (500 μL, 6.43 mmol), and the solution was warmed to room temperature with stirring until bubbling ceased (about 1 h). The solution is used as is in the subsequent step without further purification.</div><div class="NLM_p">Step 2. To a 1 L round-bottom flask equipped with a magnetic stirrer was added (<i>R</i>)-methyl 2-methyl-1-(1-(piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxylate (7.5 g, 24.97 mmol), DCM (200 mL), and <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (8.07 g, 62.43 mmol). The mixture was cooled to 0 °C in an ice bath and purged with nitrogen. To this stirred mixture of 2,2-difluoropropanoyl chloride (7.79 g, 60.62 mmol) in DCM through via an addition funnel over 15 min. The reaction was allowed to stir for an additional 30 min while warming to room temperature. The mixture was carefully quenched with saturated aqueous NaHCO<sub>3</sub>, the organic phase separated, washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting material was purified by column chromatography (120 g silica column, 10% to 30% EtOAc in hexanes) to afford methyl (<i>R</i>)-1-(1-(1-(2,2-difluoropropanoyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (9.1 g, 92% yield).</div><div class="NLM_p">Step 3. A 1 L 3-necked flask was equipped with magnetic stirrer and was fitted with a reflux condenser and an oil-filled bubbler outlet. The vessel was purged and placed under an atmosphere of nitrogen and methyl (<i>R</i>)-1-(1-(1-(2,2-difluoropropanoyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (9.1 g, 23.19 mmol) was dissolved in THF (150 mL) and cannulated into the reaction flask. The reaction was cooled to 0 °C in an ice bath and borane (1.0 M THF solution, 55 mL, 55 mmol) was added over 10 min via syringe. When intense bubbling subsided, the reaction mixture was heated to reflux for 2 h. The reaction was then cooled to 0 °C followed by the careful addition of MeOH (80 mL) (caution: vigorous H<sub>2</sub> gas evolution observed). The reaction was then stirred at 0 °C for 5 min, and then allowed to warm to room temperature. The mixture was then heated to 65 °C for 45 min, cooled to room temperature, and was transferred to a 1 L round-bottom flask. The volatiles were removed under reduced pressure. The material was purified by column chromatography (120 g silica column, 10% to 40% EtOAc in hexanes) to afford methyl (<i>R</i>)-1-(1-(1-(2,2-difluoropropyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (7.96 g, 90% yield).</div><div class="NLM_p">Step 4. In a 1 L round-bottom flask equipped with a magnetic stirrer, (<i>R</i>)-methyl 1-(1-(1-(2,2-difluoropropyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylate (7.96 g, 21.03 mmol) was dissolved in ethanol (80 mL), and a sodium hydroxide solution (6 M aqueous, 16 mL, 96 mmol) was added. The reaction was then heated to reflux (85 °C) for 16 h and was then cooled to 0 °C. A hydrochloric acid solution (2 M aqueous) was added until a pH of 6 was obtained. A precipitate formed which was collected via vacuum filtration using a Buchner funnel. The cake was washed with additional water (∼100 mL) and dried <i>in vacuo</i> to afford the title compound (7.65 g, 99% yield) as an off-white solid.</div><div class="NLM_p last">Step 5. A 500 mL round-bottom flask was charged with a magnetic stir bar, (4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methanaminium chloride (7.3 g, 35.7 mmol), DMF (60 mL), (<i>R</i>)-1-(1-(1-(2,2-difluoropropyl)piperidin-4-yl)ethyl)-2-methyl-1<i>H</i>-indole-3-carboxylic acid (7.65 g, 21.0 mmol), and Hunig’s base (15.0 mL, 84.0 mmol). The mixture was sonicated for 5 min before being cooled to 0 °C. To the stirred reaction mixture was added COMU (13.5 g, 31.5 mmol). The solution was stirred at 0 °C for 15 min before the ice bath was removed. The reaction was allowed to warm to room temperature with stirring overnight. The reaction mixture was then diluted with saturated aqueous NaHCO<sub>3</sub> (300 mL) and extracted with EtOAc (2 × 200 mL). The combined organic layer was washed with water, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified via silica gel chromatography (330 g) with DCM/MeOH (10:1) with 1% NH<sub>4</sub>OH to afford the title compound as an off-white solid. (6.1 g, 11.85 mmol, 56% yield). LC-MS <i>m</i>/<i>z</i> 515 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1 H), 7.79–7.65 (m, 2 H), 7.60 (d, <i>J</i> = 8.0 Hz, 1 H), 7.16–6.99 (m, 2 H), 6.15 (s, 1 H), 4.38–4.25 (m, 2 H), 4.21–4.10 (m, 1 H), 3.84 (s, 3 H), 3.03–2.90 (m, 1 H), 2.75–2.54 (m, 6 H), 2.25–2.11 (m, 5 H), 1.88 (br. s., 2 H), 1.66–1.45 (m, 6 H), 1.43–1.26 (m, 1 H), 1.12–0.97 (m, 1 H), 0.70–0.61 (m, 1 H).</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,3,3-tetrafluoropropyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>11</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>10</b>. LC-MS <i>m</i>/<i>z</i> 551 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, Acetone-d<sub>6</sub>) δ 12.06 (br. s, 1 H), 7.89 (d, <i>J</i> = 7.9 Hz, 1 H), 7.70 (t, <i>J</i> = 4.9 Hz, 1 H), 7.62 (d, <i>J</i> = 8.1 Hz, 1 H), 6.99–7.12 (m, 2 H), 6.15–6.48 (m, 2 H), 4.50–4.61 (m, 2 H), 4.18–4.30 (m, 1 H), 3.93 (s, 3 H), 3.04 (d, <i>J</i> = 11.5 Hz, 1 H), 2.85–2.96 (m, 2 H), 2.73–2.83 (m, 2 H), 2.71 (s, 3H), 2.28–2.43 (m, 2 H), 2.23 (br. s., 3 H), 2.00 (d, <i>J</i> = 12.8 Hz, 1H), 1.62 (d, <i>J</i> = 7.0 Hz, 3 H), 1.46 (dq, <i>J</i> = 12.2, 3.9 Hz, 1 H), 1.11–1.23 (m, 1 H), 0.79 (d, <i>J</i> = 12.8 Hz, 1 H).</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-1-(1-(1-(2,2-Difluoroethyl)piperidin-4-yl)ethyl)-<i>N</i>-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1<i>H</i>-indole-3-carboxamide (<b>12</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>10</b>. LC-MS <i>m</i>/<i>z</i> 501 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (br. s., 1 H), 7.77–7.66 (m, 2 H), 7.60 (d, <i>J</i> = 7.6 Hz, 1 H), 7.14–7.00 (m, 2 H), 6.15 (s, 1 H), 6.06 (t, <i>J</i> = 55.7 Hz, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.15 (br. s., 1 H), 3.84 (s, 3 H), 3.03–2.93 (m, 2 H), 2.73–2.62 (m, 3 H), 2.60 (s, 3 H), 2.26–2.10 (m, 4 H), 1.93–1.79 (m, 1 H), 1.59–1.46 (m, 4 H), 1.41–1.29 (m, 1 H), 1.11–0.97 (m, 1 H), 0.67 (br. s., 1 H).</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>)-<i>N</i>-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (<b>13</b>)</h4><div class="NLM_p last">Prepared in a similar manner to <b>10</b>. LC-MS <i>m</i>/<i>z</i> 519 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (s, 1 H), 7.74 (d, <i>J</i> = 7.6 Hz, 1 H), 7.71–7.66 (m, 1 H), 7.61 (d, <i>J</i> = 7.8 Hz, 1 H), 7.13–7.01 (m, 2 H), 6.15 (s, 1 H), 4.32 (d, <i>J</i> = 4.9 Hz, 2 H), 4.22–4.12 (m, 1 H), 3.84 (s, 3 H), 3.15–2.95 (m, 3 H), 2.75–2.66 (m, 1 H), 2.60 (s, 3 H), 2.39–2.31 (m, 1 H), 2.20 (s, 3 H), 2.05–1.98 (m, 1 H), 1.92–1.84 (m, 1 H), 1.56–1.46 (m, 4 H), 1.42–1.32 (m, 1 H), 1.11–1.01 (m, 1 H), 0.69–0.62 (m, 1 H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01315">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01315" class="ext-link">10.1021/acs.jmedchem.6b01315</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Co-crystal structure of inhibitor <b>10</b> bound to PRC2 available (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>); 100 g scale synthesis of inhibitor <b>13</b>; biochemical assay details; mechanism of action (moa) cell assay details, descriptions of KARPAS-422 efficacy and PK/PD experiments; methods for structural biology experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and compound data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf">jm6b01315_si_001.pdf (938.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_002.csv">jm6b01315_si_002.csv (1.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01315" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rishi G. Vaswani</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#65170c160d0c4b024b13041612040b0c250208040c094b060a08"><span class="__cf_email__" data-cfemail="4032293328296e276e36213337212e2900272d21292c6e232f2d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor S. Gehling</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83f5eae0f7ecf1ade4e6ebefeaede4c3e0ecedf0f7e6efefe2f7eaecedf3ebe2f1eee2ade0ecee"><span class="__cf_email__" data-cfemail="d3a5bab0a7bca1fdb4b6bbbfbabdb493b0bcbda0a7b6bfbfb2a7babcbda3bbb2a1beb2fdb0bcbe">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James E. Audia</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#13797a7e3d7266777a7253707c7d6067767f7f72677a7c7d637b72617e723d707c7e"><span class="__cf_email__" data-cfemail="355f5c581b5440515c5475565a5b464150595954415c5a5b455d544758541b565a58">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven J. Gamblin</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cbb8bfaebdaee5acaaa6a9a7a2a58ba8b9a2a8a0e5aaa8e5bea0"><span class="__cf_email__" data-cfemail="fc8f88998a99d29b9d919e909592bc9f8e959f97d29d9fd28997">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Les A. Dakin</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew S. Cook</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher G. Nasveschuk</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Duplessis</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priyadarshini Iyer</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srividya Balasubramanian</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Zhao</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Good</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Campbell</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Lee</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Cantone</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard T. Cummings</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emmanuel Normant</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven F. Bellon</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian K. Albrecht</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Harmange</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Trojer</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Zhang</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neil Justin</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuyang Chen</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon R. Wilson</span> - <span class="hlFld-Affiliation affiliation">Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3407-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Julian Levell for editorial suggestions and comments during the preparation of this manuscript. We would like to thank Custom NMR Services for assistance in acquisition of all NMR spectra. Y.Z., N.J., S.C., J.R.W. and S.J.G. were supported by the Francis Crick Institute, which receives its core funding (FC001078) from Cancer Research U.K., the U.K. Medical Research Council, and the Wellcome Trust. We greatly acknowledge Diamond Light Source for access to synchrotron time under proposal MX9826.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> Abbreviations Used</h2><tr><td class="NLM_term">PRC2</td><td class="NLM_def"><p class="first last">polycomb repressive complex 2</p></td></tr><tr><td class="NLM_term">H3K27</td><td class="NLM_def"><p class="first last">histone 3 lysine 27</p></td></tr><tr><td class="NLM_term">EZH2</td><td class="NLM_def"><p class="first last">enhancer of zeste homologue 2</p></td></tr><tr><td class="NLM_term">SAM</td><td class="NLM_def"><p class="first last">S-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationships</p></td></tr><tr><td class="NLM_term">MOA</td><td class="NLM_def"><p class="first last">mechanism of action</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">LiPE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">Q</td><td class="NLM_def"><p class="first last">liver blood flow</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">V<sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">SBECD</td><td class="NLM_def"><p class="first last">sulfobutyl ether β-cyclodextrin</p></td></tr><tr><td class="NLM_term">iPrNEt<sub>2</sub></td><td class="NLM_def"><p class="first last">hunig’s base</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyldiimadazole</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor-growth inhibition</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">twice a day</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once a day</p></td></tr><tr><td class="NLM_term">GLP</td><td class="NLM_def"><p class="first last">good laboratory practice</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Swalm, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span> </span><span class="NLM_article-title">Reaction Coupling Between Wild-Type and Disease-Associated Mutant EZH2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2459</span><span class="NLM_x">–</span> <span class="NLM_lpage">2464</span><span class="refDoi"> DOI: 10.1021/cb500548b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500548b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsValsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2459-2464&author=B.+M.+Swalmauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=L.+Jinauthor=K.+W.+Kuntzauthor=H.+Keilhackauthor=J.+J.+Smithauthor=R.+M.+Pollockauthor=M.+P.+Moyerauthor=M.+P.+Scottauthor=R.+A.+Copelandauthor=T.+J.+Wigle&title=Reaction+Coupling+Between+Wild-Type+and+Disease-Associated+Mutant+EZH2&doi=10.1021%2Fcb500548b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction Coupling between Wild-Type and Disease-Associated Mutant EZH2</span></div><div class="casAuthors">Swalm, Brooke M.; Knutson, Sarah K.; Warholic, Natalie M.; Jin, Lei; Kuntz, Kevin W.; Keilhack, Heike; Smith, Jesse J.; Pollock, Roy M.; Moyer, Mikel P.; Scott, Margaret Porter; Copeland, Robert A.; Wigle, Tim J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2459-2464</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 and EZH1 are protein methyltransferases (PMTs) responsible for histone H3, lysine 27 (H3K27) methylation.  Trimethylation of H3K27 (H3K27me3) is a hallmark of many cancers, including non-Hodgkin lymphoma (NHL).  Heterozygous EZH2 point mutations at Tyr641, Ala677, and Ala687 have been obsd. in NHL.  The Tyr641 mutations enhance activity on H3K27me2 but have weak or no activity on unmethylated H3K27, whereas the Ala677 and Ala687 mutations use substrates of all methylation states effectively.  It has been proposed that enzymic coupling of the wild-type and mutant enzymes leads to the oncogenic H3K27me3 mark in mutant-bearing NHL.  The authors show that coupling with the wild-type enzyme is needed to achieve H3K27me3 for several mutants, but that others are capable of achieving H3K27me3 on their own.  All forms of PRC2 (wild-type and mutants) display kinetic signatures that are consistent with a distributive mechanism of catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYJS1iNB13X7Vg90H21EOLACvtfcHk0ljR1s1wVQV53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsValsbrN&md5=bf0497c142262f217cbfd73aed8b1bb2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcb500548b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500548b%26sid%3Dliteratum%253Aachs%26aulast%3DSwalm%26aufirst%3DB.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26atitle%3DReaction%2520Coupling%2520Between%2520Wild-Type%2520and%2520Disease-Associated%2520Mutant%2520EZH2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2459%26epage%3D2464%26doi%3D10.1021%2Fcb500548b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. A.</span><span> </span><span class="NLM_article-title">Roles of the EZH2 Histone Methyltransferase in Cancer Epigenetics</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">647</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.mrfmmm.2008.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.mrfmmm.2008.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=18723033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=647&publication_year=2008&pages=21-29&author=J.+A.+Simonauthor=C.+A.+Lange&title=Roles+of+the+EZH2+Histone+Methyltransferase+in+Cancer+Epigenetics&doi=10.1016%2Fj.mrfmmm.2008.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span></div><div class="casAuthors">Simon, Jeffrey A.; Lange, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">647</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  EZH2 is the catalytic subunit of Polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3.  This methylated H3-K27 chromatin mark is commonly assocd. with silencing of differentiation genes in organisms ranging from plants to flies to humans.  Studies on human tumors show that EZH2 is frequently over-expressed in a wide variety of cancerous tissue types, including prostate and breast.  Although the mechanistic contributions of EZH2 to cancer progression are not yet detd., functional links between EZH2-mediated histone methylation and DNA methylation suggest partnership with the gene silencing machinery implicated in tumor suppressor loss.  Here we review the basic mol. biol. of EZH2 and the findings that implicate EZH2 in different cancers.  We also discuss EZH2 connections to other silencing enzymes, such as DNA methyltransferases and histone deacetylases, and we consider progress on deciphering mechanistic consequences of EZH2 overabundance and its potential roles in tumorigenesis.  Finally, we review recent findings that link EZH2 roles in stem cells and cancer, and we consider prospects for integrating EZH2 blockade into strategies for developing epigenetic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_YxVHv1IGDrVg90H21EOLACvtfcHk0ljR1s1wVQV53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP&md5=e80ac4a2ba07b9e1ab4256ba6c73b23f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2008.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2008.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DLange%26aufirst%3DC.%2BA.%26atitle%3DRoles%2520of%2520the%2520EZH2%2520Histone%2520Methyltransferase%2520in%2520Cancer%2520Epigenetics%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2008%26volume%3D647%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.mrfmmm.2008.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">The Polycomb Complex PRC2 and Its Mark in Life</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1038/nature09784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature09784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=21248841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=343-349&author=R.+Margueronauthor=D.+Reinberg&title=The+Polycomb+Complex+PRC2+and+Its+Mark+in+Life&doi=10.1038%2Fnature09784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Polycomb complex PRC2 and its mark in life</span></div><div class="casAuthors">Margueron, Raphael; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7330</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure.  In mammals, 2 main Polycomb group complexes exist: Polycomb repressive complex 1 (PRC1) and 2 (PRC2).  PRC1 compacts chromatin and catalyzes the monoubiquitination of histone H2A.  PRC2 also contributes to chromatin compaction, and catalyzes the methylation of histone H3 at Lys-27.  PRC2 is involved in various biol. processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity.  Recent studies of PRC2 have expanded the perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fYmuBqnMA7Vg90H21EOLACvtfcHk0ljhRfUu2kpJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D&md5=5f15e91cc6ff765f649842041f333841</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09784%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DThe%2520Polycomb%2520Complex%2520PRC2%2520and%2520Its%2520Mark%2520in%2520Life%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D343%26epage%3D349%26doi%3D10.1038%2Fnature09784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span> </span><span class="NLM_article-title">Regulation and Role of EZH2 in Cancer</span> <span class="citation_source-journal">Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.4143/crt.2014.46.3.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4143%2Fcrt.2014.46.3.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25038756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=209-222&author=H.+Yamaguchiauthor=M.-C.+Hung&title=Regulation+and+Role+of+EZH2+in+Cancer&doi=10.4143%2Fcrt.2014.46.3.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and role of EZH2 in cancer</span></div><div class="casAuthors">Yamaguchi, Hirohito; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-222</span>CODEN:
                <span class="NLM_cas:coden">CRTAC2</span>;
        ISSN:<span class="NLM_cas:issn">2005-9256</span>.
    
            (<span class="NLM_cas:orgname">Korean Cancer Association</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) is the epigenetic regulator that induces histone H3 lysine 27 methylation (H3K27me3) and silences specific gene transcription.  Enhancer of zeste homolog 2 (EZH2) is an enzymic subunit of PRC2, and evidence shows that EZH2 plays an essential role in cancer initiation, development, progression, metastasis, and drug resistance.  EZH2 expression is indeed regulated by various oncogenic transcription factors, tumor suppressor miRNAs, and cancer-assocd. non-coding RNA.  EZH2 activity is also controlled by post-translational modifications, which are deregulated in cancer.  The canonical role of EZH2 is gene silencing through H3K27me3, but accumulating evidence shows that EZH2 methlyates substrates other than histone and has methylase-independent functions.  These non-canonical functions of EZH2 are shown to play a role in cancer progression.  In this review, we summarize current information on the regulation and roles of EZH2 in cancer.  We also discuss various therapeutic approaches to targeting EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVidEmS4fsrVg90H21EOLACvtfcHk0ljhRfUu2kpJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlaisLk%253D&md5=78ba72a545b0b8c2c8bb8b255cc76259</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4143%2Fcrt.2014.46.3.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4143%252Fcrt.2014.46.3.209%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DHung%26aufirst%3DM.-C.%26atitle%3DRegulation%2520and%2520Role%2520of%2520EZH2%2520in%2520Cancer%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D46%26spage%3D209%26epage%3D222%26doi%3D10.4143%2Fcrt.2014.46.3.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrette, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">The Polycomb Group Protein EZH2 Is Involved In Progression of Prostate Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1038/nature01075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature01075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=12374981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=624-629&author=S.+Varamballyauthor=S.+M.+Dhanasekaranauthor=M.+Zhouauthor=T.+R.+Barretteauthor=C.+Kumar-Sinhaauthor=M.+G.+Sandaauthor=D.+Ghoshauthor=K.+J.+Pientaauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=The+Polycomb+Group+Protein+EZH2+Is+Involved+In+Progression+of+Prostate+Cancer&doi=10.1038%2Fnature01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is involved in progression of prostate cancer</span></div><div class="casAuthors">Varambally, Sooryanarayana; Dhanasekaran, Saravana M.; Zhou, Ming; Barrette, Terrence R.; Kumar-Sinha, Chandan; Sanda, Martin G.; Ghosh, Debashis; Pienta, Kenneth J.; Sewalt, Richard G. A. B.; Otte, Arie P.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6907</span>),
    <span class="NLM_cas:pages">624-629</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer.  Although effective surgical and radiation treatments exist for clin. localized prostate cancer, metastatic prostate cancer remains essentially incurable.  Here we show, through gene expression profiling, that the polycomb group protein enhancer of zeste homolog 2 (EZH2) is overexpressed in hormone-refractory, metastatic prostate cancer.  Small interfering RNA (siRNA) duplexes targeted against EZH2 reduce the amts. of EZH2 protein present in prostate cells and also inhibit cell proliferation in vitro.  Ectopic expression of EZH2 in prostate cells induces transcriptional repression of a specific cohort of genes.  Gene silencing mediated by EZH2 requires the SET domain and is attenuated by inhibiting histone deacetylase activity.  Amts. of both EZH2 mRNA and EZH2 protein are increased in metastatic prostate cancer; in addn., clin. localized prostate cancers that express higher concns. of EZH2 show a poorer prognosis.  Thus, dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.  Supplementary information on the gene expression profile can be obtained at: http://www.nature.com/nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW_h7gunzd7Vg90H21EOLACvtfcHk0li80acPaTja1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D&md5=c38f80915b4183472aa7be4f9f3ecc67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01075%26sid%3Dliteratum%253Aachs%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DBarrette%26aufirst%3DT.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DSanda%26aufirst%3DM.%2BG.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Polycomb%2520Group%2520Protein%2520EZH2%2520Is%2520Involved%2520In%2520Progression%2520of%2520Prostate%2520Cancer%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D624%26epage%3D629%26doi%3D10.1038%2Fnature01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Qi</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">EZH2 is a Marker of Aggressive Breast Cancer and Promotes Neoplastic Transformation of Breast Epithelial Cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11606</span><span class="NLM_x">–</span> <span class="NLM_lpage">11611</span><span class="refDoi"> DOI: 10.1073/pnas.1933744100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1933744100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=14500907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11606-11611&author=C.+G.+Kleerauthor=Qi+Caoauthor=S.+Varamballyauthor=R.+Shenauthor=I.+Otaauthor=S.+A.+Tomlinsauthor=D.+Ghoshauthor=R.+G.+A.+B.+Sewaltauthor=A.+P.+Otteauthor=D.+F.+Hayesauthor=M.+S.+Sabelauthor=D.+Livantauthor=S.+J.+Weissauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=EZH2+is+a+Marker+of+Aggressive+Breast+Cancer+and+Promotes+Neoplastic+Transformation+of+Breast+Epithelial+Cells&doi=10.1073%2Fpnas.1933744100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span></div><div class="casAuthors">Kleer, Celina G.; Cao, Qi; Varambally, Sooryanarayana; Shen, Ronglai; Ota, Ichiro; Tomlins, Scott A.; Ghosh, Debashis; Sewalt, Richard G. A. B.; Otte, Arie P.; Hayes, Daniel F.; Sabel, Michael S.; Livant, Donna; Weiss, Stephen J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11606-11611</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer.  Here the authors investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression.  EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia.  Tissue microarray anal., which included 917 samples from 280 patients, demonstrated that EZH2 protein levels were strongly assocd. with breast cancer aggressiveness.  Overexpression of EZH2 in immortalized human mammary epithelial cell lines promotes anchorage-independent growth and cell invasion.  EZH2-mediated cell invasion required an intact SET domain and histone deacetylase activity.  This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3vRwhSLDh7Vg90H21EOLACvtfcHk0li80acPaTja1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D&md5=a362e2d0f3c61c8e8b3afd5cea992255</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1933744100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1933744100%26sid%3Dliteratum%253Aachs%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DCao%26aufirst%3DQi%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%2BA.%2BB.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DSabel%26aufirst%3DM.%2BS.%26aulast%3DLivant%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520is%2520a%2520Marker%2520of%2520Aggressive%2520Breast%2520Cancer%2520and%2520Promotes%2520Neoplastic%2520Transformation%2520of%2520Breast%2520Epithelial%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11606%26epage%3D11611%26doi%3D10.1073%2Fpnas.1933744100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">McGrath, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Targeting Histone Lysine Methylation In Cancer</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.pharmthera.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25578037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2015&pages=1-22&author=J.+P.+McGrathauthor=P.+Trojer&title=Targeting+Histone+Lysine+Methylation+In+Cancer&doi=10.1016%2Fj.pharmthera.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone lysine methylation in cancer</span></div><div class="casAuthors">McGrath, John; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Within the vast landscape of histone modifications lysine methylation has gained increasing attention because of its profound regulatory potential.  The methylation of lysine residues on histone proteins modulates chromatin structure and thereby contributes to the regulation of DNA-based nuclear processes such as transcription, replication and repair.  Protein families with opposing catalytic activities, lysine methyltransferases (KMTs) and demethylases (KDMs), dynamically control levels of histone lysine methylation and individual enzymes within these families have become candidate oncol. targets in recent years.  A no. of high quality small mol. inhibitors of these enzymes have been identified.  Several of these compds. elicit selective cancer cell killing in vitro and robust efficacy in vivo, suggesting that targeting 'histone lysine methylation pathways' may be a relevant, emerging cancer therapeutic strategy.  Here, we discuss individual histone lysine methylation pathway targets, the properties of currently available small mol. inhibitors and their application in the context of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqKUpTpHisrVg90H21EOLACvtfcHk0lhJqVmutyR6eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KrtL4%253D&md5=225ece90384f762b248d2d7981fa120e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DJ.%2BP.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DTargeting%2520Histone%2520Lysine%2520Methylation%2520In%2520Cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D150%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.pharmthera.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bauge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazille, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lhuissier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumediene, K.</span><span> </span><span class="NLM_article-title">Histone Methylases as Novel Drug Targets: Developing Inhibitors of EZH2</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span><span class="refDoi"> DOI: 10.4155/fmc.14.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4155%2Ffmc.14.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25495986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyltrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1943-1965&author=C.+Baugeauthor=C.+Bazilleauthor=N.+Girardauthor=E.+Lhuissierauthor=K.+Boumediene&title=Histone+Methylases+as+Novel+Drug+Targets%3A+Developing+Inhibitors+of+EZH2&doi=10.4155%2Ffmc.14.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Histone methylases as novel drug targets: developing inhibitors of EZH2</span></div><div class="casAuthors">Bauge, Catherine; Bazille, Celine; Girard, Nicolas; Lhuissier, Eva; Boumediene, Karim</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1943-1965</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of histones (so-called epigenetic modifications) play a major role in transcriptional control and normal development, and are tightly regulated.  Disruption of their control is a frequent event in disease.  In particular, the methylation of lysine 27 on histone H3 (H3K27), induced by the methylase EZH2, emerges as a key control of gene expression and a major regulator of cell physiol.  The identification of driver mutations in EZH2 has already led to new prognostic and therapeutic advances, and new classes of potent and specific inhibitors for EZH2 show promising results in preclin. trials.  This review examines the roles of histone lysine methylases and demethylases in cells and focuses on the recent knowledge and developments about EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGBaalHroI3rVg90H21EOLACvtfcHk0lhJqVmutyR6eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyltrzO&md5=6f17f44b9556988d35a917ad2f500bdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.123%26sid%3Dliteratum%253Aachs%26aulast%3DBauge%26aufirst%3DC.%26aulast%3DBazille%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DN.%26aulast%3DLhuissier%26aufirst%3DE.%26aulast%3DBoumediene%26aufirst%3DK.%26atitle%3DHistone%2520Methylases%2520as%2520Novel%2520Drug%2520Targets%253A%2520Developing%2520Inhibitors%2520of%2520EZH2%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1943%26epage%3D1965%26doi%3D10.4155%2Ffmc.14.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery of Small-Molecule Inhibitors of the HMT EZH2 for the Treatment of Cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span><span class="refDoi"> DOI: 10.4155/fmc.13.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4155%2Ffmc.13.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=24047271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1661-1670&author=S.+K.+Vermaauthor=S.+D.+Knight&title=Recent+Progress+in+the+Discovery+of+Small-Molecule+Inhibitors+of+the+HMT+EZH2+for+the+Treatment+of+Cancer&doi=10.4155%2Ffmc.13.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer</span></div><div class="casAuthors">Verma, Sharad K.; Knight, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1661-1670</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The histone lysine methyltransferase EZH2 is the catalytic component of the multi-protein PRC2 complex and methylates lysine 27 on histone H3.  EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumor types.  Inhibition of aberrant EZH2 activity might attenuate tumorigenesis resulting from dysregulated gene transcription derived from aberrant EZH2 activity.  In the last year, the first reports of small mols. demonstrating potent and selective inhibition of EZH2 have been published by multiple groups.  Herein, we review recent progress reported in the discovery of small mol. inhibitors of EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIgP1C5IhnrVg90H21EOLACvtfcHk0lhJqVmutyR6eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsLfJ&md5=66387a9bea69b345504ab6d7707cc025</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.136%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520the%2520HMT%2520EZH2%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1661%26epage%3D1670%26doi%3D10.4155%2Ffmc.13.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of EZH2: The Emerging Translational Landscape</span> <span class="citation_source-journal">Epigenomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.2217/epi.15.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.2217%2Fepi.15.14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=337-341&author=H.+Keilhackauthor=J.+J.+Smith&title=Small+Molecule+Inhibitors+of+EZH2%3A+The+Emerging+Translational+Landscape&doi=10.2217%2Fepi.15.14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Fepi.15.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi.15.14%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520EZH2%253A%2520The%2520Emerging%2520Translational%2520Landscape%26jtitle%3DEpigenomics%26date%3D2015%26volume%3D7%26spage%3D337%26epage%3D341%26doi%3D10.2217%2Fepi.15.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Beguelin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezponda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elemento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A. M.</span><span> </span><span class="NLM_article-title">EZH2 Is Required for Germinal Center Formation and Somatic EZH2Mutations Promote Lymphoid Transformation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.ccr.2013.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.ccr.2013.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=677-692&author=W.+Beguelinauthor=R.+Popovicauthor=M.+Teaterauthor=Y.+Jiangauthor=K.+L.+Buntingauthor=M.+Rosenauthor=H.+Shenauthor=S.+N.+Yangauthor=L.+Wangauthor=T.+Ezpondaauthor=E.+Martinez-Garciaauthor=H.+Zhangauthor=Y.+Zhengauthor=S.+K.+Vermaauthor=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+S.+Van+Allerauthor=R.+G.+Krugerauthor=Y.+Liuauthor=C.+F.+McHughauthor=D.+W.+Scottauthor=Y.+R.+Chungauthor=N.+Kelleherauthor=R.+Shaknovichauthor=C.+L.+Creasyauthor=R.+D.+Gascoyneauthor=K.-K.+Wongauthor=L.+Cerchiettiauthor=R.+L.+Levineauthor=O.+Abdel-Wahabauthor=J.+D.+Lichtauthor=O.+Elementoauthor=A.+M.+Melnick&title=EZH2+Is+Required+for+Germinal+Center+Formation+and+Somatic+EZH2Mutations+Promote+Lymphoid+Transformation&doi=10.1016%2Fj.ccr.2013.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBeguelin%26aufirst%3DW.%26aulast%3DPopovic%26aufirst%3DR.%26aulast%3DTeater%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DBunting%26aufirst%3DK.%2BL.%26aulast%3DRosen%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEzponda%26aufirst%3DT.%26aulast%3DMartinez-Garcia%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DScott%26aufirst%3DD.%2BW.%26aulast%3DChung%26aufirst%3DY.%2BR.%26aulast%3DKelleher%26aufirst%3DN.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DElemento%26aufirst%3DO.%26aulast%3DMelnick%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520Is%2520Required%2520for%2520Germinal%2520Center%2520Formation%2520and%2520Somatic%2520EZH2Mutations%2520Promote%2520Lymphoid%2520Transformation%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D677%26epage%3D692%26doi%3D10.1016%2Fj.ccr.2013.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor of EZH2 Blocks H3K27 Methylation and Kills Mutant Lymphoma Cells</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1038/nchembio.1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnchembio.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=23023262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=890-896&author=S.+K.+Knutsonauthor=T.+J.+Wigleauthor=N.+M.+Warholicauthor=C.+J.+Sneeringerauthor=C.+J.+Allainauthor=C.+R.+Klausauthor=J.+D.+Sacksauthor=A.+Raimondiauthor=C.+R.+Majerauthor=J.+Songauthor=M.+P.+Scottauthor=L.+Jinauthor=J.+J.+Smithauthor=E.+J.+Olhavaauthor=R.+Chesworthauthor=M.+Moyerauthor=V.+M.+Richonauthor=R.+A.+Copelandauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=K.+W.+Kuntz&title=A+Selective+Inhibitor+of+EZH2+Blocks+H3K27+Methylation+and+Kills+Mutant+Lymphoma+Cells&doi=10.1038%2Fnchembio.1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span></div><div class="casAuthors">Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27).  Point mutations of EZH2 at Tyr 641 and Ala 677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation.  Here the authors report the discovery of EPZ005687, a potent inhibitor of EZH2 (Ki of 24 nM).  EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1.  The compd. reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr 641 or Ala 677 mutant cells, with minimal effects on the proliferation of wild-type cells.  These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr 641 or Ala 677) results in a crit. dependency on enzymic activity for proliferation (i.e., the equiv. of oncogene addiction), thus portending the clin. use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohlduVbTgWJrVg90H21EOLACvtfcHk0lgjFhUUFhXY8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP&md5=a9ad7a41505e3fd4aa087d9f5dae8825</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1084%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DSacks%26aufirst%3DJ.%2BD.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520EZH2%2520Blocks%2520H3K27%2520Methylation%2520and%2520Kills%2520Mutant%2520Lymphoma%2520Cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D890%26epage%3D896%26doi%3D10.1038%2Fnchembio.1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span> </span><span class="NLM_article-title">Durable Tumor Regression in Genetically Altered Malignant Rhabdoid Tumors by Inhibition of Methyltransferase EZH2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7922</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1073/pnas.1303800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1303800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=23620515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=7922-7927&author=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=T.+J.+Wigleauthor=C.+R.+Klausauthor=C.+J.+Allainauthor=A.+Raimondiauthor=M.+P.+Scottauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=V.+M.+Richonauthor=R.+M.+Pollockauthor=K.+W.+Kuntzauthor=H.+Keilhack&title=Durable+Tumor+Regression+in+Genetically+Altered+Malignant+Rhabdoid+Tumors+by+Inhibition+of+Methyltransferase+EZH2&doi=10.1073%2Fpnas.1303800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span></div><div class="casAuthors">Knutson, Sarah K.; Warholic, Natalie M.; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Scott, Margaret Porter; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Pollock, Roy M.; Kuntz, Kevin W.; Keilhack, Heike</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7922-7927, S7922/1-S7922/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid rhabdoid tumors.  This alteration is hypothesized to confer oncogenic dependency on EZH2 in these cancers.  The authors report the discovery of a potent, selective, and orally bioavailable small-mol. inhibitor of EZH2 enzymic activity, (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide).  The compd. induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.  Treatment of xenograft-bearing mice with (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide) leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation.  These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRIJfPhwLA7Vg90H21EOLACvtfcHk0lgjFhUUFhXY8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D&md5=c2c6470d48a13ab8343db0a09465ba42</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1303800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1303800110%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26atitle%3DDurable%2520Tumor%2520Regression%2520in%2520Genetically%2520Altered%2520Malignant%2520Rhabdoid%2520Tumors%2520by%2520Inhibition%2520of%2520Methyltransferase%2520EZH2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D7922%26epage%3D7927%26doi%3D10.1073%2Fpnas.1303800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter-Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span> </span><span class="NLM_article-title">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+Importance+of+Being+Me%3A+Magic+Methyls%2C+Methyltransferase+Inhibitors%2C+and+the+Discovery+of+Tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span></div><div class="casAuthors">Kuntz, Kevin W.; Campbell, John E.; Keilhack, Heike; Pollock, Roy M.; Knutson, Sarah K.; Porter-Scott, Margaret; Richon, Victoria M.; Sneeringer, Chris J.; Wigle, Tim J.; Allain, Christina J.; Majer, Christina R.; Moyer, Mikel P.; Copeland, Robert A.; Chesworth, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Posttranslational methylation of histones plays a crit. role in gene regulation.  Misregulation of histone methylation can lead to oncogenic transformation.  Enhancer of Zeste homolog 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers.  Tazemetostat, an EHZ2 inhibitor in clin. development, has shown activity in both preclin. models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors.  Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clin. development.  The importance of several Me groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryASbIgMDxAbVg90H21EOLACvtfcHk0lj3Vkaah8s6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D&md5=a26ccc4a0109f57fbb64f7fded8965a1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520Importance%2520of%2520Being%2520Me%253A%2520Magic%2520Methyls%252C%2520Methyltransferase%2520Inhibitors%252C%2520and%2520the%2520Discovery%2520of%2520Tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust In Vivo Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=491-495&author=J.+E.+Campbellauthor=K.+W.+Kuntzauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=H.+Keilhackauthor=T.+J.+Wigleauthor=A.+Raimondiauthor=C.+R.+Klausauthor=N.+Riouxauthor=A.+Yokoiauthor=S.+Kawanoauthor=Y.+Minoshimaauthor=H.-W.+Choiauthor=M.+P.+Scottauthor=N.+J.+Watersauthor=J.+J.+Smithauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copeland&title=EPZ011989%2C+A+Potent%2C+Orally-Available+EZH2+Inhibitor+with+Robust+In+Vivo+Activity&doi=10.1021%2Facsmedchemlett.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity</span></div><div class="casAuthors">Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Porter Scott, Margaret; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications.  The ability of the scientific community to explore fully the spectrum of EZH2-assocd. pathobiol. has been hampered by the lack of in vivo-active tool compds. for this enzyme.  Here the authors report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties.  EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma.  Hence, this compd. represents a powerful tool for the expanded exploration of EZH2 activity in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqfVfbr3kS67Vg90H21EOLACvtfcHk0lj3Vkaah8s6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D&md5=21fa182b2474678f663459a9dc2878e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DYokoi%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DS.%26aulast%3DMinoshima%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.-W.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEPZ011989%252C%2520A%2520Potent%252C%2520Orally-Available%2520EZH2%2520Inhibitor%2520with%2520Robust%2520In%2520Vivo%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D491%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machutta, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">Identification of Potent, Selective Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/ml3003346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1091-1096&author=S.+K.+Vermaauthor=X.+Tianauthor=L.+V.+LaFranceauthor=C.+Duquenneauthor=D.+P.+Suarezauthor=K.+A.+Newlanderauthor=S.+P.+Romerilauthor=J.+L.+Burgessauthor=S.+W.+Grantauthor=J.+A.+Brackleyauthor=A.+P.+Gravesauthor=D.+A.+Scherzerauthor=A.+Shuauthor=C.+Thompsonauthor=H.+M.+Ottauthor=G.+S.+Van+Allerauthor=C.+A.+Machuttaauthor=E.+Diazauthor=Y.+Jiangauthor=N.+W.+Johnsonauthor=S.+D.+Knightauthor=R.+G.+Krugerauthor=M.+T.+McCabeauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Creasyauthor=W.+H.+Miller&title=Identification+of+Potent%2C+Selective+Cell-Active+Inhibitors+of+the+Histone+Lysine+Methyltransferase+EZH2&doi=10.1021%2Fml3003346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml3003346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003346%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DSuarez%26aufirst%3DD.%2BP.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DBrackley%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%2BA.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DMachutta%26aufirst%3DC.%2BA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DIdentification%2520of%2520Potent%252C%2520Selective%2520Cell-Active%2520Inhibitors%2520of%2520the%2520Histone%2520Lysine%2520Methyltransferase%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1091%26epage%3D1096%26doi%3D10.1021%2Fml3003346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Pietra, A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span> </span><span class="NLM_article-title">EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2-Aactivating Mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature11606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=108-112&author=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+Ganjiauthor=S.+Korenchukauthor=C.+Thompsonauthor=G.+S.+Van+Allerauthor=Y.+Liuauthor=A.+P.+Gravesauthor=A.+Della+Pietraauthor=E.+Diazauthor=L.+V.+LaFranceauthor=M.+Mellingerauthor=C.+Duquenneauthor=X.+Tianauthor=R.+G.+Krugerauthor=C.+F.+McHughauthor=M.+Brandtauthor=W.+H.+Millerauthor=D.+Dhanakauthor=S.+K.+Vermaauthor=P.+J.+Tumminoauthor=C.+L.+Creasy&title=EZH2+Inhibition+as+a+Therapeutic+Strategy+for+Lymphoma+with+EZH2-Aactivating+Mutations&doi=10.1038%2Fnature11606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11606%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DDella%2BPietra%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26atitle%3DEZH2%2520Inhibition%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Lymphoma%2520with%2520EZH2-Aactivating%2520Mutations%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNevin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1021/cb400133j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400133j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1324-1334&author=K.+D.+Konzeauthor=A.+Maauthor=F.+Liauthor=D.+Barsyte-Lovejoyauthor=T.+Partonauthor=C.+J.+MacNevinauthor=F.+Liuauthor=C.+Gaoauthor=X.-P.+Huangauthor=E.+Kuznetsovaauthor=M.+Rougieauthor=A.+Jiangauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=L.+I.+Jamesauthor=B.+L.+Rothauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=K.+M.+Hahnauthor=G.+G.+Wangauthor=M.+Vedadiauthor=J.+Jin&title=An+Orally+Bioavailable+Chemical+Probe+of+the+Lysine+Methyltransferases+EZH2+and+EZH1&doi=10.1021%2Fcb400133j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span></div><div class="casAuthors">Konze, Kyle D.; Ma, Anqi; Li, Fengling; Barsyte-Lovejoy, Dalia; Parton, Trevor; MacNevin, Christopher J.; Liu, Feng; Gao, Cen; Huang, Xi-Ping; Kuznetsova, Ekaterina; Rougie, Marie; Jiang, Alice; Pattenden, Samantha G.; Norris, Jacqueline L.; James, Lindsey I.; Roth, Bryan L.; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Hahn, Klaus M.; Wang, Gang Greg; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1324-1334</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylation of histone H3 lysine 27 (H3K27).  The trimethylation of H3K27 (H3K27me3) is a transcriptionally repressive post-translational modification.  Overexpression of EZH2 and hypertrimethylation of H3K27 have been implicated in a no. of cancers.  Several selective inhibitors of EZH2 have been reported recently.  Herein we disclose UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wild-type and mutant EZH2 as well as EZH1, a closely related H3K27 methyltransferase that shares 96% sequence identity with EZH2 in their resp. catalytic domains.  UNC1999 was highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM and non-competitive with the peptide substrate.  This inhibitor potently reduced H3K27me3 levels in cells and selectively killed diffused large B cell lymphoma cell lines harboring the EZH2Y641N mutant.  Importantly, UNC1999 was orally bioavailable in mice, making this inhibitor a valuable tool for investigating the role of EZH2 and EZH1 in chronic animal studies.  We also designed and synthesized UNC2400, a close analog of UNC1999 with potency >1,000-fold lower than that of UNC1999 as a neg. control for cell-based studies.  Finally, we created a biotin-tagged UNC1999 (UNC2399), which enriched EZH2 in pull-down studies, and a UNC1999-dye conjugate (UNC2239) for co-localization studies with EZH2 in live cells.  Taken together, these compds. represent a set of useful tools for the biomedical community to investigate the role of EZH2 and EZH1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzhUO0iAe8BbVg90H21EOLACvtfcHk0lgnOMpTGu5EAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D&md5=311d77f5f0cc0b9e2610d8d002a6709c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb400133j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400133j%26sid%3Dliteratum%253Aachs%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DMacNevin%26aufirst%3DC.%2BJ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DKuznetsova%26aufirst%3DE.%26aulast%3DRougie%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DA.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DJames%26aufirst%3DL.%2BI.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DHahn%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DG.%2BG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DAn%2520Orally%2520Bioavailable%2520Chemical%2520Probe%2520of%2520the%2520Lysine%2520Methyltransferases%2520EZH2%2520and%2520EZH1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1324%26epage%3D1334%26doi%3D10.1021%2Fcb400133j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardayfio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span> </span><span class="NLM_article-title">Selective Inhibition of EZH2 by a Small Molecule Inhibitor Blocks Tumor Cell Proliferation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">21360</span><span class="NLM_x">–</span> <span class="NLM_lpage">21365</span><span class="refDoi"> DOI: 10.1073/pnas.1210371110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1210371110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21360-21365&author=W.+Qiauthor=H.+Chanauthor=L.+Tengauthor=L.+Liauthor=S.+Chuaiauthor=R.+Zhangauthor=J.+Zengauthor=M.+Liauthor=H.+Fanauthor=Y.+Linauthor=J.+Guauthor=O.+Ardayfioauthor=J.-H.+Zhangauthor=X.+Yanauthor=J.+Fangauthor=Y.+Miauthor=M.+Zhangauthor=T.+Zhouauthor=G.+Fengauthor=Z.+Chenauthor=G.+Liauthor=T.+Yangauthor=K.+Zhaoauthor=X.+Liuauthor=Z.+Yuauthor=C.+X.+Luauthor=P.+Atadjaauthor=E.+Li&title=Selective+Inhibition+of+EZH2+by+a+Small+Molecule+Inhibitor+Blocks+Tumor+Cell+Proliferation&doi=10.1073%2Fpnas.1210371110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210371110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210371110%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChuai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DArdayfio%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DC.%2BX.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DE.%26atitle%3DSelective%2520Inhibition%2520of%2520EZH2%2520by%2520a%2520Small%2520Molecule%2520Inhibitor%2520Blocks%2520Tumor%2520Cell%2520Proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21360%26epage%3D21365%26doi%3D10.1073%2Fpnas.1210371110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bradley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.chembiol.2014.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25457180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1463-1475&author=W.+D.+Bradleyauthor=S.+Aroraauthor=J.+Busbyauthor=S.+Balasubramanianauthor=V.+Gehlingauthor=C.+G.+Nasveschukauthor=R.+G.+Vaswaniauthor=C.-C.+Yuanauthor=C.+Hattonauthor=F.+Zhaoauthor=K.+E.+Williamsonauthor=P.+Iyerauthor=J.+M%C3%A9ndezauthor=R.+Campbellauthor=N.+Cantoneauthor=S.+Garapaty-Raoauthor=J.+Audiaauthor=A.+S.+Cookauthor=L.+A.+Dakinauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=D.+L.+Danielsauthor=R.+T.+Cummingsauthor=B.+M.+Bryantauthor=E.+Normantauthor=P.+Trojer&title=EZH2+Inhibitor+Efficacy+in+Non-Hodgkin%E2%80%99s+Lymphoma+Does+Not+Require+Suppression+of+H3K27+Monomethylation&doi=10.1016%2Fj.chembiol.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span></div><div class="casAuthors">Bradley, William D.; Arora, Shilpi; Busby, Jennifer; Balasubramanian, Srividya; Gehling, Victor S.; Nasveschuk, Christopher G.; Vaswani, Rishi G.; Yuan, Chih-Chi; Hatton, Charlie; Zhao, Feng; Williamson, Kaylyn E.; Iyer, Priyadarshini; Mendez, Jacqui; Campbell, Robert; Cantone, Nico; Garapaty-Rao, Shivani; Audia, James E.; Cook, Andrew S.; Dakin, Les A.; Albrecht, Brian K.; Harmange, Jean-Christophe; Daniels, Danette L.; Cummings, Richard T.; Bryant, Barbara M.; Normant, Emmanuel; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1475</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone lysine methyltransferase (MT) Enhancer of Zeste Homolog 2 (EZH2) is considered an oncogenic driver in a subset of germinal center B-cell-like diffuse large B cell lymphoma (GCB-DLBCL) and follicular lymphoma due to the presence of recurrent, monoallelic mutations in the EZH2 catalytic domain.  These genomic data suggest that targeting the EZH2 MT activity is a valid therapeutic strategy for the treatment of lymphoma patients with EZH2 mutations.  Here we report the identification of highly potent and selective EZH2 small mol. inhibitors, their validation by a cellular thermal shift assay, application across a large cell panel representing various non-Hodgkin's lymphoma (NHL) subtypes, and their efficacy in EZH2 mutant-contg. GCB-DLBCL xenograft models.  Surprisingly, our EZH2 inhibitors selectively affect the turnover of trimethylated, but not monomethylated histone H3 lysine 27 at pharmacol. relevant doses.  Importantly, we find that these inhibitors are broadly efficacious also in NHL models with wild-type EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxrMoLW0OWCbVg90H21EOLACvtfcHk0lhQUdpuN090Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE&md5=40b8f604e762dda9420afedede75fd36</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DW.%2BD.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DGehling%26aufirst%3DV.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DYuan%26aufirst%3DC.-C.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWilliamson%26aufirst%3DK.%2BE.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DEZH2%2520Inhibitor%2520Efficacy%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%2520Does%2520Not%2520Require%2520Suppression%2520of%2520H3K27%2520Monomethylation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1463%26epage%3D1475%26doi%3D10.1016%2Fj.chembiol.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, Design, and Synthesis of Indole-Based EZH2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+Design%2C+and+Synthesis+of+Indole-Based+EZH2+Inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520Design%252C%2520and%2520Synthesis%2520of%2520Indole-Based%2520EZH2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C. P.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1021/ml400494b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400494b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=378-383&author=C.+G.+Nasveschukauthor=A.+Gagnonauthor=S.+Garapaty-Raoauthor=S.+Balasubramanianauthor=R.+Campbellauthor=C.+Leeauthor=F.+Zhaoauthor=L.+Bergeronauthor=R.+Cummingsauthor=P.+Trojerauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.-C.+P.+Harmange&title=Discovery+and+Optimization+of+Tetramethylpiperidinyl+Benzamides+as+Inhibitors+of+EZH2&doi=10.1021%2Fml400494b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2</span></div><div class="casAuthors">Nasveschuk, Christopher G.; Gagnon, Alexandre; Garapaty-Rao, Shivani; Balasubramanian, Srividya; Campbell, Robert; Lee, Christina; Zhao, Feng; Bergeron, Louise; Cummings, Richard; Trojer, Patrick; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">378-383</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification and development of a novel series of small mol. Enhancer of Zeste Homolog 2 (EZH2) inhibitors is described.  A concise and modular synthesis enabled the rapid development of structure-activity relationships, which led to the identification of I as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-T4S47cYnxrVg90H21EOLACvtfcHk0lh7E7uL_dJmkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjtw%253D%253D&md5=059381c9e416ee50fb37a8cf3ccef239</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fml400494b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400494b%26sid%3Dliteratum%253Aachs%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%2BP.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Tetramethylpiperidinyl%2520Benzamides%2520as%2520Inhibitors%2520of%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D378%26epage%3D383%26doi%3D10.1021%2Fml400494b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.chembiol.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=24183969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1329-1339&author=S.+Garapaty-Raoauthor=C.+Nasveschukauthor=A.+Gagnonauthor=E.+Y.+Chanauthor=P.+Sandyauthor=J.+Busbyauthor=S.+Balasubramanianauthor=R.+Campbellauthor=F.+Zhaoauthor=L.+Bergeronauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=R.+Cummingsauthor=P.+Trojer&title=Identification+of+EZH2+and+EZH1+Small+Molecule+Inhibitors+with+Selective+Impact+on+Diffuse+Large+B+Cell+Lymphoma+Cell+Growth&doi=10.1016%2Fj.chembiol.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span></div><div class="casAuthors">Garapaty-Rao, Shivani; Nasveschuk, Christopher; Gagnon, Alexandre; Chan, Eric Y.; Sandy, Peter; Busby, Jennifer; Balasubramanian, Srividya; Campbell, Robert; Zhao, Feng; Bergeron, Louise; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe; Cummings, Richard; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of Zeste homolog 2 (EZH2) is a candidate oncogene due to its prevalent overexpression in malignant diseases, including late stage prostate and breast cancers.  The dependency of cancer cells on EZH2 activity is also predicated by recurrent missense mutations residing in the catalytic domain of EZH2 that have been identified in subtypes of diffuse large B cell lymphoma, follicular lymphoma and melanoma.  Herein, we report the identification of a highly selective small mol. inhibitor series of EZH2 and EZH1.  These compds. inhibit wild-type and mutant versions of EZH2 with nanomolar potency, suppress global histone H3-lysine 27 methylation, affect gene expression, and cause selective proliferation defects.  These compds. represent a structurally distinct EZH2 inhibitor chemotype for the exploration of the role of Polycomb Repressive Complex 2-mediated H3K27 methylation in various biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNGhFRO6LRbVg90H21EOLACvtfcHk0lh7E7uL_dJmkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP&md5=6079ba01ae1f1964ac1d8108aa5e1227</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DNasveschuk%26aufirst%3DC.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DE.%2BY.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520EZH2%2520and%2520EZH1%2520Small%2520Molecule%2520Inhibitors%2520with%2520Selective%2520Impact%2520on%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%2520Cell%2520Growth%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.chembiol.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Morgenthaler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Röder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span> </span><span class="NLM_article-title">Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-R%C3%B6derauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+M%C3%BCller&title=Predicting+and+Tuning+Physicochemical+Properties+in+Lead+Optimization%3A+Amine+Basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lg0PhLbITOwdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-R%25C3%25B6der%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520Tuning%2520Physicochemical%2520Properties%2520in%2520Lead%2520Optimization%253A%2520Amine%2520Basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wuitschik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span> </span><span class="NLM_article-title">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3246</span><span class="refDoi"> DOI: 10.1021/jm9018788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+M%C3%BCller&title=Oxetanes+in+Drug+Discovery%3A+Structural+and+Synthetic+Insights&doi=10.1021%2Fjm9018788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0lg0PhLbITOwdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520Drug%2520Discovery%253A%2520Structural%2520and%2520Synthetic%2520Insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246%26doi%3D10.1021%2Fjm9018788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haire, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Structural Basis of Oncogenic Histone H3K27M Inhibition of Human Polycomb Repressive Complex 2</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11316</span><span class="NLM_x">–</span> <span class="NLM_lpage">111326</span><span class="refDoi"> DOI: 10.1038/ncomms11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fncomms11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=27121947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11316-111326&author=N.+Justinauthor=Y.+Zhangauthor=C.+Tarriconeauthor=S.+R.+Martinauthor=S.+Chenauthor=E.+Underwoodauthor=V.+De+Marcoauthor=L.+F.+Haireauthor=P.+A.+Walkerauthor=D.+Reinbergauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Structural+Basis+of+Oncogenic+Histone+H3K27M+Inhibition+of+Human+Polycomb+Repressive+Complex+2&doi=10.1038%2Fncomms11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span></div><div class="casAuthors">Justin, Neil; Zhang, Ying; Tarricone, Cataldo; Martin, Stephen R.; Chen, Shuyang; Underwood, Elizabeth; De Marco, Valeria; Haire, Lesley F.; Walker, Philip A.; Reinberg, Danny; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11316</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) silences gene expression through trimethylation of K27 of histone H3 (H3K27me3) via its catalytic SET domain.  A missense mutation in the substrate of PRC2, histone H3K27M, is assocd. with certain pediatric brain cancers and is linked to a global decrease of H3K27me3 in the affected cells thought to be mediated by inhibition of PRC2 activity.  We present here the crystal structure of human PRC2 in complex with the inhibitory H3K27M peptide bound to the active site of the SET domain, with the methionine residue located in the pocket that normally accommodates the target lysine residue.  The structure and binding studies suggest a mechanism for the oncogenic inhibition of H3K27M.  The structure also reveals how binding of repressive marks, like H3K27me3, to the EED subunit of the complex leads to enhancement of the catalytic efficiency of the SET domain and thus the propagation of this repressive histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwqJGbneSdbVg90H21EOLACvtfcHk0ljEy0_mvDqI6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D&md5=516a8ef27712c9776e8ee0681cd91289</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11316%26sid%3Dliteratum%253Aachs%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520Basis%2520of%2520Oncogenic%2520Histone%2520H3K27M%2520Inhibition%2520of%2520Human%2520Polycomb%2520Repressive%2520Complex%25202%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11316%26epage%3D111326%26doi%3D10.1038%2Fncomms11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gibaja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harari, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz-Vash, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejtar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. M.</span><span> </span><span class="NLM_article-title">Development of secondary mutations in wild-type and mutant EZH2 alleles cooperate to confer resistance to EZH2 inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1038/onc.2015.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fonc.2015.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=558-566&author=V.+Gibajaauthor=F.+Shenauthor=J.+Harariauthor=J.+Kornauthor=D.+Ruddyauthor=V.+Saenz-Vashauthor=H.+Zhaiauthor=T.+Rejtarauthor=C.+G.+Parisauthor=Z.+Yuauthor=M.+Liraauthor=D.+Kingauthor=W.+Qiauthor=N.+Keenauthor=A.+Q.+Hassanauthor=H.+M.+Chan&title=Development+of+secondary+mutations+in+wild-type+and+mutant+EZH2+alleles+cooperate+to+confer+resistance+to+EZH2+inhibitors&doi=10.1038%2Fonc.2015.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.114%26sid%3Dliteratum%253Aachs%26aulast%3DGibaja%26aufirst%3DV.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DHarari%26aufirst%3DJ.%26aulast%3DKorn%26aufirst%3DJ.%26aulast%3DRuddy%26aufirst%3DD.%26aulast%3DSaenz-Vash%26aufirst%3DV.%26aulast%3DZhai%26aufirst%3DH.%26aulast%3DRejtar%26aufirst%3DT.%26aulast%3DParis%26aufirst%3DC.%2BG.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLira%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DHassan%26aufirst%3DA.%2BQ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26atitle%3DDevelopment%2520of%2520secondary%2520mutations%2520in%2520wild-type%2520and%2520mutant%2520EZH2%2520alleles%2520cooperate%2520to%2520confer%2520resistance%2520to%2520EZH2%2520inhibitors%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fonc.2015.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grable, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span> </span><span class="NLM_article-title">Polycomb Repressive Complex 2 Structure with Inhibitor Reveals a Mechanism of Activation and Drug Resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11384</span><span class="refDoi"> DOI: 10.1038/ncomms11384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fncomms11384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=27122193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11384&author=A.+Broounauthor=K.+S.+Gajiwalaauthor=Y.-L.+Dengauthor=W.+Liuauthor=B.+Bolanosauthor=P.+Binghamauthor=Y.-A.+Heauthor=W.+Diehlauthor=N.+Grableauthor=P.-P.+Kungauthor=S.+Suttonauthor=K.+A.+Maegleyauthor=X.+Yuauthor=A.+E.+Stewart&title=Polycomb+Repressive+Complex+2+Structure+with+Inhibitor+Reveals+a+Mechanism+of+Activation+and+Drug+Resistance&doi=10.1038%2Fncomms11384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span></div><div class="casAuthors">Brooun, Alexei; Gajiwala, Ketan S.; Deng, Ya-Li; Liu, Wei; Bolanos, Ben; Bingham, Patrick; He, You-Ai; Diehl, Wade; Grable, Nicole; Kung, Pei-Pei; Sutton, Scott; Maegley, Karen A.; Yu, Xiu; Stewart, Al E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11384</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) mediates gene silencing through chromatin reorganization by methylation of histone H3 lysine 27 (H3K27).  Overexpression of the complex and point mutations in the individual subunits of PRC2 have been shown to contribute to tumorigenesis.  Several inhibitors of the PRC2 activity have shown efficacy in EZH2-mutated lymphomas and are currently in clin. development, although the mol. basis of inhibitor recognition remains unknown.  Here we report the crystal structures of the inhibitor-bound wild-type and Y641N PRC2.  The structures illuminate an important role played by a stretch of 17 residues in the N-terminal region of EZH2, we call the activation loop, in the stimulation of the enzyme activity, inhibitor recognition and the potential development of the mutation-mediated drug resistance.  The work presented here provides new avenues for the design and development of next-generation PRC2 inhibitors through establishment of a structure-based drug design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuWyWQoRoObVg90H21EOLACvtfcHk0ljEy0_mvDqI6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D&md5=15ded613fdc3cafe35bee914678ab65e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fncomms11384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11384%26sid%3Dliteratum%253Aachs%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.-A.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DGrable%26aufirst%3DN.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26atitle%3DPolycomb%2520Repressive%2520Complex%25202%2520Structure%2520with%2520Inhibitor%2520Reveals%2520a%2520Mechanism%2520of%2520Activation%2520and%2520Drug%2520Resistance%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11384%26doi%3D10.1038%2Fncomms11384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83737</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1371%2Fjournal.pone.0083737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83737&author=H.+Wuauthor=H.+Zengauthor=A.+Dongauthor=F.+Liauthor=H.+Heauthor=G.+Senisterraauthor=A.+Seitovaauthor=S.+Duanauthor=P.+J.+Brownauthor=M.+Vedadiauthor=C.+H.+Arrowsmithauthor=M.+Schapira&title=Structure+of+the+Catalytic+Domain+of+EZH2+Reveals+Conformational+Plasticity+in+Cofactor+and+Substrate+Binding+Sites+and+Explains+Oncogenic+Mutations&doi=10.1371%2Fjournal.pone.0083737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083737%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DSeitova%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520EZH2%2520Reveals%2520Conformational%2520Plasticity%2520in%2520Cofactor%2520and%2520Substrate%2520Binding%2520Sites%2520and%2520Explains%2520Oncogenic%2520Mutations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83737%26doi%3D10.1371%2Fjournal.pone.0083737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span> </span><span class="NLM_article-title">A Practical Synthesis of Indoles via a Pd-Catalyzed C–N Ring Formation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4117</span><span class="refDoi"> DOI: 10.1021/ol5018118</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5018118" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=4114-4117&author=R.+G.+Vaswaniauthor=B.+K.+Albrechtauthor=J.+E.+Audiaauthor=A.+Coteauthor=L.+A.+Dakinauthor=M.+Duplessisauthor=V.+S.+Gehlingauthor=J.-C.+Harmangeauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=A.+M.+Taylor&title=A+Practical+Synthesis+of+Indoles+via+a+Pd-Catalyzed+C%E2%80%93N+Ring+Formation&doi=10.1021%2Fol5018118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol5018118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5018118%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DA%2520Practical%2520Synthesis%2520of%2520Indoles%2520via%2520a%2520Pd-Catalyzed%2520C%25E2%2580%2593N%2520Ring%2520Formation%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D4114%26epage%3D4117%26doi%3D10.1021%2Fol5018118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span>Chiral amine <b>15</b> was synthesized according to procedure outlined by <span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Cook, A. S.; Dakin, L. A.; Duplessis, M.; Gehling, V. S.; Harmange, J.-C.; Nasveschuk, C. G.; Vaswani, R. G.</span> PCT Int. Appl. WO 2013120104 A2, August 15, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chiral+amine+15+was+synthesized+according+to+procedure+outlined+by+Albrecht%2C+B.+K.%3B+Audia%2C+J.+E.%3B+Cook%2C+A.+S.%3B+Dakin%2C+L.+A.%3B+Duplessis%2C+M.%3B+Gehling%2C+V.+S.%3B+Harmange%2C+J.-C.%3B+Nasveschuk%2C+C.+G.%3B+Vaswani%2C+R.+G.+PCT+Int.+Appl.+WO+2013120104+A2%2C+August+15%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Chiral amine <b>15</b> was resolved according to the procedure outline by <span class="NLM_contrib-group">Mortimore, M.; Young, S. C.; Everitt, S. R. L.; Knegtel, R.; Pinder, J. L.; Rutherford, A. P.; Durrant, S.; Brenchley, G.; Charrier, J. D.; O’Donnell, M.</span> PCT Int. Appl. WO 2008079346 A1, July 3, 2008.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chiral+amine+15+was+resolved+according+to+the+procedure+outline+by+Mortimore%2C+M.%3B+Young%2C+S.+C.%3B+Everitt%2C+S.+R.+L.%3B+Knegtel%2C+R.%3B+Pinder%2C+J.+L.%3B+Rutherford%2C+A.+P.%3B+Durrant%2C+S.%3B+Brenchley%2C+G.%3B+Charrier%2C+J.+D.%3B+O%E2%80%99Donnell%2C+M.+PCT+Int.+Appl.+WO+2008079346+A1%2C+July+3%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMortimore%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">Supporting Information</a> section.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">Supporting Information</a> for further details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':[],'ref34':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 101 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Daohai Du, Dandan Xu, Licheng Zhu, Giulia Stazi, Clemens Zwergel, Yanli Liu, Zhongyuan Luo, Yuanqing Li, Yuanyuan Zhang, Kongkai Zhu, Yiluan Ding, Jingqiu Liu, Shijie Fan, Kaiyan Zhao, Naixia Zhang, Xiangqian Kong, Hualiang Jiang, Kaixian Chen, Kehao Zhao, Sergio Valente, Jinrong Min, Wenhu Duan, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2–EED Interaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8194-8207. <a href="https://doi.org/10.1021/acs.jmedchem.0c02261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDevelopment%252Bof%252BSmall-Molecule%252BPRC2%252BInhibitors%252BTargeting%252BEZH2%2525E2%252580%252593EED%252BInteraction%26aulast%3DDu%26aufirst%3DDaohai%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30122020%26date%3D02062021%26volume%3D64%26issue%3D12%26spage%3D8194%26epage%3D8207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhihao Liu, Xi Hu, Qiwei Wang, Xiuli Wu, Qiangsheng Zhang, Wei Wei, Xingping Su, Hualong He, Shuyan Zhou, Rong Hu, Tinghong Ye, Yongxia Zhu, Ningyu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Luoting Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2829-2848. <a href="https://doi.org/10.1021/acs.jmedchem.0c02234" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02234%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BEZH2-Based%252BPROTACs%252Bto%252BDegrade%252Bthe%252BPRC2%252BComplex%252Bfor%252BTargeting%252Bthe%252BNoncatalytic%252BActivity%252Bof%252BEZH2%26aulast%3DLiu%26aufirst%3DZhihao%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24122020%26date%3D19022021%26volume%3D64%26issue%3D5%26spage%3D2829%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pei-Pei Kung, Connie Fan, Hovhannes J. Gukasyan, Buwen Huang, Susan Kephart, Manfred Kraus, Joseph H. Lee, Scott C. Sutton, Shinji Yamazaki, <span class="NLM_string-name hlFld-ContribAuthor">Luke Zehnder</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Characterization of a Pyridone-Containing EZH2 Inhibitor Phosphate Prodrug. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1725-1732. <a href="https://doi.org/10.1021/acs.jmedchem.0c02112" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BCharacterization%252Bof%252Ba%252BPyridone-Containing%252BEZH2%252BInhibitor%252BPhosphate%252BProdrug%26aulast%3DKung%26aufirst%3DPei-Pei%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D07122020%26date%3D02022021%26volume%3D64%26issue%3D3%26spage%3D1725%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">M. Cynthia Martin, Guihua Zeng, Jindan Yu, <span class="NLM_string-name hlFld-ContribAuthor">Gary E. Schiltz</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15344-15370. <a href="https://doi.org/10.1021/acs.jmedchem.0c01344" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01344%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BApproaches%252Bfor%252BTargeting%252Bthe%252BPolycomb%252BRepressive%252BComplex%252B2%252B%252528PRC2%252529%252Bin%252BCancer%26aulast%3DMartin%26aufirst%3DM.%2BCynthia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31072020%26date%3D07122020%26volume%3D63%26issue%3D24%26spage%3D15344%26epage%3D15370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily J. Hanan, Jun Liang, Xiaojing Wang, Robert A. Blake, Nicole Blaquiere, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Monomeric Targeted Protein Degraders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11330-11361. <a href="https://doi.org/10.1021/acs.jmedchem.0c00093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMonomeric%252BTargeted%252BProtein%252BDegraders%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17012020%26date%3D15062020%26date%3D30042020%26volume%3D63%26issue%3D20%26spage%3D11330%26epage%3D11361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Avinash Khanna, Alexandre Côté, Shilpi Arora, Ludivine Moine, Victor S. Gehling, Jehrod Brenneman, Nico Cantone, Jacob I. Stuckey, Shruti Apte, Ashwin Ramakrishnan, Kamil Bruderek, William D. Bradley, James E. Audia, Richard T. Cummings, Robert J. Sims III, Patrick Trojer, <span class="NLM_string-name hlFld-ContribAuthor">Julian R. Levell</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1205-1212. <a href="https://doi.org/10.1021/acsmedchemlett.0c00045" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00045%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BSecond%252BGeneration%252BEZH2%252BInhibitors%252Bwith%252BLong%252BResidence%252BTime%26aulast%3DKhanna%26aufirst%3DAvinash%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28012020%26date%3D26032020%26date%3D02042020%26date%3D26032020%26volume%3D11%26issue%3D6%26spage%3D1205%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lihai Yu, Nikola Despotovic, Michael S. Kovacs, Christopher L. Pin, <span class="NLM_string-name hlFld-ContribAuthor">Leonard G. Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 334-340. <a href="https://doi.org/10.1021/acsmedchemlett.8b00613" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D18F-Labeled%252BPET%252BProbe%252BTargeting%252BEnhancer%252Bof%252BZeste%252BHomologue%252B2%252B%252528EZH2%252529%252Bfor%252BCancer%252BImaging%26aulast%3DYu%26aufirst%3DLihai%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06122018%26date%3D21022019%26date%3D27022019%26volume%3D10%26issue%3D3%26spage%3D334%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dmitry
I. Bugaenko, Anastasia A. Dubrovina, Marina A. Yurovskaya, <span class="NLM_string-name hlFld-ContribAuthor">Alexander V. Karchava</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Indoles via Electron-Catalyzed Intramolecular C–N Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (23)
                                     , 7358-7362. <a href="https://doi.org/10.1021/acs.orglett.8b02784" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02784%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BIndoles%252Bvia%252BElectron-Catalyzed%252BIntramolecular%252BC%2525E2%252580%252593N%252BBond%252BFormation%26aulast%3DBugaenko%26aufirst%3DDmitry%2BI.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30082018%26date%3D15112018%26volume%3D20%26issue%3D23%26spage%3D7358%26epage%3D7362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Michael L.  Martini</span>, and <span class="hlFld-ContribAuthor ">Jian  Jin</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Protein Methyltransferases and Demethylases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 989-1068. <a href="https://doi.org/10.1021/acs.chemrev.6b00801" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00801%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DInhibitors%252Bof%252BProtein%252BMethyltransferases%252Band%252BDemethylases%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259Cmit%26date%3D2018%26date%3D2017%26date%3D2016%26date%3D30112016%26date%3D24032017%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D989%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>, <span class="hlFld-ContribAuthor ">Patrick  Bingham</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Michael  Collins</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Connie  Fan</span>, <span class="hlFld-ContribAuthor ">Ketan S.  Gajiwala</span>, <span class="hlFld-ContribAuthor ">Rita  Grantner</span>, <span class="hlFld-ContribAuthor ">Hovhannes J.  Gukasyan</span>, <span class="hlFld-ContribAuthor ">Wenyue  Hu</span>, <span class="hlFld-ContribAuthor ">Buwen  Huang</span>, <span class="hlFld-ContribAuthor ">Robert  Kania</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kephart</span>, <span class="hlFld-ContribAuthor ">Cody  Krivacic</span>, <span class="hlFld-ContribAuthor ">Robert A.  Kumpf</span>, <span class="hlFld-ContribAuthor ">Penney  Khamphavong</span>, <span class="hlFld-ContribAuthor ">Manfred  Kraus</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Karen A.  Maegley</span>, <span class="hlFld-ContribAuthor ">Lisa  Nguyen</span>, <span class="hlFld-ContribAuthor ">Shijian  Ren</span>, <span class="hlFld-ContribAuthor ">Dan  Richter</span>, <span class="hlFld-ContribAuthor ">Robert A.  Rollins</span>, <span class="hlFld-ContribAuthor ">Neal  Sach</span>, <span class="hlFld-ContribAuthor ">Shikhar  Sharma</span>, <span class="hlFld-ContribAuthor ">John  Sherrill</span>, <span class="hlFld-ContribAuthor ">Jillian  Spangler</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Scott  Sutton</span>, <span class="hlFld-ContribAuthor ">Sean  Uryu</span>, <span class="hlFld-ContribAuthor ">Dominique  Verhelle</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Shuiwang  Wang</span>, <span class="hlFld-ContribAuthor ">Martin  Wythes</span>, <span class="hlFld-ContribAuthor ">Shuibo  Xin</span>, <span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">JinJiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Luke  Zehnder</span>, and <span class="hlFld-ContribAuthor ">Martin  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 650-665. <a href="https://doi.org/10.1021/acs.jmedchem.7b01375" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01375%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BOrally%252BBioavailable%252BEnhancer%252Bof%252BZeste%252BHomolog%252B2%252B%252528EZH2%252529%252BInhibitors%252BUsing%252BLigand%252Band%252BProperty-Based%252BDesign%252BStrategies%25253A%252BIdentification%252Bof%252BDevelopment%252BCandidate%252B%252528R%252529-5%25252C8-Dichloro-7-%252528methoxy%252528oxetan-3-yl%252529methyl%252529-2-%252528%2525284-methoxy-6-methyl-2-oxo-1%25252C2-dihydropyridin-3-yl%252529methyl%252529-3%25252C4-dihydroisoquinolin-1%2525282H%252529-one%252B%252528PF-06821497%252529%26aulast%3DKung%26aufirst%3DPei-Pei%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D27092017%26date%3D27122017%26date%3D08022018%26date%3D06122017%26volume%3D61%26issue%3D3%26spage%3D650%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Shen</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Caihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingsong  Cao</span>, <span class="hlFld-ContribAuthor ">Ru  Shen</span>, <span class="hlFld-ContribAuthor ">Jiayin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Wan</span>, <span class="hlFld-ContribAuthor ">Zhibin  Xu</span>, <span class="hlFld-ContribAuthor ">Ming-Hsun  Ho</span>, <span class="hlFld-ContribAuthor ">Minsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lianshan  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, and <span class="hlFld-ContribAuthor ">Weikang  Tao</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin’s Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 98-102. <a href="https://doi.org/10.1021/acsmedchemlett.7b00437" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BEBI-2511%25253A%252BA%252BHighly%252BPotent%252Band%252BOrally%252BActive%252BEZH2%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Hodgkin%2525E2%252580%252599s%252BLymphoma%26aulast%3DLu%26aufirst%3DBiao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D25102017%26date%3D29012018%26date%3D01022018%26date%3D08022018%26date%3D29012018%26volume%3D9%26issue%3D2%26spage%3D98%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Jeff  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengtian  Yu</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhang</span>, <span class="hlFld-ContribAuthor ">Youzhen  Wang</span>, <span class="hlFld-ContribAuthor ">Andreas  Lingel</span>, <span class="hlFld-ContribAuthor ">Wei  Qi</span>, <span class="hlFld-ContribAuthor ">Justin  Gu</span>, <span class="hlFld-ContribAuthor ">Kehao  Zhao</span>, <span class="hlFld-ContribAuthor ">Michael D.  Shultz</span>, <span class="hlFld-ContribAuthor ">Long  Wang</span>, <span class="hlFld-ContribAuthor ">Xingnian  Fu</span>, <span class="hlFld-ContribAuthor ">Yongfeng  Sun</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiangqing  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiangwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunye  Zhang</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Jue  Zeng</span>, <span class="hlFld-ContribAuthor ">Lijian  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Yueqin  Liu</span>, <span class="hlFld-ContribAuthor ">Man  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengxi  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhenting  Gao</span>, <span class="hlFld-ContribAuthor ">Xianghui  Liu</span>, <span class="hlFld-ContribAuthor ">Douglas  Fang</span>, <span class="hlFld-ContribAuthor ">Haibing  Guo</span>, <span class="hlFld-ContribAuthor ">Yuan  Mi</span>, <span class="hlFld-ContribAuthor ">Tobias  Gabriel</span>, <span class="hlFld-ContribAuthor ">Michael P.  Dillon</span>, <span class="hlFld-ContribAuthor ">Peter  Atadja</span>, and <span class="hlFld-ContribAuthor ">Counde  Oyang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2215-2226. <a href="https://doi.org/10.1021/acs.jmedchem.6b01576" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01576%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BFirst-in-Class%25252C%252BPotent%25252C%252Band%252BOrally%252BBioavailable%252BEmbryonic%252BEctoderm%252BDevelopment%252B%252528EED%252529%252BInhibitor%252Bwith%252BRobust%252BAnticancer%252BEfficacy%26aulast%3DHuang%26aufirst%3DYing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D26102016%26date%3D06022017%26date%3D23032017%26date%3D16012017%26volume%3D60%26issue%3D6%26spage%3D2215%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gong</span>, <span class="hlFld-ContribAuthor ">Tengrui  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhen  Tan</span>, <span class="hlFld-ContribAuthor ">Lixiang  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Epigenetics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13148-021-01045-1" title="DOI URL">https://doi.org/10.1186/s13148-021-01045-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13148-021-01045-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13148-021-01045-1%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Epigenetics%26atitle%3DFinding%252Ban%252Beasy%252Bway%252Bto%252Bharmonize%25253A%252Ba%252Breview%252Bof%252Badvances%252Bin%252Bclinical%252Bresearch%252Band%252Bcombination%252Bstrategies%252Bof%252BEZH2%252Binhibitors%26aulast%3DLi%26aufirst%3DChen%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-021-00721-x" title="DOI URL">https://doi.org/10.1186/s12929-021-00721-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-021-00721-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-021-00721-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DRecent%252Bdevelopments%252Bin%252Bepigenetic%252Bcancer%252Btherapeutics%25253A%252Bclinical%252Badvancement%252Band%252Bemerging%252Btrends%26aulast%3DNepali%26aufirst%3DKunal%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Shang</span>, <span class="hlFld-ContribAuthor ">Chenggui  Wu</span>, <span class="hlFld-ContribAuthor ">Qianwen  Gao</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Lisha  Li</span>, <span class="hlFld-ContribAuthor ">Xinping  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Gang  Cheng</span>, <span class="hlFld-ContribAuthor ">Shanshan  Liu</span>, <span class="hlFld-ContribAuthor ">Qianghui  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-oriented functionalization of 2-pyridones and uracils. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-23058-3" title="DOI URL">https://doi.org/10.1038/s41467-021-23058-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-23058-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-23058-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DDiversity-oriented%252Bfunctionalization%252Bof%252B2-pyridones%252Band%252Buracils%26aulast%3DShang%26aufirst%3DYong%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su H.  Park</span>, <span class="hlFld-ContribAuthor ">Ka-Wing  Fong</span>, <span class="hlFld-ContribAuthor ">Ezinne  Mong</span>, <span class="hlFld-ContribAuthor ">M. Cynthia  Martin</span>, <span class="hlFld-ContribAuthor ">Gary E.  Schiltz</span>, <span class="hlFld-ContribAuthor ">Jindan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Going beyond Polycomb: EZH2 functions in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2021,</strong> <em>276 </em><a href="https://doi.org/10.1038/s41388-021-01982-4" title="DOI URL">https://doi.org/10.1038/s41388-021-01982-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-021-01982-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-021-01982-4%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DGoing%252Bbeyond%252BPolycomb%25253A%252BEZH2%252Bfunctions%252Bin%252Bprostate%252Bcancer%26aulast%3DPark%26aufirst%3DSu%2BH.%26date%3D2021%26date%3D2021%26volume%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert B. A.  Quinlan</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>. </span><span class="cited-content_cbyCitation_article-title">Chemogenomics for drug discovery: clinical molecules from open access chemical probes. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2021,</strong> <em>2 </em>
                                    (3)
                                     , 759-795. <a href="https://doi.org/10.1039/D1CB00016K" title="DOI URL">https://doi.org/10.1039/D1CB00016K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CB00016K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CB00016K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DChemogenomics%252Bfor%252Bdrug%252Bdiscovery%25253A%252Bclinical%252Bmolecules%252Bfrom%252Bopen%252Baccess%252Bchemical%252Bprobes%26aulast%3DQuinlan%26aufirst%3DRobert%2BB.%2BA.%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D3%26spage%3D759%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>, <span class="hlFld-ContribAuthor ">Lawrence  Hamann</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Jahnke</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Thomas  Magauer</span>, <span class="hlFld-ContribAuthor ">Tobias  Ritter</span>, <span class="hlFld-ContribAuthor ">Vicky  Steadman</span>, <span class="hlFld-ContribAuthor ">Scott D.  Williams</span>, <span class="hlFld-ContribAuthor ">Georg  Winter</span>, <span class="hlFld-ContribAuthor ">Klemens  Hoegenauer</span>, <span class="hlFld-ContribAuthor ">Karl Heinz  Krawinkler</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>. </span><span class="cited-content_cbyCitation_article-title">The 2
              nd
              Alpine Winter Conference on Medicinal and Synthetic Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>47 </em><a href="https://doi.org/10.1002/cmdc.202100372" title="DOI URL">https://doi.org/10.1002/cmdc.202100372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100372%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252B2%252Bnd%252BAlpine%252BWinter%252BConference%252Bon%252BMedicinal%252Band%252BSynthetic%252BChemistry%26aulast%3DCiulli%26aufirst%3DAlessio%26date%3D2021%26date%3D2021%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamakoti P.  Bhat</span>, <span class="hlFld-ContribAuthor ">H.  Ümit Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Or  Gozani</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2021,</strong> <em>20 </em>
                                    (4)
                                     , 265-286. <a href="https://doi.org/10.1038/s41573-020-00108-x" title="DOI URL">https://doi.org/10.1038/s41573-020-00108-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-020-00108-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-020-00108-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DEpigenetics%252Band%252Bbeyond%25253A%252Btargeting%252Bwriters%252Bof%252Bprotein%252Blysine%252Bmethylation%252Bto%252Btreat%252Bdisease%26aulast%3DBhat%26aufirst%3DKamakoti%2BP.%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D4%26spage%3D265%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Chencheng  Han</span>, <span class="hlFld-ContribAuthor ">Panqi  Fang</span>, <span class="hlFld-ContribAuthor ">Hongyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Siwei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhifei  Ma</span>, <span class="hlFld-ContribAuthor ">Quanli  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenjia  Xia</span>, <span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Xu</span>, <span class="hlFld-ContribAuthor ">Rong  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2021,</strong> <em>78 </em>
                                    (5)
                                     , 1983-2000. <a href="https://doi.org/10.1007/s00018-020-03691-9" title="DOI URL">https://doi.org/10.1007/s00018-020-03691-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-020-03691-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-020-03691-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DLong%252Bnon-coding%252BRNAs%252Bin%252Blung%252Bcancer%25253A%252Bimplications%252Bfor%252Blineage%252Bplasticity-mediated%252BTKI%252Bresistance%26aulast%3DLiu%26aufirst%3DTongyan%26date%3D2021%26date%3D2020%26volume%3D78%26issue%3D5%26spage%3D1983%26epage%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengrui  Feng</span>, <span class="hlFld-ContribAuthor ">Daniel D.  De Carvalho</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical advances in targeting epigenetics for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>158 </em><a href="https://doi.org/10.1111/febs.15750" title="DOI URL">https://doi.org/10.1111/febs.15750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15750%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DClinical%252Badvances%252Bin%252Btargeting%252Bepigenetics%252Bfor%252Bcancer%252Btherapy%26aulast%3DFeng%26aufirst%3DShengrui%26date%3D2021%26date%3D2021%26volume%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunsuke  Hanaki</span>, <span class="hlFld-ContribAuthor ">Midori  Shimada</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting EZH2 as cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Biochemistry</span><span> <strong>2021,</strong> <em>276 </em><a href="https://doi.org/10.1093/jb/mvab007" title="DOI URL">https://doi.org/10.1093/jb/mvab007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jb/mvab007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjb%2Fmvab007%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Biochemistry%26atitle%3DTargeting%252BEZH2%252Bas%252Bcancer%252Btherapy%26aulast%3DHanaki%26aufirst%3DShunsuke%26date%3D2021%26date%3D2021%26volume%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Pyziak</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Sroka‐Porada</span>, <span class="hlFld-ContribAuthor ">Tomasz  Rzymski</span>, <span class="hlFld-ContribAuthor ">Józef  Dulak</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Łoboda</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1002/ddr.21796" title="DOI URL">https://doi.org/10.1002/ddr.21796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21796%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DPotential%252Bof%252Benhancer%252Bof%252Bzeste%252Bhomolog%252B2%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BSWI%25252FSNF%252Bmutant%252Bcancers%252Band%252Btumor%252Bmicroenvironment%252Bmodulation%26aulast%3DPyziak%26aufirst%3DKarolina%26date%3D2021%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aishat  A. Motolani</span>, <span class="hlFld-ContribAuthor ">Mengyao  Sun</span>, <span class="hlFld-ContribAuthor ">Matthew  Martin</span>, <span class="hlFld-ContribAuthor ">Steven  Sun</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.92830" title="DOI URL">https://doi.org/10.5772/intechopen.92830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.92830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.92830%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BSmall%252BMolecule%252BInhibitors%252Bfor%252BHistone%252BMethyltransferases%252Bin%252BCancer%26aulast%3DA.%2BMotolani%26aufirst%3DAishat%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DTranslational%252BResearch%252Bin%252BCancer%26aulast%3DSundaresan%26aufirst%3DSivapatham%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 519-562. <a href="https://doi.org/10.1007/978-3-030-58971-4_17" title="DOI URL">https://doi.org/10.1007/978-3-030-58971-4_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-58971-4_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-58971-4_17%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BStructural%252BPerspective%252Bon%252BGene%252BRepression%252Bby%252BPolycomb%252BRepressive%252BComplex%252B2%26aulast%3DLiu%26aufirst%3DXin%26date%3D2021%26date%3D2020%26spage%3D519%26epage%3D562%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMacromolecular%252BProtein%252BComplexes%252BIII%25253A%252BStructure%252Band%252BFunction%26aulast%3DHarris%26aufirst%3DJ.%2BRobin%26date%3D2021%26volume%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob I.  Stuckey</span>, <span class="hlFld-ContribAuthor ">Nico R.  Cantone</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Shilpi  Arora</span>, <span class="hlFld-ContribAuthor ">Valerie  Vivat</span>, <span class="hlFld-ContribAuthor ">Ashwin  Ramakrishnan</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Mertz</span>, <span class="hlFld-ContribAuthor ">Avinash  Khanna</span>, <span class="hlFld-ContribAuthor ">Jehrod  Brenneman</span>, <span class="hlFld-ContribAuthor ">Victor S.  Gehling</span>, <span class="hlFld-ContribAuthor ">Ludivine  Moine</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims</span>, <span class="hlFld-ContribAuthor ">James E.  Audia</span>, <span class="hlFld-ContribAuthor ">Patrick  Trojer</span>, <span class="hlFld-ContribAuthor ">Julian R.  Levell</span>, <span class="hlFld-ContribAuthor ">Richard T.  Cummings</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100349. <a href="https://doi.org/10.1016/j.jbc.2021.100349" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100349%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DIdentification%252Band%252Bcharacterization%252Bof%252Bsecond-generation%252BEZH2%252Binhibitors%252Bwith%252Bextended%252Bresidence%252Btimes%252Band%252Bimproved%252Bbiological%252Bactivity%26aulast%3DStuckey%26aufirst%3DJacob%2BI.%26date%3D2021%26volume%3D296%26spage%3D100349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Lisa  Eich</span>, <span class="hlFld-ContribAuthor ">Mohammad  Athar</span>, <span class="hlFld-ContribAuthor ">James E.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Sooryanarayana  Varambally</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2-Targeted Therapies in Cancer: Hype or a Reality. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2020,</strong> <em>80 </em>
                                    (24)
                                     , 5449-5458. <a href="https://doi.org/10.1158/0008-5472.CAN-20-2147" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-2147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-2147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-2147%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DEZH2-Targeted%252BTherapies%252Bin%252BCancer%25253A%252BHype%252Bor%252Ba%252BReality%26aulast%3DEich%26aufirst%3DMarie-Lisa%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D24%26spage%3D5449%26epage%3D5458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Shengtao  Zhu</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Li  Min</span>, <span class="hlFld-ContribAuthor ">Shutian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Long non-coding RNA BLACAT1, a novel promising biomarker and regulator of human cancers. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>132 </em>, 110808. <a href="https://doi.org/10.1016/j.biopha.2020.110808" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110808%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DLong%252Bnon-coding%252BRNA%252BBLACAT1%25252C%252Ba%252Bnovel%252Bpromising%252Bbiomarker%252Band%252Bregulator%252Bof%252Bhuman%252Bcancers%26aulast%3DZhu%26aufirst%3DMin%26date%3D2020%26volume%3D132%26spage%3D110808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralf  Hass</span>, <span class="hlFld-ContribAuthor ">Juliane  von der Ohe</span>, <span class="hlFld-ContribAuthor ">Hendrik  Ungefroren</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 3716. <a href="https://doi.org/10.3390/cancers12123716" title="DOI URL">https://doi.org/10.3390/cancers12123716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12123716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12123716%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DImpact%252Bof%252Bthe%252BTumor%252BMicroenvironment%252Bon%252BTumor%252BHeterogeneity%252Band%252BConsequences%252Bfor%252BCancer%252BCell%252BPlasticity%252Band%252BStemness%26aulast%3DHass%26aufirst%3DRalf%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D3716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Perner</span>, <span class="hlFld-ContribAuthor ">Scott A.  Armstrong</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2721. <a href="https://doi.org/10.3390/cells9122721" title="DOI URL">https://doi.org/10.3390/cells9122721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9122721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9122721%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTargeting%252BChromatin%252BComplexes%252Bin%252BMyeloid%252BMalignancies%252Band%252BBeyond%25253A%252BFrom%252BBasic%252BMechanisms%252Bto%252BClinical%252BInnovation%26aulast%3DPerner%26aufirst%3DFlorian%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ran  Duan</span>, <span class="hlFld-ContribAuthor ">Wenfang  Du</span>, <span class="hlFld-ContribAuthor ">Weijian  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2: a novel target for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-020-00937-8" title="DOI URL">https://doi.org/10.1186/s13045-020-00937-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-020-00937-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-020-00937-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DEZH2%25253A%252Ba%252Bnovel%252Btarget%252Bfor%252Bcancer%252Btreatment%26aulast%3DDuan%26aufirst%3DRan%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Dao‐Hai  Du</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao‐Qing  Cai</span>, <span class="hlFld-ContribAuthor ">Alicia X.  Deng</span>, <span class="hlFld-ContribAuthor ">Olivier  Nosjean</span>, <span class="hlFld-ContribAuthor ">Jean A.  Boutin</span>, <span class="hlFld-ContribAuthor ">Pierre  Renard</span>, <span class="hlFld-ContribAuthor ">De‐Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Ming‐Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of catalytic and non‐catalytic activity inhibitors against PRC2‐EZH2 complex through multiple high‐throughput screening campaigns. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (4)
                                     , 1024-1051. <a href="https://doi.org/10.1111/cbdd.13702" title="DOI URL">https://doi.org/10.1111/cbdd.13702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13702%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Bof%252Bcatalytic%252Band%252Bnon%2525E2%252580%252590catalytic%252Bactivity%252Binhibitors%252Bagainst%252BPRC2%2525E2%252580%252590EZH2%252Bcomplex%252Bthrough%252Bmultiple%252Bhigh%2525E2%252580%252590throughput%252Bscreening%252Bcampaigns%26aulast%3DZhou%26aufirst%3DYan%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D4%26spage%3D1024%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nok-Hei Mickey  Wong</span>, <span class="hlFld-ContribAuthor ">Chi Wai Eric  So</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapeutic strategies for MLL-rearranged leukemias. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</span><span> <strong>2020,</strong> <em>1863 </em>
                                    (9)
                                     , 194584. <a href="https://doi.org/10.1016/j.bbagrm.2020.194584" title="DOI URL">https://doi.org/10.1016/j.bbagrm.2020.194584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagrm.2020.194584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagrm.2020.194584%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Gene%2520Regulatory%2520Mechanisms%26atitle%3DNovel%252Btherapeutic%252Bstrategies%252Bfor%252BMLL-rearranged%252Bleukemias%26aulast%3DWong%26aufirst%3DNok-Hei%2BMickey%26date%3D2020%26volume%3D1863%26issue%3D9%26spage%3D194584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita E.  Neganova</span>, <span class="hlFld-ContribAuthor ">Sergey G.  Klochkov</span>, <span class="hlFld-ContribAuthor ">Yulia R.  Aleksandrova</span>, <span class="hlFld-ContribAuthor ">Gjumrakch  Aliev</span>. </span><span class="cited-content_cbyCitation_article-title">Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2020,</strong> <em>42 </em><a href="https://doi.org/10.1016/j.semcancer.2020.07.015" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DHistone%252Bmodifications%252Bin%252Bepigenetic%252Bregulation%252Bof%252Bcancer%25253A%252BPerspectives%252Band%252Bachieved%252Bprogress%26aulast%3DNeganova%26aufirst%3DMargarita%2BE.%26date%3D2020%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Kang</span>, <span class="hlFld-ContribAuthor ">Mark  Eccleston</span>, <span class="hlFld-ContribAuthor ">Pier-Luc  Clermont</span>, <span class="hlFld-ContribAuthor ">Maryam  Latarani</span>, <span class="hlFld-ContribAuthor ">David Kingsley  Male</span>, <span class="hlFld-ContribAuthor ">Yuzhuo  Wang</span>, <span class="hlFld-ContribAuthor ">Francesco  Crea</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 inhibition: a promising strategy to prevent cancer immune editing. </span><span class="cited-content_cbyCitation_journal-name">Epigenomics</span><span> <strong>2020,</strong> <em>12 </em>
                                    (16)
                                     , 1457-1476. <a href="https://doi.org/10.2217/epi-2020-0186" title="DOI URL">https://doi.org/10.2217/epi-2020-0186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/epi-2020-0186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fepi-2020-0186%26sid%3Dliteratum%253Aachs%26jtitle%3DEpigenomics%26atitle%3DEZH2%252Binhibition%25253A%252Ba%2525C2%2525A0promising%2525C2%2525A0strategy%252Bto%252Bprevent%252Bcancer%252Bimmune%252Bediting%26aulast%3DKang%26aufirst%3DNing%26date%3D2020%26volume%3D12%26issue%3D16%26spage%3D1457%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hope S.  Rugo</span>, <span class="hlFld-ContribAuthor ">Ira  Jacobs</span>, <span class="hlFld-ContribAuthor ">Shikhar  Sharma</span>, <span class="hlFld-ContribAuthor ">Frank  Scappaticci</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Paul</span>, <span class="hlFld-ContribAuthor ">Kristen  Jensen-Pergakes</span>, <span class="hlFld-ContribAuthor ">Gabriel G.  Malouf</span>. </span><span class="cited-content_cbyCitation_article-title">The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review. </span><span class="cited-content_cbyCitation_journal-name">Advances in Therapy</span><span> <strong>2020,</strong> <em>37 </em>
                                    (7)
                                     , 3059-3082. <a href="https://doi.org/10.1007/s12325-020-01379-x" title="DOI URL">https://doi.org/10.1007/s12325-020-01379-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12325-020-01379-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12325-020-01379-x%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Therapy%26atitle%3DThe%252BPromise%252Bfor%252BHistone%252BMethyltransferase%252BInhibitors%252Bfor%252BEpigenetic%252BTherapy%252Bin%252BClinical%252BOncology%25253A%252BA%252BNarrative%252BReview%26aulast%3DRugo%26aufirst%3DHope%2BS.%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D7%26spage%3D3059%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allyson E.  Koyen</span>, <span class="hlFld-ContribAuthor ">Matthew Z.  Madden</span>, <span class="hlFld-ContribAuthor ">Dongkyoo  Park</span>, <span class="hlFld-ContribAuthor ">Elizabeth V.  Minten</span>, <span class="hlFld-ContribAuthor ">Priya  Kapoor-Vazirani</span>, <span class="hlFld-ContribAuthor ">Erica  Werner</span>, <span class="hlFld-ContribAuthor ">Neil T.  Pfister</span>, <span class="hlFld-ContribAuthor ">Ramona  Haji-Seyed-Javadi</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Nikita  Deng</span>, <span class="hlFld-ContribAuthor ">Duc M.  Duong</span>, <span class="hlFld-ContribAuthor ">Turner J.  Pecen</span>, <span class="hlFld-ContribAuthor ">Zoë  Frazier</span>, <span class="hlFld-ContribAuthor ">Zachary D.  Nagel</span>, <span class="hlFld-ContribAuthor ">Jean-Bernard  Lazaro</span>, <span class="hlFld-ContribAuthor ">Kent W.  Mouw</span>, <span class="hlFld-ContribAuthor ">Nicholas T.  Seyfried</span>, <span class="hlFld-ContribAuthor ">Carlos S.  Moreno</span>, <span class="hlFld-ContribAuthor ">Taofeek K.  Owonikoko</span>, <span class="hlFld-ContribAuthor ">Xingming  Deng</span>, <span class="hlFld-ContribAuthor ">David S.  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (25)
                                     , 4798-4813. <a href="https://doi.org/10.1038/s41388-020-1332-2" title="DOI URL">https://doi.org/10.1038/s41388-020-1332-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-020-1332-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-020-1332-2%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DEZH2%252Bhas%252Ba%252Bnon-catalytic%252Band%252BPRC2-independent%252Brole%252Bin%252Bstabilizing%252BDDB2%252Bto%252Bpromote%252Bnucleotide%252Bexcision%252Brepair%26aulast%3DKoyen%26aufirst%3DAllyson%2BE.%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D25%26spage%3D4798%26epage%3D4813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laia  Richart</span>, <span class="hlFld-ContribAuthor ">Raphaël  Margueron</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging histone methyltransferases in cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2020,</strong> <em>56 </em>, 51-62. <a href="https://doi.org/10.1016/j.cbpa.2019.11.009" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DDrugging%252Bhistone%252Bmethyltransferases%252Bin%252Bcancer%26aulast%3DRichart%26aufirst%3DLaia%26date%3D2020%26volume%3D56%26spage%3D51%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongyu  Tao</span>, <span class="hlFld-ContribAuthor ">Ling  Zuo</span>, <span class="hlFld-ContribAuthor ">Huanli  Xu</span>, <span class="hlFld-ContribAuthor ">Cong  Li</span>, <span class="hlFld-ContribAuthor ">Gan  Qiao</span>, <span class="hlFld-ContribAuthor ">Mingyue  Guo</span>, <span class="hlFld-ContribAuthor ">Xiukun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years. </span><span class="cited-content_cbyCitation_journal-name">Recent Patents on Anti-Cancer Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 2-13. <a href="https://doi.org/10.2174/1574892815666200131120618" title="DOI URL">https://doi.org/10.2174/1574892815666200131120618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574892815666200131120618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574892815666200131120618%26sid%3Dliteratum%253Aachs%26jtitle%3DRecent%2520Patents%2520on%2520Anti-Cancer%2520Drug%2520Discovery%26atitle%3DAlkaloids%252Bas%252BAnticancer%252BAgents%25253A%252BA%252BReview%252Bof%252BChinese%252BPatents%252Bin%252BRecent%252B5%252BYears%26aulast%3DTao%26aufirst%3DHongyu%26date%3D2020%26volume%3D15%26issue%3D1%26spage%3D2%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Hovhannes J.  Gukasyan</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Sean  Uryu</span>, <span class="hlFld-ContribAuthor ">Shikhar  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Epigenetic Regulator Enhancer of Zeste Homolog 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>373 </em>
                                    (2)
                                     , 220-229. <a href="https://doi.org/10.1124/jpet.119.263491" title="DOI URL">https://doi.org/10.1124/jpet.119.263491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.263491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.263491%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DTranslational%252BPharmacokinetic-Pharmacodynamic%252BModeling%252Bfor%252Ban%252BOrally%252BAvailable%252BNovel%252BInhibitor%252Bof%252BEpigenetic%252BRegulator%252BEnhancer%252Bof%252BZeste%252BHomolog%252B2%26aulast%3DYamazaki%26aufirst%3DShinji%26date%3D2020%26date%3D2020%26volume%3D373%26issue%3D2%26spage%3D220%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyu  Du</span>, <span class="hlFld-ContribAuthor ">Qifan  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjiao  Sun</span>, <span class="hlFld-ContribAuthor ">Cheng  Yang</span>, <span class="hlFld-ContribAuthor ">Chunfu  Wu</span>, <span class="hlFld-ContribAuthor ">Lihui  Wang</span>, <span class="hlFld-ContribAuthor ">Guoliang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">5-Hydroxyindole-Based EZH2 Inhibitors Assembled via TCCA-Catalyzed Condensation and Nenitzescu Reactions. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2059. <a href="https://doi.org/10.3390/molecules25092059" title="DOI URL">https://doi.org/10.3390/molecules25092059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092059%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D5-Hydroxyindole-Based%252BEZH2%252BInhibitors%252BAssembled%252Bvia%252BTCCA-Catalyzed%252BCondensation%252Band%252BNenitzescu%252BReactions%26aulast%3DDu%26aufirst%3DFangyu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong  Wan</span>, <span class="hlFld-ContribAuthor ">Huabo  Jiang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Shuhui  Zhu</span>, <span class="hlFld-ContribAuthor ">Jingjing  Hou</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (7)
                                     , 115379. <a href="https://doi.org/10.1016/j.bmc.2020.115379" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115379%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCarcinogenic%252Broles%252Band%252Btherapeutic%252Beffects%252Bof%252BEZH2%252Bin%252Bgynecological%252Bcancers%26aulast%3DWan%26aufirst%3DZhong%26date%3D2020%26volume%3D28%26issue%3D7%26spage%3D115379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qifan  Zhou</span>, <span class="hlFld-ContribAuthor ">Lina  Jia</span>, <span class="hlFld-ContribAuthor ">Fangyu  Du</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Dong</span>, <span class="hlFld-ContribAuthor ">Wanyu  Sun</span>, <span class="hlFld-ContribAuthor ">Lihui  Wang</span>, <span class="hlFld-ContribAuthor ">Guoliang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activities of pyrrole-3-carboxamide derivatives as EZH2 (enhancer of zeste homologue 2) inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (6)
                                     , 2247-2255. <a href="https://doi.org/10.1039/C9NJ04713A" title="DOI URL">https://doi.org/10.1039/C9NJ04713A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ04713A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ04713A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bpyrrole-3-carboxamide%252Bderivatives%252Bas%252BEZH2%252B%252528enhancer%252Bof%252Bzeste%252Bhomologue%252B2%252529%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DZhou%26aufirst%3DQifan%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D6%26spage%3D2247%26epage%3D2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dading  Huang</span>, <span class="hlFld-ContribAuthor ">Shuaizhen  Tian</span>, <span class="hlFld-ContribAuthor ">Yifei  Qi</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Modes of Small‐Molecule Inhibitors to the EED Pocket of PRC2. </span><span class="cited-content_cbyCitation_journal-name">ChemPhysChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (3)
                                     , 263-271. <a href="https://doi.org/10.1002/cphc.201900903" title="DOI URL">https://doi.org/10.1002/cphc.201900903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphc.201900903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphc.201900903%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhysChem%26atitle%3DBinding%252BModes%252Bof%252BSmall%2525E2%252580%252590Molecule%252BInhibitors%252Bto%252Bthe%252BEED%252BPocket%252Bof%252BPRC2%26aulast%3DHuang%26aufirst%3DDading%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D3%26spage%3D263%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anqi  Ma</span>, <span class="hlFld-ContribAuthor ">Elias  Stratikopoulos</span>, <span class="hlFld-ContribAuthor ">Kwang-Su  Park</span>, <span class="hlFld-ContribAuthor ">Jieli  Wei</span>, <span class="hlFld-ContribAuthor ">Tiphaine C.  Martin</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Megan  Schwarz</span>, <span class="hlFld-ContribAuthor ">Violetta  Leshchenko</span>, <span class="hlFld-ContribAuthor ">Alexander  Rialdi</span>, <span class="hlFld-ContribAuthor ">Brandon  Dale</span>, <span class="hlFld-ContribAuthor ">Alessandro  Lagana</span>, <span class="hlFld-ContribAuthor ">Ernesto  Guccione</span>, <span class="hlFld-ContribAuthor ">Samir  Parekh</span>, <span class="hlFld-ContribAuthor ">Ramon  Parsons</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a first-in-class EZH2 selective degrader. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (2)
                                     , 214-222. <a href="https://doi.org/10.1038/s41589-019-0421-4" title="DOI URL">https://doi.org/10.1038/s41589-019-0421-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0421-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0421-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252Bfirst-in-class%252BEZH2%252Bselective%252Bdegrader%26aulast%3DMa%26aufirst%3DAnqi%26date%3D2020%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D214%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. Ann  Boriack‐Sjodin</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic Proteins as Emerging Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 423-448. <a href="https://doi.org/10.1002/9781118681121.ch18" title="DOI URL">https://doi.org/10.1002/9781118681121.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DEpigenetic%252BProteins%252Bas%252BEmerging%252BDrug%252BTargets%26aulast%3DBoriack%25E2%2580%2590Sjodin%26aufirst%3DP.%2BAnn%26date%3D2020%26date%3D2020%26spage%3D423%26epage%3D448%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomohiro  Kozako</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Shin-ichiro  Honda</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic Control Using Small Molecules in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 111-148. <a href="https://doi.org/10.1007/978-3-030-32857-3_6" title="DOI URL">https://doi.org/10.1007/978-3-030-32857-3_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-32857-3_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-32857-3_6%26sid%3Dliteratum%253Aachs%26atitle%3DEpigenetic%252BControl%252BUsing%252BSmall%252BMolecules%252Bin%252BCancer%26aulast%3DKozako%26aufirst%3DTomohiro%26date%3D2020%26date%3D2020%26spage%3D111%26epage%3D148%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DApproaching%252BComplex%252BDiseases%26aulast%3DBizzarri%26aufirst%3DMariano%26date%3D2020%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soufiane  Boumahdi</span>, <span class="hlFld-ContribAuthor ">Frederic J.  de Sauvage</span>. </span><span class="cited-content_cbyCitation_article-title">The great escape: tumour cell plasticity in resistance to targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 39-56. <a href="https://doi.org/10.1038/s41573-019-0044-1" title="DOI URL">https://doi.org/10.1038/s41573-019-0044-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0044-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0044-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DThe%252Bgreat%252Bescape%25253A%252Btumour%252Bcell%252Bplasticity%252Bin%252Bresistance%252Bto%252Btargeted%252Btherapy%26aulast%3DBoumahdi%26aufirst%3DSoufiane%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D1%26spage%3D39%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boheng  Li</span>, <span class="hlFld-ContribAuthor ">Wee-Joo  Chng</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-019-0814-6" title="DOI URL">https://doi.org/10.1186/s13045-019-0814-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-019-0814-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-019-0814-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DEZH2%252Babnormalities%252Bin%252Blymphoid%252Bmalignancies%25253A%252Bunderlying%252Bmechanisms%252Band%252Btherapeutic%252Bimplications%26aulast%3DLi%26aufirst%3DBoheng%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renato  Ferreira de Freitas</span>, <span class="hlFld-ContribAuthor ">Danton  Ivanochko</span>, <span class="hlFld-ContribAuthor ">Matthieu  Schapira</span>. </span><span class="cited-content_cbyCitation_article-title">Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (24)
                                     , 4492. <a href="https://doi.org/10.3390/molecules24244492" title="DOI URL">https://doi.org/10.3390/molecules24244492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24244492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24244492%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMethyltransferase%252BInhibitors%25253A%252BCompeting%252Bwith%25252C%252Bor%252BExploiting%252Bthe%252BBound%252BCofactor%26aulast%3DFerreira%2Bde%2BFreitas%26aufirst%3DRenato%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D24%26spage%3D4492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixin  Yang</span>, <span class="hlFld-ContribAuthor ">Yongqing  Liu</span>, <span class="hlFld-ContribAuthor ">Minghua  Fan</span>, <span class="hlFld-ContribAuthor ">Guiwang  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Jing  Liang</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Zhuo  Huang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111656. <a href="https://doi.org/10.1016/j.ejmech.2019.111656" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111656%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252Bcharacterization%252Bof%252Bbenzo%25255Bd%25255Doxazol-2%2525283H%252529-one%252Bderivatives%252Bas%252Bthe%252Bfirst%252Bpotent%252Band%252Bselective%252Bsmall-molecule%252Binhibitors%252Bof%252Bchromodomain%252Bprotein%252BCDYL%26aulast%3DYang%26aufirst%3DLixin%26date%3D2019%26volume%3D182%26spage%3D111656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas Westergaard  Højfeldt</span>, <span class="hlFld-ContribAuthor ">Lin  Hedehus</span>, <span class="hlFld-ContribAuthor ">Anne  Laugesen</span>, <span class="hlFld-ContribAuthor ">Tülin  Tatar</span>, <span class="hlFld-ContribAuthor ">Laura  Wiehle</span>, <span class="hlFld-ContribAuthor ">Kristian  Helin</span>. </span><span class="cited-content_cbyCitation_article-title">Non-core Subunits of the PRC2 Complex Are Collectively Required for Its Target-Site Specificity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2019,</strong> <em>76 </em>
                                    (3)
                                     , 423-436.e3. <a href="https://doi.org/10.1016/j.molcel.2019.07.031" title="DOI URL">https://doi.org/10.1016/j.molcel.2019.07.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2019.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2019.07.031%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DNon-core%252BSubunits%252Bof%252Bthe%252BPRC2%252BComplex%252BAre%252BCollectively%252BRequired%252Bfor%252BIts%252BTarget-Site%252BSpecificity%26aulast%3DH%25C3%25B8jfeldt%26aufirst%3DJonas%2BWestergaard%26date%3D2019%26volume%3D76%26issue%3D3%26spage%3D423%26epage%3D436.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcelo L.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Diana  Reyes-Garau</span>, <span class="hlFld-ContribAuthor ">Marc  Armengol</span>, <span class="hlFld-ContribAuthor ">Miranda  Fernández-Serrano</span>, <span class="hlFld-ContribAuthor ">Gaël  Roué</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Genetics</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fgene.2019.00986" title="DOI URL">https://doi.org/10.3389/fgene.2019.00986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fgene.2019.00986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffgene.2019.00986%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Genetics%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BTargeting%252Bof%252BEpigenetic%252BRegulators%252Bin%252BB-Cell%252BNon-Hodgkin%252BLymphoma%26aulast%3DRibeiro%26aufirst%3DMarcelo%2BL.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhumitha  Kedhari Sundaram</span>, <span class="hlFld-ContribAuthor ">Arif  Hussain</span>, <span class="hlFld-ContribAuthor ">Shafiul  Haque</span>, <span class="hlFld-ContribAuthor ">Ritu  Raina</span>, <span class="hlFld-ContribAuthor ">Nazia  Afroze</span>. </span><span class="cited-content_cbyCitation_article-title">Quercetin modifies 5′CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2019,</strong> <em>120 </em>
                                    (10)
                                     , 18357-18369. <a href="https://doi.org/10.1002/jcb.29147" title="DOI URL">https://doi.org/10.1002/jcb.29147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29147%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DQuercetin%252Bmodifies%252B5%2525E2%252580%2525B2CpG%252Bpromoter%252Bmethylation%252Band%252Breactivates%252Bvarious%252Btumor%252Bsuppressor%252Bgenes%252Bby%252Bmodulating%252Bepigenetic%252Bmarks%252Bin%252Bhuman%252Bcervical%252Bcancer%252Bcells%26aulast%3DKedhari%2BSundaram%26aufirst%3DMadhumitha%26date%3D2019%26date%3D2019%26volume%3D120%26issue%3D10%26spage%3D18357%26epage%3D18369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Feng</span>, <span class="hlFld-ContribAuthor ">Hualong  He</span>, <span class="hlFld-ContribAuthor ">Tiantao  Gao</span>, <span class="hlFld-ContribAuthor ">Qiangsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Tao</span>, <span class="hlFld-ContribAuthor ">Yongxia  Zhu</span>, <span class="hlFld-ContribAuthor ">Lidan  Zhang</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of benzomorpholine derivatives as novel EZH2 inhibitors for anti-non-small cell lung cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 681-696. <a href="https://doi.org/10.1007/s11030-018-9903-7" title="DOI URL">https://doi.org/10.1007/s11030-018-9903-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9903-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9903-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbenzomorpholine%252Bderivatives%252Bas%252Bnovel%252BEZH2%252Binhibitors%252Bfor%252Banti-non-small%252Bcell%252Blung%252Bcancer%252Bactivity%26aulast%3DFeng%26aufirst%3DQiang%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D3%26spage%3D681%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Archana  Kumari</span>, <span class="hlFld-ContribAuthor ">Rajesh K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103021. <a href="https://doi.org/10.1016/j.bioorg.2019.103021" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bof%252Bindole%252Bderivatives%25253A%252BCurrent%252Bto%252Bfuture%252Btherapeutic%252Bprospectives%26aulast%3DKumari%26aufirst%3DArchana%26date%3D2019%26volume%3D89%26spage%3D103021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia-Ray  Yu</span>, <span class="hlFld-ContribAuthor ">Chul-Hwan  Lee</span>, <span class="hlFld-ContribAuthor ">Ozgur  Oksuz</span>, <span class="hlFld-ContribAuthor ">James M.  Stafford</span>, <span class="hlFld-ContribAuthor ">Danny  Reinberg</span>. </span><span class="cited-content_cbyCitation_article-title">PRC2 is high maintenance. </span><span class="cited-content_cbyCitation_journal-name">Genes & Development</span><span> <strong>2019,</strong> <em>33 </em>
                                    (15-16)
                                     , 903-935. <a href="https://doi.org/10.1101/gad.325050.119" title="DOI URL">https://doi.org/10.1101/gad.325050.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/gad.325050.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fgad.325050.119%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Development%26atitle%3DPRC2%252Bis%252Bhigh%252Bmaintenance%26aulast%3DYu%26aufirst%3DJia-Ray%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D15-16%26spage%3D903%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Bayo</span>, <span class="hlFld-ContribAuthor ">Esteban J.  Fiore</span>, <span class="hlFld-ContribAuthor ">Luciana M.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Alejandrina  Real</span>, <span class="hlFld-ContribAuthor ">Mariana  Malvicini</span>, <span class="hlFld-ContribAuthor ">Manglio  Rizzo</span>, <span class="hlFld-ContribAuthor ">Catalina  Atorrasagasti</span>, <span class="hlFld-ContribAuthor ">Mariana G.  García</span>, <span class="hlFld-ContribAuthor ">Josepmaria  Argemi</span>, <span class="hlFld-ContribAuthor ">Elisabeth D.  Martinez</span>, <span class="hlFld-ContribAuthor ">Guillermo D.  Mazzolini</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2019,</strong> <em>71 </em>
                                    (1)
                                     , 78-90. <a href="https://doi.org/10.1016/j.jhep.2019.03.007" title="DOI URL">https://doi.org/10.1016/j.jhep.2019.03.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2019.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2019.03.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DA%252Bcomprehensive%252Bstudy%252Bof%252Bepigenetic%252Balterations%252Bin%252Bhepatocellular%252Bcarcinoma%252Bidentifies%252Bpotential%252Btherapeutic%252Btargets%26aulast%3DBayo%26aufirst%3DJuan%26date%3D2019%26volume%3D71%26issue%3D1%26spage%3D78%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seung Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Tabitha T.  Schempp</span>, <span class="hlFld-ContribAuthor ">Jason R.  Zbieg</span>, <span class="hlFld-ContribAuthor ">Craig E.  Stivala</span>, <span class="hlFld-ContribAuthor ">Michael J.  Krische</span>. </span><span class="cited-content_cbyCitation_article-title">Regio‐ and Enantioselective Iridium‐Catalyzed N‐Allylation of Indoles and Related Azoles with Racemic Branched Alkyl‐Substituted Allylic Acetates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (23)
                                     , 7844-7848. <a href="https://doi.org/10.1002/ange.201902799" title="DOI URL">https://doi.org/10.1002/ange.201902799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201902799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201902799%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRegio%2525E2%252580%252590%252Band%252BEnantioselective%252BIridium%2525E2%252580%252590Catalyzed%252BN%2525E2%252580%252590Allylation%252Bof%252BIndoles%252Band%252BRelated%252BAzoles%252Bwith%252BRacemic%252BBranched%252BAlkyl%2525E2%252580%252590Substituted%252BAllylic%252BAcetates%26aulast%3DKim%26aufirst%3DSeung%2BWook%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D23%26spage%3D7844%26epage%3D7848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seung Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Tabitha T.  Schempp</span>, <span class="hlFld-ContribAuthor ">Jason R.  Zbieg</span>, <span class="hlFld-ContribAuthor ">Craig E.  Stivala</span>, <span class="hlFld-ContribAuthor ">Michael J.  Krische</span>. </span><span class="cited-content_cbyCitation_article-title">Regio‐ and Enantioselective Iridium‐Catalyzed N‐Allylation of Indoles and Related Azoles with Racemic Branched Alkyl‐Substituted Allylic Acetates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (23)
                                     , 7762-7766. <a href="https://doi.org/10.1002/anie.201902799" title="DOI URL">https://doi.org/10.1002/anie.201902799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201902799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201902799%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRegio%2525E2%252580%252590%252Band%252BEnantioselective%252BIridium%2525E2%252580%252590Catalyzed%252BN%2525E2%252580%252590Allylation%252Bof%252BIndoles%252Band%252BRelated%252BAzoles%252Bwith%252BRacemic%252BBranched%252BAlkyl%2525E2%252580%252590Substituted%252BAllylic%252BAcetates%26aulast%3DKim%26aufirst%3DSeung%2BWook%26date%3D2019%26volume%3D58%26issue%3D23%26spage%3D7762%26epage%3D7766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Li</span>, <span class="hlFld-ContribAuthor ">Xiaozhe  Wan</span>, <span class="hlFld-ContribAuthor ">Jing  Xing</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Tan</span>, <span class="hlFld-ContribAuthor ">Xutong  Li</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Jihui  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Zhaojun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Wencong  Lu</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Deep Neural Network Classifier for Virtual Screening Inhibitors of (S)-Adenosyl-L-Methionine (SAM)-Dependent Methyltransferase Family. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fchem.2019.00324" title="DOI URL">https://doi.org/10.3389/fchem.2019.00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2019.00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2019.00324%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DDeep%252BNeural%252BNetwork%252BClassifier%252Bfor%252BVirtual%252BScreening%252BInhibitors%252Bof%252B%252528S%252529-Adenosyl-L-Methionine%252B%252528SAM%252529-Dependent%252BMethyltransferase%252BFamily%26aulast%3DLi%26aufirst%3DFei%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole K.H.  Yiew</span>, <span class="hlFld-ContribAuthor ">Charlotte  Greenway</span>, <span class="hlFld-ContribAuthor ">Abdalrahman  Zarzour</span>, <span class="hlFld-ContribAuthor ">Samah  Ahmadieh</span>, <span class="hlFld-ContribAuthor ">Brandee  Goo</span>, <span class="hlFld-ContribAuthor ">David  Kim</span>, <span class="hlFld-ContribAuthor ">Tyler W.  Benson</span>, <span class="hlFld-ContribAuthor ">Mourad  Ogbi</span>, <span class="hlFld-ContribAuthor ">Yao Liang  Tang</span>, <span class="hlFld-ContribAuthor ">Weiqin  Chen</span>, <span class="hlFld-ContribAuthor ">David  Stepp</span>, <span class="hlFld-ContribAuthor ">Vijay  Patel</span>, <span class="hlFld-ContribAuthor ">Renee  Hilton</span>, <span class="hlFld-ContribAuthor ">Xin-Yun  Lu</span>, <span class="hlFld-ContribAuthor ">David Y.  Hui</span>, <span class="hlFld-ContribAuthor ">Ha Won  Kim</span>, <span class="hlFld-ContribAuthor ">Neal L.  Weintraub</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (21)
                                     , 8577-8591. <a href="https://doi.org/10.1074/jbc.RA118.006871" title="DOI URL">https://doi.org/10.1074/jbc.RA118.006871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.006871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.006871%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DEnhancer%252Bof%252Bzeste%252Bhomolog%252B2%252B%252528EZH2%252529%252Bregulates%252Badipocyte%252Blipid%252Bmetabolism%252Bindependent%252Bof%252Badipogenic%252Bdifferentiation%25253A%252BRole%252Bof%252Bapolipoprotein%252BE%26aulast%3DYiew%26aufirst%3DNicole%2BK.H.%26date%3D2019%26volume%3D294%26issue%3D21%26spage%3D8577%26epage%3D8591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Laugesen</span>, <span class="hlFld-ContribAuthor ">Jonas Westergaard  Højfeldt</span>, <span class="hlFld-ContribAuthor ">Kristian  Helin</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2019,</strong> <em>74 </em>
                                    (1)
                                     , 8-18. <a href="https://doi.org/10.1016/j.molcel.2019.03.011" title="DOI URL">https://doi.org/10.1016/j.molcel.2019.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2019.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2019.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DMolecular%252BMechanisms%252BDirecting%252BPRC2%252BRecruitment%252Band%252BH3K27%252BMethylation%26aulast%3DLaugesen%26aufirst%3DAnne%26date%3D2019%26volume%3D74%26issue%3D1%26spage%3D8%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 351-368. <a href="https://doi.org/10.1016/j.ejmech.2019.01.069" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.069%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Bmethyl%252Btransferases%25253A%252BA%252Bclass%252Bof%252Bepigenetic%252Bopportunities%252Bto%252Bcounter%252Buncontrolled%252Bcell%252Bproliferation%26aulast%3DSingh%26aufirst%3DPankaj%2BKumar%26date%3D2019%26volume%3D166%26spage%3D351%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helai P.  Mohammad</span>, <span class="hlFld-ContribAuthor ">Olena  Barbash</span>, <span class="hlFld-ContribAuthor ">Caretha L.  Creasy</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2019,</strong> <em>25 </em>
                                    (3)
                                     , 403-418. <a href="https://doi.org/10.1038/s41591-019-0376-8" title="DOI URL">https://doi.org/10.1038/s41591-019-0376-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-019-0376-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-019-0376-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DTargeting%252Bepigenetic%252Bmodifications%252Bin%252Bcancer%252Btherapy%25253A%252Berasing%252Bthe%252Broadmap%252Bto%252Bcancer%26aulast%3DMohammad%26aufirst%3DHelai%2BP.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D3%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Liya  Ding</span>, <span class="hlFld-ContribAuthor ">Dejie  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenqing  Ye</span>, <span class="hlFld-ContribAuthor ">Yundong  He</span>, <span class="hlFld-ContribAuthor ">Linlin  Ma</span>, <span class="hlFld-ContribAuthor ">Runzhi  Zhu</span>, <span class="hlFld-ContribAuthor ">Yunqian  Pan</span>, <span class="hlFld-ContribAuthor ">Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Kun  Pang</span>, <span class="hlFld-ContribAuthor ">Xiaonan  Hou</span>, <span class="hlFld-ContribAuthor ">Saravut J  Weroha</span>, <span class="hlFld-ContribAuthor ">Conghui  Han</span>, <span class="hlFld-ContribAuthor ">Roger  Coleman</span>, <span class="hlFld-ContribAuthor ">Ilsa  Coleman</span>, <span class="hlFld-ContribAuthor ">R Jeffery  Karnes</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Peter S  Nelson</span>, <span class="hlFld-ContribAuthor ">Liguo  Wang</span>, <span class="hlFld-ContribAuthor ">Haojie  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">EZH
              2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis. </span><span class="cited-content_cbyCitation_journal-name">The EMBO Journal</span><span> <strong>2019,</strong> <em>38 </em>
                                    (5)
                                     <a href="https://doi.org/10.15252/embj.201899599" title="DOI URL">https://doi.org/10.15252/embj.201899599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/embj.201899599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Fembj.201899599%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520EMBO%2520Journal%26atitle%3DEZH%252B2%252Bcooperates%252Bwith%252Bgain%2525E2%252580%252590of%2525E2%252580%252590function%252Bp53%252Bmutants%252Bto%252Bpromote%252Bcancer%252Bgrowth%252Band%252Bmetastasis%26aulast%3DZhao%26aufirst%3DYu%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Small‐Molecule Inhibitors of Protein Methyltransferases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 201-220. <a href="https://doi.org/10.1002/9783527809257.ch9" title="DOI URL">https://doi.org/10.1002/9783527809257.ch9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch9%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252BSmall%2525E2%252580%252590Molecule%252BInhibitors%252Bof%252BProtein%252BMethyltransferases%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259Cmit%26date%3D2019%26date%3D2019%26spage%3D201%26epage%3D220%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>. </span><span class="cited-content_cbyCitation_article-title">Lysine Methyltransferases and Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 123-157. <a href="https://doi.org/10.1007/7355_2019_72" title="DOI URL">https://doi.org/10.1007/7355_2019_72</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_72%26sid%3Dliteratum%253Aachs%26atitle%3DLysine%252BMethyltransferases%252Band%252BTheir%252BInhibitors%26aulast%3DStazi%26aufirst%3DGiulia%26date%3D2019%26date%3D2019%26spage%3D123%26epage%3D157%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cameron  Lindsay</span>, <span class="hlFld-ContribAuthor ">Morris  Kostiuk</span>, <span class="hlFld-ContribAuthor ">Vincent L.  Biron</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacoepigenetics of EZH2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 447-462. <a href="https://doi.org/10.1016/B978-0-12-813939-4.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-813939-4.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813939-4.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813939-4.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacoepigenetics%252Bof%252BEZH2%252BInhibitors%26aulast%3DLindsay%26aufirst%3DCameron%26date%3D2019%26spage%3D447%26epage%3D462%26pub%3DElsevier%26atitle%3DPharmacoepigenetics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sathish Kumar  Mungamuri</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Epigenome as a Therapeutic Strategy for Pancreatic Tumors: DNA and Histone Modifying Enzymes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 133-157. <a href="https://doi.org/10.1016/B978-0-12-817661-0.00009-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-817661-0.00009-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817661-0.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817661-0.00009-3%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252Bthe%252BEpigenome%252Bas%252Ba%252BTherapeutic%252BStrategy%252Bfor%252BPancreatic%252BTumors%25253A%252BDNA%252Band%252BHistone%252BModifying%252BEnzymes%26aulast%3DMungamuri%26aufirst%3DSathish%2BKumar%26date%3D2019%26spage%3D133%26epage%3D157%26pub%3DElsevier%26atitle%3DBreaking%252BTolerance%252Bto%252BPancreatic%252BCancer%252BUnresponsiveness%252Bto%252BChemotherapy%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Hirano</span>, <span class="hlFld-ContribAuthor ">Shuichi  Mori</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kagechika</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Chemical Tools for the Regulation and Study of Protein Lysine Methyltransferases. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1745-1759. <a href="https://doi.org/10.1002/tcr.201800034" title="DOI URL">https://doi.org/10.1002/tcr.201800034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201800034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201800034%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DRecent%252BAdvances%252Bin%252BChemical%252BTools%252Bfor%252Bthe%252BRegulation%252Band%252BStudy%252Bof%252BProtein%252BLysine%252BMethyltransferases%26aulast%3DHirano%26aufirst%3DTomoya%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1745%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Fioravanti</span>, <span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Six Years (2012–2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2‐Pyridone Compounds. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1818-1832. <a href="https://doi.org/10.1002/tcr.201800091" title="DOI URL">https://doi.org/10.1002/tcr.201800091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201800091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201800091%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DSix%252BYears%252B%2525282012%2525E2%252580%2525932018%252529%252Bof%252BResearches%252Bon%252BCatalytic%252BEZH2%252BInhibitors%25253A%252BThe%252BBoom%252Bof%252Bthe%252B2%2525E2%252580%252590Pyridone%252BCompounds%26aulast%3DFioravanti%26aufirst%3DRossella%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1818%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Bratkowski</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-27175-w" title="DOI URL">https://doi.org/10.1038/s41598-018-27175-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-27175-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-27175-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAn%252BEvolutionarily%252BConserved%252BStructural%252BPlatform%252Bfor%252BPRC2%252BInhibition%252Bby%252Ba%252BClass%252Bof%252BEzh2%252BInhibitors%26aulast%3DBratkowski%26aufirst%3DMatthew%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Soo Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Kyung  Kim</span>, <span class="hlFld-ContribAuthor ">Jung Woo  Han</span>, <span class="hlFld-ContribAuthor ">Kyoo-Ho  Shin</span>, <span class="hlFld-ContribAuthor ">Hyuk  Hu</span>, <span class="hlFld-ContribAuthor ">Kyung Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Young Deuk  Choi</span>, <span class="hlFld-ContribAuthor ">Sunghoon  Kim</span>, <span class="hlFld-ContribAuthor ">Young Han  Lee</span>, <span class="hlFld-ContribAuthor ">Jin-Suck  Suh</span>, <span class="hlFld-ContribAuthor ">Joong Bae  Ahn</span>, <span class="hlFld-ContribAuthor ">Hyun Cheol  Chung</span>, <span class="hlFld-ContribAuthor ">Sung Hoon  Noh</span>, <span class="hlFld-ContribAuthor ">Sun Young  Rha</span>, <span class="hlFld-ContribAuthor ">Sung-Taek  Jung</span>, <span class="hlFld-ContribAuthor ">Hyo Song  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-018-4066-6" title="DOI URL">https://doi.org/10.1186/s12885-018-4066-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-018-4066-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-018-4066-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DPrognostic%252Bimplications%252Bof%252Bpolycomb%252Bproteins%252Bezh2%25252C%252Bsuz12%25252C%252Band%252Beed1%252Band%252Bhistone%252Bmodification%252Bby%252BH3K27me3%252Bin%252Bsarcoma%26aulast%3DCho%26aufirst%3DYong%2BJin%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Gan</span>, <span class="hlFld-ContribAuthor ">Yanan  Yang</span>, <span class="hlFld-ContribAuthor ">Qian  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Feng</span>, <span class="hlFld-ContribAuthor ">Tianshu  Liu</span>, <span class="hlFld-ContribAuthor ">Weijian  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Biomarker Research</span><span> <strong>2018,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40364-018-0122-2" title="DOI URL">https://doi.org/10.1186/s40364-018-0122-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40364-018-0122-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40364-018-0122-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomarker%2520Research%26atitle%3DEpigenetic%252Bregulation%252Bof%252Bcancer%252Bprogression%252Bby%252BEZH2%25253A%252Bfrom%252Bbiological%252Binsights%252Bto%252Btherapeutic%252Bpotential%26aulast%3DGan%26aufirst%3DLu%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer K.  Lue</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Amengual</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging EZH2 Inhibitors and Their Application in Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Current Hematologic Malignancy Reports</span><span> <strong>2018,</strong> <em>13 </em>
                                    (5)
                                     , 369-382. <a href="https://doi.org/10.1007/s11899-018-0466-6" title="DOI URL">https://doi.org/10.1007/s11899-018-0466-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11899-018-0466-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11899-018-0466-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Hematologic%2520Malignancy%2520Reports%26atitle%3DEmerging%252BEZH2%252BInhibitors%252Band%252BTheir%252BApplication%252Bin%252BLymphoma%26aulast%3DLue%26aufirst%3DJennifer%2BK.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D5%26spage%3D369%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lindsay E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Trievel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure, mechanism, and regulation of polycomb-repressive complex 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (36)
                                     , 13805-13814. <a href="https://doi.org/10.1074/jbc.R117.800367" title="DOI URL">https://doi.org/10.1074/jbc.R117.800367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.R117.800367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.R117.800367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DStructure%25252C%252Bmechanism%25252C%252Band%252Bregulation%252Bof%252Bpolycomb-repressive%252Bcomplex%252B2%26aulast%3DMoritz%26aufirst%3DLindsay%2BE.%26date%3D2018%26volume%3D293%26issue%3D36%26spage%3D13805%26epage%3D13814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Wen  Lo</span>, <span class="hlFld-ContribAuthor ">Jiun-Jie  Shie</span>, <span class="hlFld-ContribAuthor ">Chein-Hung  Chen</span>, <span class="hlFld-ContribAuthor ">Chung-Yi  Wu</span>, <span class="hlFld-ContribAuthor ">Tsui-Ling  Hsu</span>, <span class="hlFld-ContribAuthor ">Chi-Huey  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">O
              -GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (28)
                                     , 7302-7307. <a href="https://doi.org/10.1073/pnas.1801850115" title="DOI URL">https://doi.org/10.1073/pnas.1801850115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1801850115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1801850115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DO%252B-GlcNAcylation%252Bregulates%252Bthe%252Bstability%252Band%252Benzymatic%252Bactivity%252Bof%252Bthe%252Bhistone%252Bmethyltransferase%252BEZH2%26aulast%3DLo%26aufirst%3DPei-Wen%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D28%26spage%3D7302%26epage%3D7307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitya  Gulati</span>, <span class="hlFld-ContribAuthor ">Wendy  Béguelin</span>, <span class="hlFld-ContribAuthor ">Lisa  Giulino-Roth</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancer of zeste homolog 2 (EZH2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2018,</strong> <em>59 </em>
                                    (7)
                                     , 1574-1585. <a href="https://doi.org/10.1080/10428194.2018.1430795" title="DOI URL">https://doi.org/10.1080/10428194.2018.1430795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10428194.2018.1430795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10428194.2018.1430795%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DEnhancer%252Bof%252Bzeste%252Bhomolog%252B2%252B%252528EZH2%252529%252Binhibitors%26aulast%3DGulati%26aufirst%3DNitya%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D7%26spage%3D1574%26epage%3D1585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Mellini</span>, <span class="hlFld-ContribAuthor ">Biagina  Marrocco</span>, <span class="hlFld-ContribAuthor ">Diana  Borovika</span>, <span class="hlFld-ContribAuthor ">Lucia  Polletta</span>, <span class="hlFld-ContribAuthor ">Ilaria  Carnevale</span>, <span class="hlFld-ContribAuthor ">Serena  Saladini</span>, <span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Peteris  Trapencieris</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Ferretti</span>, <span class="hlFld-ContribAuthor ">Marco  Tafani</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Philosophical Transactions of the Royal Society B: Biological Sciences</span><span> <strong>2018,</strong> <em>373 </em>
                                    (1748)
                                     , 20170150. <a href="https://doi.org/10.1098/rstb.2017.0150" title="DOI URL">https://doi.org/10.1098/rstb.2017.0150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rstb.2017.0150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frstb.2017.0150%26sid%3Dliteratum%253Aachs%26jtitle%3DPhilosophical%2520Transactions%2520of%2520the%2520Royal%2520Society%2520B%253A%2520Biological%2520Sciences%26atitle%3DPyrazole-based%252Binhibitors%252Bof%252Benhancer%252Bof%252Bzeste%252Bhomologue%252B2%252Binduce%252Bapoptosis%252Band%252Bautophagy%252Bin%252Bcancer%252Bcells%26aulast%3DMellini%26aufirst%3DPaolo%26date%3D2018%26date%3D2018%26volume%3D373%26issue%3D1748%26spage%3D20170150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Wang</span>, <span class="hlFld-ContribAuthor ">Jason  Quiros</span>, <span class="hlFld-ContribAuthor ">Kelly  Mahuron</span>, <span class="hlFld-ContribAuthor ">Chien-Chun  Pai</span>, <span class="hlFld-ContribAuthor ">Valeria  Ranzani</span>, <span class="hlFld-ContribAuthor ">Arabella  Young</span>, <span class="hlFld-ContribAuthor ">Stephanie  Silveria</span>, <span class="hlFld-ContribAuthor ">Tory  Harwin</span>, <span class="hlFld-ContribAuthor ">Arbi  Abnousian</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Pagani</span>, <span class="hlFld-ContribAuthor ">Michael D.  Rosenblum</span>, <span class="hlFld-ContribAuthor ">Frederic  Van Gool</span>, <span class="hlFld-ContribAuthor ">Lawrence  Fong</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Bluestone</span>, <span class="hlFld-ContribAuthor ">Michel  DuPage</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>23 </em>
                                    (11)
                                     , 3262-3274. <a href="https://doi.org/10.1016/j.celrep.2018.05.050" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.05.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.05.050%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DTargeting%252BEZH2%252BReprograms%252BIntratumoral%252BRegulatory%252BT%252BCells%252Bto%252BEnhance%252BCancer%252BImmunity%26aulast%3DWang%26aufirst%3DDavid%26date%3D2018%26volume%3D23%26issue%3D11%26spage%3D3262%26epage%3D3274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mélanie  Lambert</span>, <span class="hlFld-ContribAuthor ">Samy  Jambon</span>, <span class="hlFld-ContribAuthor ">Sabine  Depauw</span>, <span class="hlFld-ContribAuthor ">Marie-Hélène  David-Cordonnier</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Transcription Factors for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (6)
                                     , 1479. <a href="https://doi.org/10.3390/molecules23061479" title="DOI URL">https://doi.org/10.3390/molecules23061479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23061479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23061479%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252BTranscription%252BFactors%252Bfor%252BCancer%252BTreatment%26aulast%3DLambert%26aufirst%3DM%25C3%25A9lanie%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D6%26spage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen Hao  Neo</span>, <span class="hlFld-ContribAuthor ">Christopher A. G.  Booth</span>, <span class="hlFld-ContribAuthor ">Emanuele  Azzoni</span>, <span class="hlFld-ContribAuthor ">Lijun  Chi</span>, <span class="hlFld-ContribAuthor ">Paul  Delgado-Olguín</span>, <span class="hlFld-ContribAuthor ">Marella F. T. R.  de Bruijn</span>, <span class="hlFld-ContribAuthor ">Sten Eirik W.  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Adam J.  Mead</span>. </span><span class="cited-content_cbyCitation_article-title">Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cells. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2018,</strong> <em>131 </em>
                                    (20)
                                     , 2223-2234. <a href="https://doi.org/10.1182/blood-2017-10-811455" title="DOI URL">https://doi.org/10.1182/blood-2017-10-811455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2017-10-811455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2017-10-811455%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DCell-extrinsic%252Bhematopoietic%252Bimpact%252Bof%252BEzh2%252Binactivation%252Bin%252Bfetal%252Bliver%252Bendothelial%252Bcells%26aulast%3DNeo%26aufirst%3DWen%2BHao%26date%3D2018%26volume%3D131%26issue%3D20%26spage%3D2223%26epage%3D2234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chul-Hwan  Lee</span>, <span class="hlFld-ContribAuthor ">Marlene  Holder</span>, <span class="hlFld-ContribAuthor ">Daniel  Grau</span>, <span class="hlFld-ContribAuthor ">Ricardo  Saldaña-Meyer</span>, <span class="hlFld-ContribAuthor ">Jia-Ray  Yu</span>, <span class="hlFld-ContribAuthor ">Rais Ahmad  Ganai</span>, <span class="hlFld-ContribAuthor ">Jenny  Zhang</span>, <span class="hlFld-ContribAuthor ">Miao  Wang</span>, <span class="hlFld-ContribAuthor ">Gary  LeRoy</span>, <span class="hlFld-ContribAuthor ">Marc-Werner  Dobenecker</span>, <span class="hlFld-ContribAuthor ">Danny  Reinberg</span>, <span class="hlFld-ContribAuthor ">Karim-Jean  Armache</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2018,</strong> <em>70 </em>
                                    (3)
                                     , 435-448.e5. <a href="https://doi.org/10.1016/j.molcel.2018.03.019" title="DOI URL">https://doi.org/10.1016/j.molcel.2018.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2018.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2018.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DDistinct%252BStimulatory%252BMechanisms%252BRegulate%252Bthe%252BCatalytic%252BActivity%252Bof%252BPolycomb%252BRepressive%252BComplex%252B2%26aulast%3DLee%26aufirst%3DChul-Hwan%26date%3D2018%26volume%3D70%26issue%3D3%26spage%3D435%26epage%3D448.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alastair H.  Davies</span>, <span class="hlFld-ContribAuthor ">Himisha  Beltran</span>, <span class="hlFld-ContribAuthor ">Amina  Zoubeidi</span>. </span><span class="cited-content_cbyCitation_article-title">Cellular plasticity and the neuroendocrine phenotype in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Urology</span><span> <strong>2018,</strong> <em>15 </em>
                                    (5)
                                     , 271-286. <a href="https://doi.org/10.1038/nrurol.2018.22" title="DOI URL">https://doi.org/10.1038/nrurol.2018.22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrurol.2018.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrurol.2018.22%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Urology%26atitle%3DCellular%252Bplasticity%252Band%252Bthe%252Bneuroendocrine%252Bphenotype%252Bin%252Bprostate%252Bcancer%26aulast%3DDavies%26aufirst%3DAlastair%2BH.%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D5%26spage%3D271%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brooke  Paradise</span>, <span class="hlFld-ContribAuthor ">Whitney  Barham</span>, <span class="hlFld-ContribAuthor ">Martín  Fernandez-Zapico</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (5)
                                     , 128. <a href="https://doi.org/10.3390/cancers10050128" title="DOI URL">https://doi.org/10.3390/cancers10050128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10050128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10050128%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BEpigenetic%252BAberrations%252Bin%252BPancreatic%252BCancer%25252C%252Ba%252BNew%252BPath%252Bto%252BImprove%252BPatient%252BOutcomes%25253F%26aulast%3DParadise%26aufirst%3DBrooke%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D5%26spage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bayley A.  Jones</span>, <span class="hlFld-ContribAuthor ">Sooryanarayana  Varambally</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Arend</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (3)
                                     , 591-602. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0437" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0437%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DHistone%252BMethyltransferase%252BEZH2%25253A%252BA%252BTherapeutic%252BTarget%252Bfor%252BOvarian%252BCancer%26aulast%3DJones%26aufirst%3DBayley%2BA.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Copeland</span>, <span class="hlFld-ContribAuthor ">P. Ann  Boriack-Sjodin</span>. </span><span class="cited-content_cbyCitation_article-title">The Elements of Translational Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (2)
                                     , 128-134. <a href="https://doi.org/10.1016/j.chembiol.2017.11.003" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DThe%252BElements%252Bof%252BTranslational%252BChemical%252BBiology%26aulast%3DCopeland%26aufirst%3DRobert%2BA.%26date%3D2018%26volume%3D25%26issue%3D2%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shijun  Wen</span>, <span class="hlFld-ContribAuthor ">Jiankang  Wang</span>, <span class="hlFld-ContribAuthor ">Panpan  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqing  Li</span>, <span class="hlFld-ContribAuthor ">Wenhua  Lu</span>, <span class="hlFld-ContribAuthor ">Yumin  Hu</span>, <span class="hlFld-ContribAuthor ">Jinyun  Liu</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  He</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2018,</strong> <em>413 </em>, 35-45. <a href="https://doi.org/10.1016/j.canlet.2017.10.015" title="DOI URL">https://doi.org/10.1016/j.canlet.2017.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2017.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2017.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DNovel%252Bcombination%252Bof%252Bhistone%252Bmethylation%252Bmodulators%252Bwith%252Btherapeutic%252Bsynergy%252Bagainst%252Bacute%252Bmyeloid%252Bleukemia%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DWen%26aufirst%3DShijun%26date%3D2018%26volume%3D413%26spage%3D35%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuchen  Chen</span>, <span class="hlFld-ContribAuthor ">Xinran  Liu</span>, <span class="hlFld-ContribAuthor ">Yangkai  Li</span>, <span class="hlFld-ContribAuthor ">Chuntao  Quan</span>, <span class="hlFld-ContribAuthor ">Ling  Zheng</span>, <span class="hlFld-ContribAuthor ">Kun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2018,</strong> <em>16 </em>, 211-223. <a href="https://doi.org/10.1016/j.csbj.2018.06.001" title="DOI URL">https://doi.org/10.1016/j.csbj.2018.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2018.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2018.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DLung%252BCancer%252BTherapy%252BTargeting%252BHistone%252BMethylation%25253A%252BOpportunities%252Band%252BChallenges%26aulast%3DChen%26aufirst%3DYuchen%26date%3D2018%26volume%3D16%26spage%3D211%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen G.  Jarred</span>, <span class="hlFld-ContribAuthor ">Heidi  Bildsoe</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Western</span>. </span><span class="cited-content_cbyCitation_article-title">Out of sight, out of mind? Germ cells and the potential impacts of epigenomic drugs. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2018,</strong> <em>7 </em>, 1967. <a href="https://doi.org/10.12688/f1000research.15935.1" title="DOI URL">https://doi.org/10.12688/f1000research.15935.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.15935.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.15935.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DOut%252Bof%252Bsight%25252C%252Bout%252Bof%252Bmind%25253F%252BGerm%252Bcells%252Band%252Bthe%252Bpotential%252Bimpacts%252Bof%252Bepigenomic%252Bdrugs%26aulast%3DJarred%26aufirst%3DEllen%2BG.%26date%3D2018%26date%3D2018%26volume%3D7%26spage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paweł  Borowiecki</span>, <span class="hlFld-ContribAuthor ">Iwona  Justyniak</span>, <span class="hlFld-ContribAuthor ">Zbigniew  Ochal</span>. </span><span class="cited-content_cbyCitation_article-title">Lipase-catalyzed kinetic resolution approach toward enantiomerically enriched 1-(β-hydroxypropyl)indoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (12)
                                     , 1717-1732. <a href="https://doi.org/10.1016/j.tetasy.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.tetasy.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DLipase-catalyzed%252Bkinetic%252Bresolution%252Bapproach%252Btoward%252Benantiomerically%252Benriched%252B1-%252528%2525CE%2525B2-hydroxypropyl%252529indoles%26aulast%3DBorowiecki%26aufirst%3DPawe%25C5%2582%26date%3D2017%26volume%3D28%26issue%3D12%26spage%3D1717%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Paolicchi</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Fornaro</span>, <span class="hlFld-ContribAuthor ">Stefano  Landi</span>, <span class="hlFld-ContribAuthor ">Sushilaben  Rigas</span>, <span class="hlFld-ContribAuthor ">Francesco  Crea</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 Single Nucleotide Variants (SNVs): Diagnostic and Prognostic Role in 10 Solid Tumor Types. </span><span class="cited-content_cbyCitation_journal-name">Epigenomes</span><span> <strong>2017,</strong> <em>1 </em>
                                    (3)
                                     , 18. <a href="https://doi.org/10.3390/epigenomes1030018" title="DOI URL">https://doi.org/10.3390/epigenomes1030018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/epigenomes1030018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fepigenomes1030018%26sid%3Dliteratum%253Aachs%26jtitle%3DEpigenomes%26atitle%3DEZH2%252BSingle%252BNucleotide%252BVariants%252B%252528SNVs%252529%25253A%252BDiagnostic%252Band%252BPrognostic%252BRole%252Bin%252B10%252BSolid%252BTumor%252BTypes%26aulast%3DPaolicchi%26aufirst%3DElisa%26date%3D2017%26date%3D2017%26volume%3D1%26issue%3D3%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Drugs Targeting the Epigenome. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmacology Reports</span><span> <strong>2017,</strong> <em>3 </em>
                                    (5)
                                     , 268-285. <a href="https://doi.org/10.1007/s40495-017-0100-7" title="DOI URL">https://doi.org/10.1007/s40495-017-0100-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40495-017-0100-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40495-017-0100-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmacology%2520Reports%26atitle%3DNovel%252BDrugs%252BTargeting%252Bthe%252BEpigenome%26aulast%3DChen%26aufirst%3DZhuo%26date%3D2017%26date%3D2017%26volume%3D3%26issue%3D5%26spage%3D268%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Honma</span>, <span class="hlFld-ContribAuthor ">Osamu  Kanno</span>, <span class="hlFld-ContribAuthor ">Jun  Watanabe</span>, <span class="hlFld-ContribAuthor ">Junzo  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Makoto  Hirasawa</span>, <span class="hlFld-ContribAuthor ">Emi  Nosaka</span>, <span class="hlFld-ContribAuthor ">Machiko  Shiroishi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Takizawa</span>, <span class="hlFld-ContribAuthor ">Isao  Yasumatsu</span>, <span class="hlFld-ContribAuthor ">Takao  Horiuchi</span>, <span class="hlFld-ContribAuthor ">Akira  Nakao</span>, <span class="hlFld-ContribAuthor ">Keisuke  Suzuki</span>, <span class="hlFld-ContribAuthor ">Tomonori  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Katsuyoshi  Nakajima</span>, <span class="hlFld-ContribAuthor ">Miho  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Takanori  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Ajay Singh  Yadav</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Adachi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2017,</strong> <em>108 </em>
                                    (10)
                                     , 2069-2078. <a href="https://doi.org/10.1111/cas.13326" title="DOI URL">https://doi.org/10.1111/cas.13326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13326%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DNovel%252Borally%252Bbioavailable%252BEZH1%25252F2%252Bdual%252Binhibitors%252Bwith%252Bgreater%252Bantitumor%252Befficacy%252Bthan%252Ban%252BEZH2%252Bselective%252Binhibitor%26aulast%3DHonma%26aufirst%3DDaisuke%26date%3D2017%26date%3D2017%26volume%3D108%26issue%3D10%26spage%3D2069%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. Ümit  Kaniskan</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in developing selective inhibitors of protein methyltransferases. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2017,</strong> <em>39 </em>, 100-108. <a href="https://doi.org/10.1016/j.cbpa.2017.06.013" title="DOI URL">https://doi.org/10.1016/j.cbpa.2017.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2017.06.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DRecent%252Bprogress%252Bin%252Bdeveloping%252Bselective%252Binhibitors%252Bof%252Bprotein%252Bmethyltransferases%26aulast%3DKaniskan%26aufirst%3DH.%2B%25C3%259Cmit%26date%3D2017%26volume%3D39%26spage%3D100%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 inhibitors: a patent review (2014-2016). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 797-813. <a href="https://doi.org/10.1080/13543776.2017.1316976" title="DOI URL">https://doi.org/10.1080/13543776.2017.1316976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1316976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1316976%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEZH2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-2016%252529%26aulast%3DStazi%26aufirst%3DGiulia%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D797%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke-Sin  Yan</span>, <span class="hlFld-ContribAuthor ">Chia-Yuan  Lin</span>, <span class="hlFld-ContribAuthor ">Tan-Wei  Liao</span>, <span class="hlFld-ContribAuthor ">Cheng-Ming  Peng</span>, <span class="hlFld-ContribAuthor ">Shou-Chun  Lee</span>, <span class="hlFld-ContribAuthor ">Yi-Jui  Liu</span>, <span class="hlFld-ContribAuthor ">Wing  Chan</span>, <span class="hlFld-ContribAuthor ">Ruey-Hwang  Chou</span>. </span><span class="cited-content_cbyCitation_article-title">EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (6)
                                     , 1172. <a href="https://doi.org/10.3390/ijms18061172" title="DOI URL">https://doi.org/10.3390/ijms18061172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18061172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18061172%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEZH2%252Bin%252BCancer%252BProgression%252Band%252BPotential%252BApplication%252Bin%252BCancer%252BTherapy%25253A%252BA%252BFriend%252Bor%252BFoe%25253F%26aulast%3DYan%26aufirst%3DKe-Sin%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D6%26spage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koorosh  Korfi</span>, <span class="hlFld-ContribAuthor ">Sara  Ali</span>, <span class="hlFld-ContribAuthor ">James A.  Heward</span>, <span class="hlFld-ContribAuthor ">Jude  Fitzgibbon</span>. </span><span class="cited-content_cbyCitation_article-title">Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations. </span><span class="cited-content_cbyCitation_journal-name">Epigenetics</span><span> <strong>2017,</strong> <em>12 </em>
                                    (5)
                                     , 370-377. <a href="https://doi.org/10.1080/15592294.2017.1282587" title="DOI URL">https://doi.org/10.1080/15592294.2017.1282587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15592294.2017.1282587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15592294.2017.1282587%26sid%3Dliteratum%253Aachs%26jtitle%3DEpigenetics%26atitle%3DFollicular%252Blymphoma%25252C%252Ba%252BB%252Bcell%252Bmalignancy%252Baddicted%252Bto%252Bepigenetic%252Bmutations%26aulast%3DKorfi%26aufirst%3DKoorosh%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D5%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.6b01315&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-21%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01315%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=101&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported EZH2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General trends in structure–activity relationships.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Surface representation of the co-crystal structure of <b>10</b> (yellow spheres) bound to the PRC2 complex (EED (gray), SUZ12 (pink), EZH2 (pale blue at N-terminus to blue at C-terminus) (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>). (B) Electron density (NCS averaged Fourier Map (2Fo-Fc map contoured at 2σ)) surrounding compound <b>10</b>. Main interactions are between pyridone of <b>10</b> and key residues from the SET-I and SAL domains of EZH2 and from EED (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>). (C) The PRC2-compound <b>10</b> complex (colored as above) superimposed on the PRC2 complex with SAH cofactor and peptide (green). (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). (D) The pyridone and indole are constrained in a binding site composed of residues from both the SET domain (blue) and SAL region (pale blue) of EZH2 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the EZH2 C-terminus with the SET domain active site. (A) Human PRC2 complex with compound <b>10</b>. (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>) (B) Equivalent region of the human PRC2-H3K27M-SAH complex, (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>) with cofactor (orange) and histone H3 peptide (red). (C) Overlay of residues forming the SET domain lysine channel for both complexes, highlighting that the position of the C-terminus conformation observed in the compound complex is incompatible with substrate binding (red). (D) and (E) Surface representations showing that the lysine binding channel is closed in the PRC2-compound <b>10</b> complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>) but accessible in the SAH/substrate complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN">5HYN</a>). (F) Surface representation of EZH2 observed in the PRC2-compound <b>10</b> complex but with the H3 peptide overlaid from the PRC2-H3K27M-SAH complex, confirming that substrate binding is incompatible with the EZH2 conformation in the PRC2-compound <b>10</b> complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mouse pharmacokinetic profile of <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Palladium Mediated Intramolecular C–N Arylation to Indole <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, <i>t-</i>BuOH, reflux (76% yield); (b) RuPhos precatalyst (generation III) (2 mol %), RuPhos (3 mol %), NaOMe (1.5 equiv), 1,4-dioxane, 100 °C, followed by HCl (4 M in 1,4-dioxane) (81% yield over two steps).</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>10</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,2,2-trifluoroacetic anhydride (1.4 equiv), <i>i</i>-PrNEt<sub>2</sub> (2.5 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) BH<sub>3</sub>·THF (2.2 equiv), THF, 70 °C; (c) 6 N aq NaOH (6.0 equiv), EtOH, 85 °C; (d) CDI (1.3 equiv), THF, 60 °C</p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/medium/jm-2016-01315e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumor xenograft with <b>13</b>. (A) Effect of dosing analogue <b>13</b> at 160 mpk BID for 25 days on KARPAS-422 tumor growth in mouse xenograft. (B) Corresponding body weight change during the course of the study. (C) Pharmacodynamic effect of <b>13</b> on reduction of H3K27me3 normalized to total H3. (D) Analysis of plasma and tumor concentrations of <b>13</b> at 1 h post last dose on day 25.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b01315/20170531/images/large/jm-2016-01315e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01315&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Swalm, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span> </span><span class="NLM_article-title">Reaction Coupling Between Wild-Type and Disease-Associated Mutant EZH2</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2459</span><span class="NLM_x">–</span> <span class="NLM_lpage">2464</span><span class="refDoi"> DOI: 10.1021/cb500548b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500548b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsValsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2459-2464&author=B.+M.+Swalmauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=L.+Jinauthor=K.+W.+Kuntzauthor=H.+Keilhackauthor=J.+J.+Smithauthor=R.+M.+Pollockauthor=M.+P.+Moyerauthor=M.+P.+Scottauthor=R.+A.+Copelandauthor=T.+J.+Wigle&title=Reaction+Coupling+Between+Wild-Type+and+Disease-Associated+Mutant+EZH2&doi=10.1021%2Fcb500548b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction Coupling between Wild-Type and Disease-Associated Mutant EZH2</span></div><div class="casAuthors">Swalm, Brooke M.; Knutson, Sarah K.; Warholic, Natalie M.; Jin, Lei; Kuntz, Kevin W.; Keilhack, Heike; Smith, Jesse J.; Pollock, Roy M.; Moyer, Mikel P.; Scott, Margaret Porter; Copeland, Robert A.; Wigle, Tim J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2459-2464</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 and EZH1 are protein methyltransferases (PMTs) responsible for histone H3, lysine 27 (H3K27) methylation.  Trimethylation of H3K27 (H3K27me3) is a hallmark of many cancers, including non-Hodgkin lymphoma (NHL).  Heterozygous EZH2 point mutations at Tyr641, Ala677, and Ala687 have been obsd. in NHL.  The Tyr641 mutations enhance activity on H3K27me2 but have weak or no activity on unmethylated H3K27, whereas the Ala677 and Ala687 mutations use substrates of all methylation states effectively.  It has been proposed that enzymic coupling of the wild-type and mutant enzymes leads to the oncogenic H3K27me3 mark in mutant-bearing NHL.  The authors show that coupling with the wild-type enzyme is needed to achieve H3K27me3 for several mutants, but that others are capable of achieving H3K27me3 on their own.  All forms of PRC2 (wild-type and mutants) display kinetic signatures that are consistent with a distributive mechanism of catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYJS1iNB13X7Vg90H21EOLACvtfcHk0lgvrIVM4EDzeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsValsbrN&md5=bf0497c142262f217cbfd73aed8b1bb2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcb500548b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500548b%26sid%3Dliteratum%253Aachs%26aulast%3DSwalm%26aufirst%3DB.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26atitle%3DReaction%2520Coupling%2520Between%2520Wild-Type%2520and%2520Disease-Associated%2520Mutant%2520EZH2%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2459%26epage%3D2464%26doi%3D10.1021%2Fcb500548b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Simon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. A.</span><span> </span><span class="NLM_article-title">Roles of the EZH2 Histone Methyltransferase in Cancer Epigenetics</span> <span class="citation_source-journal">Mutat. Res., Fundam. Mol. Mech. Mutagen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">647</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.mrfmmm.2008.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.mrfmmm.2008.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=18723033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=647&publication_year=2008&pages=21-29&author=J.+A.+Simonauthor=C.+A.+Lange&title=Roles+of+the+EZH2+Histone+Methyltransferase+in+Cancer+Epigenetics&doi=10.1016%2Fj.mrfmmm.2008.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the EZH2 histone methyltransferase in cancer epigenetics</span></div><div class="casAuthors">Simon, Jeffrey A.; Lange, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">647</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  EZH2 is the catalytic subunit of Polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3.  This methylated H3-K27 chromatin mark is commonly assocd. with silencing of differentiation genes in organisms ranging from plants to flies to humans.  Studies on human tumors show that EZH2 is frequently over-expressed in a wide variety of cancerous tissue types, including prostate and breast.  Although the mechanistic contributions of EZH2 to cancer progression are not yet detd., functional links between EZH2-mediated histone methylation and DNA methylation suggest partnership with the gene silencing machinery implicated in tumor suppressor loss.  Here we review the basic mol. biol. of EZH2 and the findings that implicate EZH2 in different cancers.  We also discuss EZH2 connections to other silencing enzymes, such as DNA methyltransferases and histone deacetylases, and we consider progress on deciphering mechanistic consequences of EZH2 overabundance and its potential roles in tumorigenesis.  Finally, we review recent findings that link EZH2 roles in stem cells and cancer, and we consider prospects for integrating EZH2 blockade into strategies for developing epigenetic therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_YxVHv1IGDrVg90H21EOLACvtfcHk0lgO2APnHpifoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyks7nP&md5=e80ac4a2ba07b9e1ab4256ba6c73b23f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2008.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2008.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DLange%26aufirst%3DC.%2BA.%26atitle%3DRoles%2520of%2520the%2520EZH2%2520Histone%2520Methyltransferase%2520in%2520Cancer%2520Epigenetics%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2008%26volume%3D647%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.mrfmmm.2008.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Margueron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span> </span><span class="NLM_article-title">The Polycomb Complex PRC2 and Its Mark in Life</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">469</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1038/nature09784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature09784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=21248841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=469&publication_year=2011&pages=343-349&author=R.+Margueronauthor=D.+Reinberg&title=The+Polycomb+Complex+PRC2+and+Its+Mark+in+Life&doi=10.1038%2Fnature09784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Polycomb complex PRC2 and its mark in life</span></div><div class="casAuthors">Margueron, Raphael; Reinberg, Danny</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">469</span>
        (<span class="NLM_cas:issue">7330</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure.  In mammals, 2 main Polycomb group complexes exist: Polycomb repressive complex 1 (PRC1) and 2 (PRC2).  PRC1 compacts chromatin and catalyzes the monoubiquitination of histone H2A.  PRC2 also contributes to chromatin compaction, and catalyzes the methylation of histone H3 at Lys-27.  PRC2 is involved in various biol. processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity.  Recent studies of PRC2 have expanded the perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fYmuBqnMA7Vg90H21EOLACvtfcHk0lgO2APnHpifoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVOisA%253D%253D&md5=5f15e91cc6ff765f649842041f333841</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature09784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09784%26sid%3Dliteratum%253Aachs%26aulast%3DMargueron%26aufirst%3DR.%26aulast%3DReinberg%26aufirst%3DD.%26atitle%3DThe%2520Polycomb%2520Complex%2520PRC2%2520and%2520Its%2520Mark%2520in%2520Life%26jtitle%3DNature%26date%3D2011%26volume%3D469%26spage%3D343%26epage%3D349%26doi%3D10.1038%2Fnature09784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span> </span><span class="NLM_article-title">Regulation and Role of EZH2 in Cancer</span> <span class="citation_source-journal">Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.4143/crt.2014.46.3.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4143%2Fcrt.2014.46.3.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25038756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2014&pages=209-222&author=H.+Yamaguchiauthor=M.-C.+Hung&title=Regulation+and+Role+of+EZH2+in+Cancer&doi=10.4143%2Fcrt.2014.46.3.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and role of EZH2 in cancer</span></div><div class="casAuthors">Yamaguchi, Hirohito; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-222</span>CODEN:
                <span class="NLM_cas:coden">CRTAC2</span>;
        ISSN:<span class="NLM_cas:issn">2005-9256</span>.
    
            (<span class="NLM_cas:orgname">Korean Cancer Association</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) is the epigenetic regulator that induces histone H3 lysine 27 methylation (H3K27me3) and silences specific gene transcription.  Enhancer of zeste homolog 2 (EZH2) is an enzymic subunit of PRC2, and evidence shows that EZH2 plays an essential role in cancer initiation, development, progression, metastasis, and drug resistance.  EZH2 expression is indeed regulated by various oncogenic transcription factors, tumor suppressor miRNAs, and cancer-assocd. non-coding RNA.  EZH2 activity is also controlled by post-translational modifications, which are deregulated in cancer.  The canonical role of EZH2 is gene silencing through H3K27me3, but accumulating evidence shows that EZH2 methlyates substrates other than histone and has methylase-independent functions.  These non-canonical functions of EZH2 are shown to play a role in cancer progression.  In this review, we summarize current information on the regulation and roles of EZH2 in cancer.  We also discuss various therapeutic approaches to targeting EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVidEmS4fsrVg90H21EOLACvtfcHk0lgO2APnHpifoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlaisLk%253D&md5=78ba72a545b0b8c2c8bb8b255cc76259</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4143%2Fcrt.2014.46.3.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4143%252Fcrt.2014.46.3.209%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DHung%26aufirst%3DM.-C.%26atitle%3DRegulation%2520and%2520Role%2520of%2520EZH2%2520in%2520Cancer%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D46%26spage%3D209%26epage%3D222%26doi%3D10.4143%2Fcrt.2014.46.3.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanasekaran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrette, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar-Sinha, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">The Polycomb Group Protein EZH2 Is Involved In Progression of Prostate Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1038/nature01075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature01075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=12374981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=624-629&author=S.+Varamballyauthor=S.+M.+Dhanasekaranauthor=M.+Zhouauthor=T.+R.+Barretteauthor=C.+Kumar-Sinhaauthor=M.+G.+Sandaauthor=D.+Ghoshauthor=K.+J.+Pientaauthor=R.+G.+Sewaltauthor=A.+P.+Otteauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=The+Polycomb+Group+Protein+EZH2+Is+Involved+In+Progression+of+Prostate+Cancer&doi=10.1038%2Fnature01075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The polycomb group protein EZH2 is involved in progression of prostate cancer</span></div><div class="casAuthors">Varambally, Sooryanarayana; Dhanasekaran, Saravana M.; Zhou, Ming; Barrette, Terrence R.; Kumar-Sinha, Chandan; Sanda, Martin G.; Ghosh, Debashis; Pienta, Kenneth J.; Sewalt, Richard G. A. B.; Otte, Arie P.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6907</span>),
    <span class="NLM_cas:pages">624-629</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer.  Although effective surgical and radiation treatments exist for clin. localized prostate cancer, metastatic prostate cancer remains essentially incurable.  Here we show, through gene expression profiling, that the polycomb group protein enhancer of zeste homolog 2 (EZH2) is overexpressed in hormone-refractory, metastatic prostate cancer.  Small interfering RNA (siRNA) duplexes targeted against EZH2 reduce the amts. of EZH2 protein present in prostate cells and also inhibit cell proliferation in vitro.  Ectopic expression of EZH2 in prostate cells induces transcriptional repression of a specific cohort of genes.  Gene silencing mediated by EZH2 requires the SET domain and is attenuated by inhibiting histone deacetylase activity.  Amts. of both EZH2 mRNA and EZH2 protein are increased in metastatic prostate cancer; in addn., clin. localized prostate cancers that express higher concns. of EZH2 show a poorer prognosis.  Thus, dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.  Supplementary information on the gene expression profile can be obtained at: http://www.nature.com/nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW_h7gunzd7Vg90H21EOLACvtfcHk0lh-abViIFVxNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ontrk%253D&md5=c38f80915b4183472aa7be4f9f3ecc67</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01075%26sid%3Dliteratum%253Aachs%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DDhanasekaran%26aufirst%3DS.%2BM.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DBarrette%26aufirst%3DT.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DSanda%26aufirst%3DM.%2BG.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DThe%2520Polycomb%2520Group%2520Protein%2520EZH2%2520Is%2520Involved%2520In%2520Progression%2520of%2520Prostate%2520Cancer%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D624%26epage%3D629%26doi%3D10.1038%2Fnature01075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Qi</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varambally, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlins, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sewalt, R. G. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">EZH2 is a Marker of Aggressive Breast Cancer and Promotes Neoplastic Transformation of Breast Epithelial Cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">11606</span><span class="NLM_x">–</span> <span class="NLM_lpage">11611</span><span class="refDoi"> DOI: 10.1073/pnas.1933744100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1933744100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=14500907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=11606-11611&author=C.+G.+Kleerauthor=Qi+Caoauthor=S.+Varamballyauthor=R.+Shenauthor=I.+Otaauthor=S.+A.+Tomlinsauthor=D.+Ghoshauthor=R.+G.+A.+B.+Sewaltauthor=A.+P.+Otteauthor=D.+F.+Hayesauthor=M.+S.+Sabelauthor=D.+Livantauthor=S.+J.+Weissauthor=M.+A.+Rubinauthor=A.+M.+Chinnaiyan&title=EZH2+is+a+Marker+of+Aggressive+Breast+Cancer+and+Promotes+Neoplastic+Transformation+of+Breast+Epithelial+Cells&doi=10.1073%2Fpnas.1933744100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells</span></div><div class="casAuthors">Kleer, Celina G.; Cao, Qi; Varambally, Sooryanarayana; Shen, Ronglai; Ota, Ichiro; Tomlins, Scott A.; Ghosh, Debashis; Sewalt, Richard G. A. B.; Otte, Arie P.; Hayes, Daniel F.; Sabel, Michael S.; Livant, Donna; Weiss, Stephen J.; Rubin, Mark A.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11606-11611</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to aggressive prostate cancer.  Here the authors investigate the functional role of EZH2 in cancer cell invasion and breast cancer progression.  EZH2 transcript and protein were consistently elevated in invasive breast carcinoma compared with normal breast epithelia.  Tissue microarray anal., which included 917 samples from 280 patients, demonstrated that EZH2 protein levels were strongly assocd. with breast cancer aggressiveness.  Overexpression of EZH2 in immortalized human mammary epithelial cell lines promotes anchorage-independent growth and cell invasion.  EZH2-mediated cell invasion required an intact SET domain and histone deacetylase activity.  This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3vRwhSLDh7Vg90H21EOLACvtfcHk0lh-abViIFVxNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKmt7g%253D&md5=a362e2d0f3c61c8e8b3afd5cea992255</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1933744100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1933744100%26sid%3Dliteratum%253Aachs%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DCao%26aufirst%3DQi%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSewalt%26aufirst%3DR.%2BG.%2BA.%2BB.%26aulast%3DOtte%26aufirst%3DA.%2BP.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DSabel%26aufirst%3DM.%2BS.%26aulast%3DLivant%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520is%2520a%2520Marker%2520of%2520Aggressive%2520Breast%2520Cancer%2520and%2520Promotes%2520Neoplastic%2520Transformation%2520of%2520Breast%2520Epithelial%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D11606%26epage%3D11611%26doi%3D10.1073%2Fpnas.1933744100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">McGrath, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Targeting Histone Lysine Methylation In Cancer</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.pharmthera.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25578037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2015&pages=1-22&author=J.+P.+McGrathauthor=P.+Trojer&title=Targeting+Histone+Lysine+Methylation+In+Cancer&doi=10.1016%2Fj.pharmthera.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting histone lysine methylation in cancer</span></div><div class="casAuthors">McGrath, John; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Within the vast landscape of histone modifications lysine methylation has gained increasing attention because of its profound regulatory potential.  The methylation of lysine residues on histone proteins modulates chromatin structure and thereby contributes to the regulation of DNA-based nuclear processes such as transcription, replication and repair.  Protein families with opposing catalytic activities, lysine methyltransferases (KMTs) and demethylases (KDMs), dynamically control levels of histone lysine methylation and individual enzymes within these families have become candidate oncol. targets in recent years.  A no. of high quality small mol. inhibitors of these enzymes have been identified.  Several of these compds. elicit selective cancer cell killing in vitro and robust efficacy in vivo, suggesting that targeting 'histone lysine methylation pathways' may be a relevant, emerging cancer therapeutic strategy.  Here, we discuss individual histone lysine methylation pathway targets, the properties of currently available small mol. inhibitors and their application in the context of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqKUpTpHisrVg90H21EOLACvtfcHk0lij5VsfnW44eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KrtL4%253D&md5=225ece90384f762b248d2d7981fa120e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DJ.%2BP.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DTargeting%2520Histone%2520Lysine%2520Methylation%2520In%2520Cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D150%26spage%3D1%26epage%3D22%26doi%3D10.1016%2Fj.pharmthera.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bauge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazille, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lhuissier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boumediene, K.</span><span> </span><span class="NLM_article-title">Histone Methylases as Novel Drug Targets: Developing Inhibitors of EZH2</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span><span class="refDoi"> DOI: 10.4155/fmc.14.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4155%2Ffmc.14.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25495986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyltrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1943-1965&author=C.+Baugeauthor=C.+Bazilleauthor=N.+Girardauthor=E.+Lhuissierauthor=K.+Boumediene&title=Histone+Methylases+as+Novel+Drug+Targets%3A+Developing+Inhibitors+of+EZH2&doi=10.4155%2Ffmc.14.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Histone methylases as novel drug targets: developing inhibitors of EZH2</span></div><div class="casAuthors">Bauge, Catherine; Bazille, Celine; Girard, Nicolas; Lhuissier, Eva; Boumediene, Karim</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1943-1965</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of histones (so-called epigenetic modifications) play a major role in transcriptional control and normal development, and are tightly regulated.  Disruption of their control is a frequent event in disease.  In particular, the methylation of lysine 27 on histone H3 (H3K27), induced by the methylase EZH2, emerges as a key control of gene expression and a major regulator of cell physiol.  The identification of driver mutations in EZH2 has already led to new prognostic and therapeutic advances, and new classes of potent and specific inhibitors for EZH2 show promising results in preclin. trials.  This review examines the roles of histone lysine methylases and demethylases in cells and focuses on the recent knowledge and developments about EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGBaalHroI3rVg90H21EOLACvtfcHk0lij5VsfnW44eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyltrzO&md5=6f17f44b9556988d35a917ad2f500bdf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.123%26sid%3Dliteratum%253Aachs%26aulast%3DBauge%26aufirst%3DC.%26aulast%3DBazille%26aufirst%3DC.%26aulast%3DGirard%26aufirst%3DN.%26aulast%3DLhuissier%26aufirst%3DE.%26aulast%3DBoumediene%26aufirst%3DK.%26atitle%3DHistone%2520Methylases%2520as%2520Novel%2520Drug%2520Targets%253A%2520Developing%2520Inhibitors%2520of%2520EZH2%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1943%26epage%3D1965%26doi%3D10.4155%2Ffmc.14.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery of Small-Molecule Inhibitors of the HMT EZH2 for the Treatment of Cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span><span class="refDoi"> DOI: 10.4155/fmc.13.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.4155%2Ffmc.13.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=24047271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1661-1670&author=S.+K.+Vermaauthor=S.+D.+Knight&title=Recent+Progress+in+the+Discovery+of+Small-Molecule+Inhibitors+of+the+HMT+EZH2+for+the+Treatment+of+Cancer&doi=10.4155%2Ffmc.13.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer</span></div><div class="casAuthors">Verma, Sharad K.; Knight, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1661-1670</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The histone lysine methyltransferase EZH2 is the catalytic component of the multi-protein PRC2 complex and methylates lysine 27 on histone H3.  EZH2 overexpression is implicated in tumorigenesis and correlates with poor prognosis in several tumor types.  Inhibition of aberrant EZH2 activity might attenuate tumorigenesis resulting from dysregulated gene transcription derived from aberrant EZH2 activity.  In the last year, the first reports of small mols. demonstrating potent and selective inhibition of EZH2 have been published by multiple groups.  Herein, we review recent progress reported in the discovery of small mol. inhibitors of EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovIgP1C5IhnrVg90H21EOLACvtfcHk0lh_Gcu_OiVsxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsLfJ&md5=66387a9bea69b345504ab6d7707cc025</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.136%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520the%2520HMT%2520EZH2%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1661%26epage%3D1670%26doi%3D10.4155%2Ffmc.13.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of EZH2: The Emerging Translational Landscape</span> <span class="citation_source-journal">Epigenomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.2217/epi.15.14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.2217%2Fepi.15.14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=337-341&author=H.+Keilhackauthor=J.+J.+Smith&title=Small+Molecule+Inhibitors+of+EZH2%3A+The+Emerging+Translational+Landscape&doi=10.2217%2Fepi.15.14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Fepi.15.14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fepi.15.14%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520EZH2%253A%2520The%2520Emerging%2520Translational%2520Landscape%26jtitle%3DEpigenomics%26date%3D2015%26volume%3D7%26spage%3D337%26epage%3D341%26doi%3D10.2217%2Fepi.15.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Beguelin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunting, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezponda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaknovich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchietti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elemento, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A. M.</span><span> </span><span class="NLM_article-title">EZH2 Is Required for Germinal Center Formation and Somatic EZH2Mutations Promote Lymphoid Transformation</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.ccr.2013.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.ccr.2013.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=677-692&author=W.+Beguelinauthor=R.+Popovicauthor=M.+Teaterauthor=Y.+Jiangauthor=K.+L.+Buntingauthor=M.+Rosenauthor=H.+Shenauthor=S.+N.+Yangauthor=L.+Wangauthor=T.+Ezpondaauthor=E.+Martinez-Garciaauthor=H.+Zhangauthor=Y.+Zhengauthor=S.+K.+Vermaauthor=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+S.+Van+Allerauthor=R.+G.+Krugerauthor=Y.+Liuauthor=C.+F.+McHughauthor=D.+W.+Scottauthor=Y.+R.+Chungauthor=N.+Kelleherauthor=R.+Shaknovichauthor=C.+L.+Creasyauthor=R.+D.+Gascoyneauthor=K.-K.+Wongauthor=L.+Cerchiettiauthor=R.+L.+Levineauthor=O.+Abdel-Wahabauthor=J.+D.+Lichtauthor=O.+Elementoauthor=A.+M.+Melnick&title=EZH2+Is+Required+for+Germinal+Center+Formation+and+Somatic+EZH2Mutations+Promote+Lymphoid+Transformation&doi=10.1016%2Fj.ccr.2013.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBeguelin%26aufirst%3DW.%26aulast%3DPopovic%26aufirst%3DR.%26aulast%3DTeater%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DBunting%26aufirst%3DK.%2BL.%26aulast%3DRosen%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DEzponda%26aufirst%3DT.%26aulast%3DMartinez-Garcia%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DScott%26aufirst%3DD.%2BW.%26aulast%3DChung%26aufirst%3DY.%2BR.%26aulast%3DKelleher%26aufirst%3DN.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DElemento%26aufirst%3DO.%26aulast%3DMelnick%26aufirst%3DA.%2BM.%26atitle%3DEZH2%2520Is%2520Required%2520for%2520Germinal%2520Center%2520Formation%2520and%2520Somatic%2520EZH2Mutations%2520Promote%2520Lymphoid%2520Transformation%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D677%26epage%3D692%26doi%3D10.1016%2Fj.ccr.2013.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olhava, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor of EZH2 Blocks H3K27 Methylation and Kills Mutant Lymphoma Cells</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1038/nchembio.1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnchembio.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=23023262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=890-896&author=S.+K.+Knutsonauthor=T.+J.+Wigleauthor=N.+M.+Warholicauthor=C.+J.+Sneeringerauthor=C.+J.+Allainauthor=C.+R.+Klausauthor=J.+D.+Sacksauthor=A.+Raimondiauthor=C.+R.+Majerauthor=J.+Songauthor=M.+P.+Scottauthor=L.+Jinauthor=J.+J.+Smithauthor=E.+J.+Olhavaauthor=R.+Chesworthauthor=M.+Moyerauthor=V.+M.+Richonauthor=R.+A.+Copelandauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=K.+W.+Kuntz&title=A+Selective+Inhibitor+of+EZH2+Blocks+H3K27+Methylation+and+Kills+Mutant+Lymphoma+Cells&doi=10.1038%2Fnchembio.1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells</span></div><div class="casAuthors">Knutson, Sarah K.; Wigle, Tim J.; Warholic, Natalie M.; Sneeringer, Christopher J.; Allain, Christina J.; Klaus, Christine R.; Sacks, Joelle D.; Raimondi, Alejandra; Majer, Christina R.; Song, Jeffrey; Scott, Margaret Porter; Jin, Lei; Smith, Jesse J.; Olhava, Edward J.; Chesworth, Richard; Moyer, Mikel P.; Richon, Victoria M.; Copeland, Robert A.; Keilhack, Heike; Pollock, Roy M.; Kuntz, Kevin W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">890-896</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27).  Point mutations of EZH2 at Tyr 641 and Ala 677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive H3K27 hypertrimethylation.  Here the authors report the discovery of EPZ005687, a potent inhibitor of EZH2 (Ki of 24 nM).  EPZ005687 has greater than 500-fold selectivity against 15 other protein methyltransferases and has 50-fold selectivity against the closely related enzyme EZH1.  The compd. reduces H3K27 methylation in various lymphoma cells; this translates into apoptotic cell killing in heterozygous Tyr 641 or Ala 677 mutant cells, with minimal effects on the proliferation of wild-type cells.  These data suggest that genetic alteration of EZH2 (for example, mutations at Tyr 641 or Ala 677) results in a crit. dependency on enzymic activity for proliferation (i.e., the equiv. of oncogene addiction), thus portending the clin. use of EZH2 inhibitors for cancers in which EZH2 is genetically altered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohlduVbTgWJrVg90H21EOLACvtfcHk0lieY4VlGKf4gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqtrvP&md5=a9ad7a41505e3fd4aa087d9f5dae8825</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1084%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DSacks%26aufirst%3DJ.%2BD.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DOlhava%26aufirst%3DE.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26atitle%3DA%2520Selective%2520Inhibitor%2520of%2520EZH2%2520Blocks%2520H3K27%2520Methylation%2520and%2520Kills%2520Mutant%2520Lymphoma%2520Cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D890%26epage%3D896%26doi%3D10.1038%2Fnchembio.1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span> </span><span class="NLM_article-title">Durable Tumor Regression in Genetically Altered Malignant Rhabdoid Tumors by Inhibition of Methyltransferase EZH2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">7922</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span><span class="refDoi"> DOI: 10.1073/pnas.1303800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1303800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=23620515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=7922-7927&author=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=T.+J.+Wigleauthor=C.+R.+Klausauthor=C.+J.+Allainauthor=A.+Raimondiauthor=M.+P.+Scottauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=V.+M.+Richonauthor=R.+M.+Pollockauthor=K.+W.+Kuntzauthor=H.+Keilhack&title=Durable+Tumor+Regression+in+Genetically+Altered+Malignant+Rhabdoid+Tumors+by+Inhibition+of+Methyltransferase+EZH2&doi=10.1073%2Fpnas.1303800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2</span></div><div class="casAuthors">Knutson, Sarah K.; Warholic, Natalie M.; Wigle, Tim J.; Klaus, Christine R.; Allain, Christina J.; Raimondi, Alejandra; Scott, Margaret Porter; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.; Richon, Victoria M.; Pollock, Roy M.; Kuntz, Kevin W.; Keilhack, Heike</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7922-7927, S7922/1-S7922/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid rhabdoid tumors.  This alteration is hypothesized to confer oncogenic dependency on EZH2 in these cancers.  The authors report the discovery of a potent, selective, and orally bioavailable small-mol. inhibitor of EZH2 enzymic activity, (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide).  The compd. induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.  Treatment of xenograft-bearing mice with (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide) leads to dose-dependent regression of MRTs with correlative diminution of intratumoral trimethylation levels of lysine 27 on histone H3, and prevention of tumor regrowth after dosing cessation.  These data demonstrate the dependency of SMARCB1 mutant MRTs on EZH2 enzymic activity and portend the utility of EZH2-targeted drugs for the treatment of these genetically defined cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRIJfPhwLA7Vg90H21EOLACvtfcHk0lieY4VlGKf4gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGrurw%253D&md5=c2c6470d48a13ab8343db0a09465ba42</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1303800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1303800110%26sid%3Dliteratum%253Aachs%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKeilhack%26aufirst%3DH.%26atitle%3DDurable%2520Tumor%2520Regression%2520in%2520Genetically%2520Altered%2520Malignant%2520Rhabdoid%2520Tumors%2520by%2520Inhibition%2520of%2520Methyltransferase%2520EZH2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D7922%26epage%3D7927%26doi%3D10.1073%2Fpnas.1303800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter-Scott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneeringer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span> </span><span class="NLM_article-title">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1556</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01501</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01501" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1556-1564&author=K.+W.+Kuntzauthor=J.+E.+Campbellauthor=H.+Keilhackauthor=R.+M.+Pollockauthor=S.+K.+Knutsonauthor=M.+Porter-Scottauthor=V.+M.+Richonauthor=C.+J.+Sneeringerauthor=T.+J.+Wigleauthor=C.+J.+Allainauthor=C.+R.+Majerauthor=M.+P.+Moyerauthor=R.+A.+Copelandauthor=R.+Chesworth&title=The+Importance+of+Being+Me%3A+Magic+Methyls%2C+Methyltransferase+Inhibitors%2C+and+the+Discovery+of+Tazemetostat&doi=10.1021%2Facs.jmedchem.5b01501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat</span></div><div class="casAuthors">Kuntz, Kevin W.; Campbell, John E.; Keilhack, Heike; Pollock, Roy M.; Knutson, Sarah K.; Porter-Scott, Margaret; Richon, Victoria M.; Sneeringer, Chris J.; Wigle, Tim J.; Allain, Christina J.; Majer, Christina R.; Moyer, Mikel P.; Copeland, Robert A.; Chesworth, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1556-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Posttranslational methylation of histones plays a crit. role in gene regulation.  Misregulation of histone methylation can lead to oncogenic transformation.  Enhancer of Zeste homolog 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers.  Tazemetostat, an EHZ2 inhibitor in clin. development, has shown activity in both preclin. models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors.  Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clin. development.  The importance of several Me groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryASbIgMDxAbVg90H21EOLACvtfcHk0lgoanhjxIW5yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotF2qsA%253D%253D&md5=a26ccc4a0109f57fbb64f7fded8965a1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01501%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DPollock%26aufirst%3DR.%2BM.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DPorter-Scott%26aufirst%3DM.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSneeringer%26aufirst%3DC.%2BJ.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DAllain%26aufirst%3DC.%2BJ.%26aulast%3DMajer%26aufirst%3DC.%2BR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DChesworth%26aufirst%3DR.%26atitle%3DThe%2520Importance%2520of%2520Being%2520Me%253A%2520Magic%2520Methyls%252C%2520Methyltransferase%2520Inhibitors%252C%2520and%2520the%2520Discovery%2520of%2520Tazemetostat%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1556%26epage%3D1564%26doi%3D10.1021%2Facs.jmedchem.5b01501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knutson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warholic, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigle, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoshima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust In Vivo Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00037</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=491-495&author=J.+E.+Campbellauthor=K.+W.+Kuntzauthor=S.+K.+Knutsonauthor=N.+M.+Warholicauthor=H.+Keilhackauthor=T.+J.+Wigleauthor=A.+Raimondiauthor=C.+R.+Klausauthor=N.+Riouxauthor=A.+Yokoiauthor=S.+Kawanoauthor=Y.+Minoshimaauthor=H.-W.+Choiauthor=M.+P.+Scottauthor=N.+J.+Watersauthor=J.+J.+Smithauthor=R.+Chesworthauthor=M.+P.+Moyerauthor=R.+A.+Copeland&title=EPZ011989%2C+A+Potent%2C+Orally-Available+EZH2+Inhibitor+with+Robust+In+Vivo+Activity&doi=10.1021%2Facsmedchemlett.5b00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity</span></div><div class="casAuthors">Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Porter Scott, Margaret; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications.  The ability of the scientific community to explore fully the spectrum of EZH2-assocd. pathobiol. has been hampered by the lack of in vivo-active tool compds. for this enzyme.  Here the authors report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties.  EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma.  Hence, this compd. represents a powerful tool for the expanded exploration of EZH2 activity in biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqfVfbr3kS67Vg90H21EOLACvtfcHk0lgoanhjxIW5yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslelsL8%253D&md5=21fa182b2474678f663459a9dc2878e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00037%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DKnutson%26aufirst%3DS.%2BK.%26aulast%3DWarholic%26aufirst%3DN.%2BM.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DWigle%26aufirst%3DT.%2BJ.%26aulast%3DRaimondi%26aufirst%3DA.%26aulast%3DKlaus%26aufirst%3DC.%2BR.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DYokoi%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DS.%26aulast%3DMinoshima%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.-W.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DWaters%26aufirst%3DN.%2BJ.%26aulast%3DSmith%26aufirst%3DJ.%2BJ.%26aulast%3DChesworth%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEPZ011989%252C%2520A%2520Potent%252C%2520Orally-Available%2520EZH2%2520Inhibitor%2520with%2520Robust%2520In%2520Vivo%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D491%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.5b00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherzer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machutta, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">Identification of Potent, Selective Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1021/ml3003346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1091-1096&author=S.+K.+Vermaauthor=X.+Tianauthor=L.+V.+LaFranceauthor=C.+Duquenneauthor=D.+P.+Suarezauthor=K.+A.+Newlanderauthor=S.+P.+Romerilauthor=J.+L.+Burgessauthor=S.+W.+Grantauthor=J.+A.+Brackleyauthor=A.+P.+Gravesauthor=D.+A.+Scherzerauthor=A.+Shuauthor=C.+Thompsonauthor=H.+M.+Ottauthor=G.+S.+Van+Allerauthor=C.+A.+Machuttaauthor=E.+Diazauthor=Y.+Jiangauthor=N.+W.+Johnsonauthor=S.+D.+Knightauthor=R.+G.+Krugerauthor=M.+T.+McCabeauthor=D.+Dhanakauthor=P.+J.+Tumminoauthor=C.+L.+Creasyauthor=W.+H.+Miller&title=Identification+of+Potent%2C+Selective+Cell-Active+Inhibitors+of+the+Histone+Lysine+Methyltransferase+EZH2&doi=10.1021%2Fml3003346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml3003346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003346%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DSuarez%26aufirst%3DD.%2BP.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DBrackley%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DScherzer%26aufirst%3DD.%2BA.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DMachutta%26aufirst%3DC.%2BA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DN.%2BW.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DIdentification%2520of%2520Potent%252C%2520Selective%2520Cell-Active%2520Inhibitors%2520of%2520the%2520Histone%2520Lysine%2520Methyltransferase%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1091%26epage%3D1096%26doi%3D10.1021%2Fml3003346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">McCabe, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganji, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Pietra, A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFrance, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquenne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasy, C. L.</span><span> </span><span class="NLM_article-title">EZH2 Inhibition as a Therapeutic Strategy for Lymphoma with EZH2-Aactivating Mutations</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">492</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fnature11606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=108-112&author=M.+T.+McCabeauthor=H.+M.+Ottauthor=G.+Ganjiauthor=S.+Korenchukauthor=C.+Thompsonauthor=G.+S.+Van+Allerauthor=Y.+Liuauthor=A.+P.+Gravesauthor=A.+Della+Pietraauthor=E.+Diazauthor=L.+V.+LaFranceauthor=M.+Mellingerauthor=C.+Duquenneauthor=X.+Tianauthor=R.+G.+Krugerauthor=C.+F.+McHughauthor=M.+Brandtauthor=W.+H.+Millerauthor=D.+Dhanakauthor=S.+K.+Vermaauthor=P.+J.+Tumminoauthor=C.+L.+Creasy&title=EZH2+Inhibition+as+a+Therapeutic+Strategy+for+Lymphoma+with+EZH2-Aactivating+Mutations&doi=10.1038%2Fnature11606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11606%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DM.%2BT.%26aulast%3DOtt%26aufirst%3DH.%2BM.%26aulast%3DGanji%26aufirst%3DG.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGraves%26aufirst%3DA.%2BP.%26aulast%3DDella%2BPietra%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DLaFrance%26aufirst%3DL.%2BV.%26aulast%3DMellinger%26aufirst%3DM.%26aulast%3DDuquenne%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DMcHugh%26aufirst%3DC.%2BF.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DVerma%26aufirst%3DS.%2BK.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCreasy%26aufirst%3DC.%2BL.%26atitle%3DEZH2%2520Inhibition%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Lymphoma%2520with%2520EZH2-Aactivating%2520Mutations%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D108%26epage%3D112%26doi%3D10.1038%2Fnature11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Konze, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNevin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuznetsova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattenden, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span><span class="refDoi"> DOI: 10.1021/cb400133j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400133j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1324-1334&author=K.+D.+Konzeauthor=A.+Maauthor=F.+Liauthor=D.+Barsyte-Lovejoyauthor=T.+Partonauthor=C.+J.+MacNevinauthor=F.+Liuauthor=C.+Gaoauthor=X.-P.+Huangauthor=E.+Kuznetsovaauthor=M.+Rougieauthor=A.+Jiangauthor=S.+G.+Pattendenauthor=J.+L.+Norrisauthor=L.+I.+Jamesauthor=B.+L.+Rothauthor=P.+J.+Brownauthor=S.+V.+Fryeauthor=C.+H.+Arrowsmithauthor=K.+M.+Hahnauthor=G.+G.+Wangauthor=M.+Vedadiauthor=J.+Jin&title=An+Orally+Bioavailable+Chemical+Probe+of+the+Lysine+Methyltransferases+EZH2+and+EZH1&doi=10.1021%2Fcb400133j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1</span></div><div class="casAuthors">Konze, Kyle D.; Ma, Anqi; Li, Fengling; Barsyte-Lovejoy, Dalia; Parton, Trevor; MacNevin, Christopher J.; Liu, Feng; Gao, Cen; Huang, Xi-Ping; Kuznetsova, Ekaterina; Rougie, Marie; Jiang, Alice; Pattenden, Samantha G.; Norris, Jacqueline L.; James, Lindsey I.; Roth, Bryan L.; Brown, Peter J.; Frye, Stephen V.; Arrowsmith, Cheryl H.; Hahn, Klaus M.; Wang, Gang Greg; Vedadi, Masoud; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1324-1334</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EZH2 or EZH1 is the catalytic subunit of the polycomb repressive complex 2 that catalyzes methylation of histone H3 lysine 27 (H3K27).  The trimethylation of H3K27 (H3K27me3) is a transcriptionally repressive post-translational modification.  Overexpression of EZH2 and hypertrimethylation of H3K27 have been implicated in a no. of cancers.  Several selective inhibitors of EZH2 have been reported recently.  Herein we disclose UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wild-type and mutant EZH2 as well as EZH1, a closely related H3K27 methyltransferase that shares 96% sequence identity with EZH2 in their resp. catalytic domains.  UNC1999 was highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM and non-competitive with the peptide substrate.  This inhibitor potently reduced H3K27me3 levels in cells and selectively killed diffused large B cell lymphoma cell lines harboring the EZH2Y641N mutant.  Importantly, UNC1999 was orally bioavailable in mice, making this inhibitor a valuable tool for investigating the role of EZH2 and EZH1 in chronic animal studies.  We also designed and synthesized UNC2400, a close analog of UNC1999 with potency >1,000-fold lower than that of UNC1999 as a neg. control for cell-based studies.  Finally, we created a biotin-tagged UNC1999 (UNC2399), which enriched EZH2 in pull-down studies, and a UNC1999-dye conjugate (UNC2239) for co-localization studies with EZH2 in live cells.  Taken together, these compds. represent a set of useful tools for the biomedical community to investigate the role of EZH2 and EZH1 in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzhUO0iAe8BbVg90H21EOLACvtfcHk0lhPoZFc4xQypA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gsrk%253D&md5=311d77f5f0cc0b9e2610d8d002a6709c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb400133j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400133j%26sid%3Dliteratum%253Aachs%26aulast%3DKonze%26aufirst%3DK.%2BD.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DParton%26aufirst%3DT.%26aulast%3DMacNevin%26aufirst%3DC.%2BJ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DKuznetsova%26aufirst%3DE.%26aulast%3DRougie%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DA.%26aulast%3DPattenden%26aufirst%3DS.%2BG.%26aulast%3DNorris%26aufirst%3DJ.%2BL.%26aulast%3DJames%26aufirst%3DL.%2BI.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DHahn%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DG.%2BG.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DAn%2520Orally%2520Bioavailable%2520Chemical%2520Probe%2520of%2520the%2520Lysine%2520Methyltransferases%2520EZH2%2520and%2520EZH1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1324%26epage%3D1334%26doi%3D10.1021%2Fcb400133j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardayfio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, E.</span><span> </span><span class="NLM_article-title">Selective Inhibition of EZH2 by a Small Molecule Inhibitor Blocks Tumor Cell Proliferation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">21360</span><span class="NLM_x">–</span> <span class="NLM_lpage">21365</span><span class="refDoi"> DOI: 10.1073/pnas.1210371110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1073%2Fpnas.1210371110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=21360-21365&author=W.+Qiauthor=H.+Chanauthor=L.+Tengauthor=L.+Liauthor=S.+Chuaiauthor=R.+Zhangauthor=J.+Zengauthor=M.+Liauthor=H.+Fanauthor=Y.+Linauthor=J.+Guauthor=O.+Ardayfioauthor=J.-H.+Zhangauthor=X.+Yanauthor=J.+Fangauthor=Y.+Miauthor=M.+Zhangauthor=T.+Zhouauthor=G.+Fengauthor=Z.+Chenauthor=G.+Liauthor=T.+Yangauthor=K.+Zhaoauthor=X.+Liuauthor=Z.+Yuauthor=C.+X.+Luauthor=P.+Atadjaauthor=E.+Li&title=Selective+Inhibition+of+EZH2+by+a+Small+Molecule+Inhibitor+Blocks+Tumor+Cell+Proliferation&doi=10.1073%2Fpnas.1210371110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1210371110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1210371110%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DTeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChuai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DArdayfio%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DC.%2BX.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DE.%26atitle%3DSelective%2520Inhibition%2520of%2520EZH2%2520by%2520a%2520Small%2520Molecule%2520Inhibitor%2520Blocks%2520Tumor%2520Cell%2520Proliferation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D21360%26epage%3D21365%26doi%3D10.1073%2Fpnas.1210371110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bradley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1475</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2014.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.chembiol.2014.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=25457180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1463-1475&author=W.+D.+Bradleyauthor=S.+Aroraauthor=J.+Busbyauthor=S.+Balasubramanianauthor=V.+Gehlingauthor=C.+G.+Nasveschukauthor=R.+G.+Vaswaniauthor=C.-C.+Yuanauthor=C.+Hattonauthor=F.+Zhaoauthor=K.+E.+Williamsonauthor=P.+Iyerauthor=J.+M%C3%A9ndezauthor=R.+Campbellauthor=N.+Cantoneauthor=S.+Garapaty-Raoauthor=J.+Audiaauthor=A.+S.+Cookauthor=L.+A.+Dakinauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=D.+L.+Danielsauthor=R.+T.+Cummingsauthor=B.+M.+Bryantauthor=E.+Normantauthor=P.+Trojer&title=EZH2+Inhibitor+Efficacy+in+Non-Hodgkin%E2%80%99s+Lymphoma+Does+Not+Require+Suppression+of+H3K27+Monomethylation&doi=10.1016%2Fj.chembiol.2014.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation</span></div><div class="casAuthors">Bradley, William D.; Arora, Shilpi; Busby, Jennifer; Balasubramanian, Srividya; Gehling, Victor S.; Nasveschuk, Christopher G.; Vaswani, Rishi G.; Yuan, Chih-Chi; Hatton, Charlie; Zhao, Feng; Williamson, Kaylyn E.; Iyer, Priyadarshini; Mendez, Jacqui; Campbell, Robert; Cantone, Nico; Garapaty-Rao, Shivani; Audia, James E.; Cook, Andrew S.; Dakin, Les A.; Albrecht, Brian K.; Harmange, Jean-Christophe; Daniels, Danette L.; Cummings, Richard T.; Bryant, Barbara M.; Normant, Emmanuel; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1463-1475</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone lysine methyltransferase (MT) Enhancer of Zeste Homolog 2 (EZH2) is considered an oncogenic driver in a subset of germinal center B-cell-like diffuse large B cell lymphoma (GCB-DLBCL) and follicular lymphoma due to the presence of recurrent, monoallelic mutations in the EZH2 catalytic domain.  These genomic data suggest that targeting the EZH2 MT activity is a valid therapeutic strategy for the treatment of lymphoma patients with EZH2 mutations.  Here we report the identification of highly potent and selective EZH2 small mol. inhibitors, their validation by a cellular thermal shift assay, application across a large cell panel representing various non-Hodgkin's lymphoma (NHL) subtypes, and their efficacy in EZH2 mutant-contg. GCB-DLBCL xenograft models.  Surprisingly, our EZH2 inhibitors selectively affect the turnover of trimethylated, but not monomethylated histone H3 lysine 27 at pharmacol. relevant doses.  Importantly, we find that these inhibitors are broadly efficacious also in NHL models with wild-type EZH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxrMoLW0OWCbVg90H21EOLACvtfcHk0ljj0OfYHV5aBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2nu7rE&md5=40b8f604e762dda9420afedede75fd36</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DW.%2BD.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DGehling%26aufirst%3DV.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DYuan%26aufirst%3DC.-C.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DWilliamson%26aufirst%3DK.%2BE.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DEZH2%2520Inhibitor%2520Efficacy%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%2520Does%2520Not%2520Require%2520Suppression%2520of%2520H3K27%2520Monomethylation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1463%26epage%3D1475%26doi%3D10.1016%2Fj.chembiol.2014.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery, Design, and Synthesis of Indole-Based EZH2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3649</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+Design%2C+and+Synthesis+of+Indole-Based+EZH2+Inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520Design%252C%2520and%2520Synthesis%2520of%2520Indole-Based%2520EZH2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C. P.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1021/ml400494b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400494b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=378-383&author=C.+G.+Nasveschukauthor=A.+Gagnonauthor=S.+Garapaty-Raoauthor=S.+Balasubramanianauthor=R.+Campbellauthor=C.+Leeauthor=F.+Zhaoauthor=L.+Bergeronauthor=R.+Cummingsauthor=P.+Trojerauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.-C.+P.+Harmange&title=Discovery+and+Optimization+of+Tetramethylpiperidinyl+Benzamides+as+Inhibitors+of+EZH2&doi=10.1021%2Fml400494b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2</span></div><div class="casAuthors">Nasveschuk, Christopher G.; Gagnon, Alexandre; Garapaty-Rao, Shivani; Balasubramanian, Srividya; Campbell, Robert; Lee, Christina; Zhao, Feng; Bergeron, Louise; Cummings, Richard; Trojer, Patrick; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">378-383</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification and development of a novel series of small mol. Enhancer of Zeste Homolog 2 (EZH2) inhibitors is described.  A concise and modular synthesis enabled the rapid development of structure-activity relationships, which led to the identification of I as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-T4S47cYnxrVg90H21EOLACvtfcHk0ljj0OfYHV5aBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjtw%253D%253D&md5=059381c9e416ee50fb37a8cf3ccef239</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fml400494b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400494b%26sid%3Dliteratum%253Aachs%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%2BP.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Tetramethylpiperidinyl%2520Benzamides%2520as%2520Inhibitors%2520of%2520EZH2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D378%26epage%3D383%26doi%3D10.1021%2Fml400494b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Garapaty-Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagnon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramanian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojer, P.</span><span> </span><span class="NLM_article-title">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1016%2Fj.chembiol.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=24183969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1329-1339&author=S.+Garapaty-Raoauthor=C.+Nasveschukauthor=A.+Gagnonauthor=E.+Y.+Chanauthor=P.+Sandyauthor=J.+Busbyauthor=S.+Balasubramanianauthor=R.+Campbellauthor=F.+Zhaoauthor=L.+Bergeronauthor=J.+E.+Audiaauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=R.+Cummingsauthor=P.+Trojer&title=Identification+of+EZH2+and+EZH1+Small+Molecule+Inhibitors+with+Selective+Impact+on+Diffuse+Large+B+Cell+Lymphoma+Cell+Growth&doi=10.1016%2Fj.chembiol.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth</span></div><div class="casAuthors">Garapaty-Rao, Shivani; Nasveschuk, Christopher; Gagnon, Alexandre; Chan, Eric Y.; Sandy, Peter; Busby, Jennifer; Balasubramanian, Srividya; Campbell, Robert; Zhao, Feng; Bergeron, Louise; Audia, James E.; Albrecht, Brian K.; Harmange, Jean-Christophe; Cummings, Richard; Trojer, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1329-1339</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The histone methyltransferase enhancer of Zeste homolog 2 (EZH2) is a candidate oncogene due to its prevalent overexpression in malignant diseases, including late stage prostate and breast cancers.  The dependency of cancer cells on EZH2 activity is also predicated by recurrent missense mutations residing in the catalytic domain of EZH2 that have been identified in subtypes of diffuse large B cell lymphoma, follicular lymphoma and melanoma.  Herein, we report the identification of a highly selective small mol. inhibitor series of EZH2 and EZH1.  These compds. inhibit wild-type and mutant versions of EZH2 with nanomolar potency, suppress global histone H3-lysine 27 methylation, affect gene expression, and cause selective proliferation defects.  These compds. represent a structurally distinct EZH2 inhibitor chemotype for the exploration of the role of Polycomb Repressive Complex 2-mediated H3K27 methylation in various biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwNGhFRO6LRbVg90H21EOLACvtfcHk0lhZ73G4ii3uWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWmtrrP&md5=6079ba01ae1f1964ac1d8108aa5e1227</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DGarapaty-Rao%26aufirst%3DS.%26aulast%3DNasveschuk%26aufirst%3DC.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DE.%2BY.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DBusby%26aufirst%3DJ.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DTrojer%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520EZH2%2520and%2520EZH1%2520Small%2520Molecule%2520Inhibitors%2520with%2520Selective%2520Impact%2520on%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%2520Cell%2520Growth%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1329%26epage%3D1339%26doi%3D10.1016%2Fj.chembiol.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Morgenthaler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Röder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span> </span><span class="NLM_article-title">Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-R%C3%B6derauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+M%C3%BCller&title=Predicting+and+Tuning+Physicochemical+Properties+in+Lead+Optimization%3A+Amine+Basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhZ73G4ii3uWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-R%25C3%25B6der%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520Tuning%2520Physicochemical%2520Properties%2520in%2520Lead%2520Optimization%253A%2520Amine%2520Basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wuitschik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span> </span><span class="NLM_article-title">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3227</span><span class="NLM_x">–</span> <span class="NLM_lpage">3246</span><span class="refDoi"> DOI: 10.1021/jm9018788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9018788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3227-3246&author=G.+Wuitschikauthor=E.+M.+Carreiraauthor=B.+Wagnerauthor=H.+Fischerauthor=I.+Parrillaauthor=F.+Schulerauthor=M.+Rogers-Evansauthor=K.+M%C3%BCller&title=Oxetanes+in+Drug+Discovery%3A+Structural+and+Synthetic+Insights&doi=10.1021%2Fjm9018788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Oxetanes in Drug Discovery: Structural and Synthetic Insights</span></div><div class="casAuthors">Wuitschik, Georg; Carreira, Erick M.; Wagner, Bjorn; Fischer, Holger; Parrilla, Isabelle; Schuler, Franz; Rogers-Evans, Mark; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3227-3246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of oxetanes as replacements for gem-di-Me or carbonyl groups and their effects on the aq. soly., lipophilicity, metabolic stability, and conformation for various compds. are studied; methods for the prepn. of a variety of substituted oxetanes are given.  The magnitude of changes in properties and in metabolic stability with oxetane substitution depends on the structural context; for example, substitution of a gem-di-Me group with an oxetane, aq. soly. may increase by a factor of 4 to more than 4000 while reducing the rate of metabolic degrdn. in most cases.  Incorporation of an oxetane into an aliph. chain increases in some cases the preference for synclinal conformations rather than antiplanar conformations of the chain.  Spirocyclic oxetanes such as an oxazaspiroheptane resemble commonly used fragments in drug discovery, such as morpholines, and in some cases increase aq. soly. more effectively than morpholines.  An improved chemoselective oxidn. of 3-oxetanol to 3-oxetanone is disclosed; olefination of 3-oxetanone by a variety of methods yields alkylideneoxetanes I [R = (EtO)2P(:O), OHC, O2N, EtO2C, NC, PhO2S, MeCO, 1-(4-chlorophenyl)-1-cyclobutanecarbonyl].  I (R = EtO2C, OHC, O2N) undergo addn. reactions with nucleophiles such as amines, carbonyl compds., and arylboronic acids to give oxetanes such as II.  The crystal structures of a variety of oxetanes are detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYbJqJGrlPJrVg90H21EOLACvtfcHk0ljHHK-f-_RWfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjt7s%253D&md5=e95742d38e933c2fb0d76d638ccc773c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm9018788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018788%26sid%3Dliteratum%253Aachs%26aulast%3DWuitschik%26aufirst%3DG.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DParrilla%26aufirst%3DI.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DOxetanes%2520in%2520Drug%2520Discovery%253A%2520Structural%2520and%2520Synthetic%2520Insights%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3227%26epage%3D3246%26doi%3D10.1021%2Fjm9018788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Justin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Marco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haire, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamblin, S. J.</span><span> </span><span class="NLM_article-title">Structural Basis of Oncogenic Histone H3K27M Inhibition of Human Polycomb Repressive Complex 2</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11316</span><span class="NLM_x">–</span> <span class="NLM_lpage">111326</span><span class="refDoi"> DOI: 10.1038/ncomms11316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fncomms11316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=27121947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11316-111326&author=N.+Justinauthor=Y.+Zhangauthor=C.+Tarriconeauthor=S.+R.+Martinauthor=S.+Chenauthor=E.+Underwoodauthor=V.+De+Marcoauthor=L.+F.+Haireauthor=P.+A.+Walkerauthor=D.+Reinbergauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Structural+Basis+of+Oncogenic+Histone+H3K27M+Inhibition+of+Human+Polycomb+Repressive+Complex+2&doi=10.1038%2Fncomms11316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2</span></div><div class="casAuthors">Justin, Neil; Zhang, Ying; Tarricone, Cataldo; Martin, Stephen R.; Chen, Shuyang; Underwood, Elizabeth; De Marco, Valeria; Haire, Lesley F.; Walker, Philip A.; Reinberg, Danny; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11316</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) silences gene expression through trimethylation of K27 of histone H3 (H3K27me3) via its catalytic SET domain.  A missense mutation in the substrate of PRC2, histone H3K27M, is assocd. with certain pediatric brain cancers and is linked to a global decrease of H3K27me3 in the affected cells thought to be mediated by inhibition of PRC2 activity.  We present here the crystal structure of human PRC2 in complex with the inhibitory H3K27M peptide bound to the active site of the SET domain, with the methionine residue located in the pocket that normally accommodates the target lysine residue.  The structure and binding studies suggest a mechanism for the oncogenic inhibition of H3K27M.  The structure also reveals how binding of repressive marks, like H3K27me3, to the EED subunit of the complex leads to enhancement of the catalytic efficiency of the SET domain and thus the propagation of this repressive histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIwqJGbneSdbVg90H21EOLACvtfcHk0ljHHK-f-_RWfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu78%253D&md5=516a8ef27712c9776e8ee0681cd91289</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fncomms11316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11316%26sid%3Dliteratum%253Aachs%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DDe%2BMarco%26aufirst%3DV.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DReinberg%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520Basis%2520of%2520Oncogenic%2520Histone%2520H3K27M%2520Inhibition%2520of%2520Human%2520Polycomb%2520Repressive%2520Complex%25202%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11316%26epage%3D111326%26doi%3D10.1038%2Fncomms11316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gibaja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harari, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz-Vash, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejtar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paris, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. M.</span><span> </span><span class="NLM_article-title">Development of secondary mutations in wild-type and mutant EZH2 alleles cooperate to confer resistance to EZH2 inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1038/onc.2015.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fonc.2015.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=558-566&author=V.+Gibajaauthor=F.+Shenauthor=J.+Harariauthor=J.+Kornauthor=D.+Ruddyauthor=V.+Saenz-Vashauthor=H.+Zhaiauthor=T.+Rejtarauthor=C.+G.+Parisauthor=Z.+Yuauthor=M.+Liraauthor=D.+Kingauthor=W.+Qiauthor=N.+Keenauthor=A.+Q.+Hassanauthor=H.+M.+Chan&title=Development+of+secondary+mutations+in+wild-type+and+mutant+EZH2+alleles+cooperate+to+confer+resistance+to+EZH2+inhibitors&doi=10.1038%2Fonc.2015.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.114%26sid%3Dliteratum%253Aachs%26aulast%3DGibaja%26aufirst%3DV.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DHarari%26aufirst%3DJ.%26aulast%3DKorn%26aufirst%3DJ.%26aulast%3DRuddy%26aufirst%3DD.%26aulast%3DSaenz-Vash%26aufirst%3DV.%26aulast%3DZhai%26aufirst%3DH.%26aulast%3DRejtar%26aufirst%3DT.%26aulast%3DParis%26aufirst%3DC.%2BG.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DLira%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DHassan%26aufirst%3DA.%2BQ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26atitle%3DDevelopment%2520of%2520secondary%2520mutations%2520in%2520wild-type%2520and%2520mutant%2520EZH2%2520alleles%2520cooperate%2520to%2520confer%2520resistance%2520to%2520EZH2%2520inhibitors%26jtitle%3DOncogene%26date%3D2016%26volume%3D35%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fonc.2015.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grable, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span> </span><span class="NLM_article-title">Polycomb Repressive Complex 2 Structure with Inhibitor Reveals a Mechanism of Activation and Drug Resistance</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">11384</span><span class="refDoi"> DOI: 10.1038/ncomms11384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1038%2Fncomms11384" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=27122193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11384&author=A.+Broounauthor=K.+S.+Gajiwalaauthor=Y.-L.+Dengauthor=W.+Liuauthor=B.+Bolanosauthor=P.+Binghamauthor=Y.-A.+Heauthor=W.+Diehlauthor=N.+Grableauthor=P.-P.+Kungauthor=S.+Suttonauthor=K.+A.+Maegleyauthor=X.+Yuauthor=A.+E.+Stewart&title=Polycomb+Repressive+Complex+2+Structure+with+Inhibitor+Reveals+a+Mechanism+of+Activation+and+Drug+Resistance&doi=10.1038%2Fncomms11384"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance</span></div><div class="casAuthors">Brooun, Alexei; Gajiwala, Ketan S.; Deng, Ya-Li; Liu, Wei; Bolanos, Ben; Bingham, Patrick; He, You-Ai; Diehl, Wade; Grable, Nicole; Kung, Pei-Pei; Sutton, Scott; Maegley, Karen A.; Yu, Xiu; Stewart, Al E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11384</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) mediates gene silencing through chromatin reorganization by methylation of histone H3 lysine 27 (H3K27).  Overexpression of the complex and point mutations in the individual subunits of PRC2 have been shown to contribute to tumorigenesis.  Several inhibitors of the PRC2 activity have shown efficacy in EZH2-mutated lymphomas and are currently in clin. development, although the mol. basis of inhibitor recognition remains unknown.  Here we report the crystal structures of the inhibitor-bound wild-type and Y641N PRC2.  The structures illuminate an important role played by a stretch of 17 residues in the N-terminal region of EZH2, we call the activation loop, in the stimulation of the enzyme activity, inhibitor recognition and the potential development of the mutation-mediated drug resistance.  The work presented here provides new avenues for the design and development of next-generation PRC2 inhibitors through establishment of a structure-based drug design platform.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXuWyWQoRoObVg90H21EOLACvtfcHk0ljHHK-f-_RWfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFeiu7w%253D&md5=15ded613fdc3cafe35bee914678ab65e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fncomms11384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11384%26sid%3Dliteratum%253Aachs%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.-A.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DGrable%26aufirst%3DN.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26atitle%3DPolycomb%2520Repressive%2520Complex%25202%2520Structure%2520with%2520Inhibitor%2520Reveals%2520a%2520Mechanism%2520of%2520Activation%2520and%2520Drug%2520Resistance%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11384%26doi%3D10.1038%2Fncomms11384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senisterra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83737</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;key=10.1371%2Fjournal.pone.0083737" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83737&author=H.+Wuauthor=H.+Zengauthor=A.+Dongauthor=F.+Liauthor=H.+Heauthor=G.+Senisterraauthor=A.+Seitovaauthor=S.+Duanauthor=P.+J.+Brownauthor=M.+Vedadiauthor=C.+H.+Arrowsmithauthor=M.+Schapira&title=Structure+of+the+Catalytic+Domain+of+EZH2+Reveals+Conformational+Plasticity+in+Cofactor+and+Substrate+Binding+Sites+and+Explains+Oncogenic+Mutations&doi=10.1371%2Fjournal.pone.0083737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083737%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DSenisterra%26aufirst%3DG.%26aulast%3DSeitova%26aufirst%3DA.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520EZH2%2520Reveals%2520Conformational%2520Plasticity%2520in%2520Cofactor%2520and%2520Substrate%2520Binding%2520Sites%2520and%2520Explains%2520Oncogenic%2520Mutations%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83737%26doi%3D10.1371%2Fjournal.pone.0083737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span> </span><span class="NLM_article-title">A Practical Synthesis of Indoles via a Pd-Catalyzed C–N Ring Formation</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4114</span><span class="NLM_x">–</span> <span class="NLM_lpage">4117</span><span class="refDoi"> DOI: 10.1021/ol5018118</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5018118" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=4114-4117&author=R.+G.+Vaswaniauthor=B.+K.+Albrechtauthor=J.+E.+Audiaauthor=A.+Coteauthor=L.+A.+Dakinauthor=M.+Duplessisauthor=V.+S.+Gehlingauthor=J.-C.+Harmangeauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=A.+M.+Taylor&title=A+Practical+Synthesis+of+Indoles+via+a+Pd-Catalyzed+C%E2%80%93N+Ring+Formation&doi=10.1021%2Fol5018118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol5018118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5018118%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DA%2520Practical%2520Synthesis%2520of%2520Indoles%2520via%2520a%2520Pd-Catalyzed%2520C%25E2%2580%2593N%2520Ring%2520Formation%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D4114%26epage%3D4117%26doi%3D10.1021%2Fol5018118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span>Chiral amine <b>15</b> was synthesized according to procedure outlined by <span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Cook, A. S.; Dakin, L. A.; Duplessis, M.; Gehling, V. S.; Harmange, J.-C.; Nasveschuk, C. G.; Vaswani, R. G.</span> PCT Int. Appl. WO 2013120104 A2, August 15, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chiral+amine+15+was+synthesized+according+to+procedure+outlined+by+Albrecht%2C+B.+K.%3B+Audia%2C+J.+E.%3B+Cook%2C+A.+S.%3B+Dakin%2C+L.+A.%3B+Duplessis%2C+M.%3B+Gehling%2C+V.+S.%3B+Harmange%2C+J.-C.%3B+Nasveschuk%2C+C.+G.%3B+Vaswani%2C+R.+G.+PCT+Int.+Appl.+WO+2013120104+A2%2C+August+15%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Chiral amine <b>15</b> was resolved according to the procedure outline by <span class="NLM_contrib-group">Mortimore, M.; Young, S. C.; Everitt, S. R. L.; Knegtel, R.; Pinder, J. L.; Rutherford, A. P.; Durrant, S.; Brenchley, G.; Charrier, J. D.; O’Donnell, M.</span> PCT Int. Appl. WO 2008079346 A1, July 3, 2008.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chiral+amine+15+was+resolved+according+to+the+procedure+outline+by+Mortimore%2C+M.%3B+Young%2C+S.+C.%3B+Everitt%2C+S.+R.+L.%3B+Knegtel%2C+R.%3B+Pinder%2C+J.+L.%3B+Rutherford%2C+A.+P.%3B+Durrant%2C+S.%3B+Brenchley%2C+G.%3B+Charrier%2C+J.+D.%3B+O%E2%80%99Donnell%2C+M.+PCT+Int.+Appl.+WO+2008079346+A1%2C+July+3%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMortimore%26aufirst%3DM." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">Supporting Information</a> section.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf" class="ext-link">Supporting Information</a> for further details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6','PDB','5LS6'); return false;">PDB: 5LS6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HYN','PDB','5HYN'); return false;">PDB: 5HYN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ7','PDB','5IJ7'); return false;">PDB: 5IJ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IJ8','PDB','5IJ8'); return false;">PDB: 5IJ8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01315">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85463"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01315">10.1021/acs.jmedchem.6b01315</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Co-crystal structure of inhibitor <b>10</b> bound to PRC2 available (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LS6">5LS6</a>); 100 g scale synthesis of inhibitor <b>13</b>; biochemical assay details; mechanism of action (moa) cell assay details, descriptions of KARPAS-422 efficacy and PK/PD experiments; methods for structural biology experiments (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and compound data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_001.pdf">jm6b01315_si_001.pdf (938.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01315/suppl_file/jm6b01315_si_002.csv">jm6b01315_si_002.csv (1.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-21%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01315%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01315" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998b652fd61252","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
